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Abstract
CD8+ T lymphocytes play a crucial role in controlling bacterial infections, as they
promote pathogen clearance. Recent studies emphasize that besides antigen (ag) dose
and inammatory cytokine milieu, the T cell receptor (TCR) stimulation contributes
to the programming of the CD8+ T cell response. This strongly suggests that the
initiation of a distinct developmental program, the nal magnitude, and the duration of
clonal expansion, as well as the timing of the onset of T cell contraction, are determined
by the TCR signaling strength. It is well known that weak TCR stimulation results
in a diminished magnitude of expansion and accelerates the onset of contraction, as it
favors the development of memory cells at the expense of eector cells. The interferon
regulatory factor 4 (IRF4) is a transcription factor (TF), which is upregulated in CD8+
T cells following TCR ligand interaction. Furthermore, the modulation of its expression
level is highly dependent on the TCR signaling strength, which initiated activation. The
IRF4 expression prole is tightly regulated, as it translates the TCR signaling strength
of the activating signal and transmits it into a proper transcriptional and developmental
program.
Results of the present study show that IRF4-decient CD8+ T cells become initially
activated and proliferate after strong TCR engagement. Nonetheless, in contrast to their
wild type (WT) counterparts, they display drastically impaired cytokine production and
decreased cytotoxic activity, as well as an altered dierentiation pattern. This study
provide unique evidence that the absence of IRF4 expression in CD8+ T cells leads to a
hasted termination of clonal expansion and a premature contraction, which was initiated
by the FAS -mediated cell death pathway. Furthermore, IRF4-decient CD8+ T cells
exposed phosphatidylserine on their cell surface and showed increased complement path-
way activation, both facilitate their recognition and uptake by phagocytes. The ndings
of this study strongly indicate that IRF4 deciency drives a molecular dierentiation
program that give rise to an early memory formation and results in a premature onset
of eector CD8+ T cell contraction, which is characterized by a lower nal magnitude
of proliferation and a drastically diminished frequency of ag-specifc CD8+ T cells al-
ready early after infection. IRF4 deciency mimics weak TCR engagement and in turn
transmits every TCR signal, independent of its actually anity and duration, into a
developmental program, which initiates a cell fate very similar to the fate of low anity
TCR activated WT CD8+ T cells.
Taken together, present results demonstrate that similar to the fate of low anity
TCR activated WT CD8+ T cells, IRF4-decient CD8+ T cells were prone to die early
during immune response, as they were more susceptible to cell death and phagocytosis.
This study extend previous knowledge of the central role of the IRF4 playing an essential
TF for the dierentiation and functionality of ag-specic eector CD8+ T cells after
primary infection. Moreover, these results additionally show that IRF4 is a key regulator
of the CD8+ T cell response, as it furthermore drastically inuences the magnitude and
kinetic of the eector response and dictates the onset of CD8+ T cell contraction via
the activation of several death and phagocytosis inducing pathways.
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Zusammenfassung
CD8+ T Lymphozyten spielen eine sehr wichtige Rolle bei der Bekämpfung bakterieller
Infektionen, da sie die Beseitigung von Pathogenen vermitteln. Aktuelle Studien be-
tonen, dass neben der Antigendosis und dem inammatorischen Zytokinmilieu, auch
die Stimulation durch den T Zell-Rezeptor (TZR) einen entscheidenden Einuss auf
die Programmierung der CD8+ T Zellenantwort hat. Das deutet stark darauf hin,
dass die Initialisierung eines bestimmten transkriptionellen Programms, die nale Gröÿe
der klonalen Expansion und das Einleiten der Kontraktionsphase durch die Stärke des
TZR-Signales bestimmt werden. Es ist bekannt, dass eine schwache TZR-Stimulation
zu einer verminderten Expansion führt und eine frühzeitige Kontraktionsphase vermit-
telt, da diese eine Entwicklung von Gedächtniszellen auf den Kosten der Eektorzellen
favorisiert. Die Expression des Interferon Regulatorischen Faktors 4 (IRF4) wird nach
TZR-Ligand-Interaktion in CD8+ T Zellen hochreguliert. Des weiteren ist das Expres-
sionslevel von IRF4 stark von der Signalstärke der TZR-Aktivierung abhängig. Die
Kinetik der IRF4 Expression übersetzt die Stärke des aktivierenden TZR-Signales und
sorgt für die Umsetzung in ein entsprechendes transkriptionelles und dierentielles Pro-
gramm.
In dieser Arbeit konnte gezeigt werden, dass IRF4-deziente CD8+ T Zellen nach
Stimulation mit einem starken TZR-Signal zwar zu Beginn aktiviert werden und eine
klonale Expansion initiiert wird, aber nichtsdestotrotz im Vergleich zu normalen CD8+
T Zellen eine stark verminderte Zytokinexpression und zytotoxische Aktivität zeigten,
sowie ein verändertes Dierenzierungsmuster aufwiesen. Es konnte zudem erstmals
gezeigt werden, dass die Dezienz von IRF4 in CD8+ T Zellen zu einem verfrühten
Abbruch der klonalen Expansion führt und zu einem vorzeitigen Beginn der Kontrak-
tionsphase, die durch den FAS-vermittelten Tod-induzierenden Signalweg initiiert wird.
Des weiteren präsentieren IRF4-deziente CD8+ T Zellen vermehrt Phosphatidylserine
an deren Oberäche und weisen eine erhöhte Aktivierung des Komplementsignalweges
auf, dies vermittelt deren Erkennung und Aufnahme durch Phagozyten. Diese Ergeb-
nisse weisen stark darauf hin, dass die fehlende Expression von IRF4 in CD8+ T Zellen
ein molekulares Dierenzierungsprogramm initiiert, welches zu einer Verkürzung der
Expansionsphase führt und eine verfrühte Kontraktionsphase der Eektorzellen auslöst.
Dies wiederum ist durch eine verminderte Proliferation und einer drastisch reduzierten
Anzahl von antigen-spezischen CD8+ T Zellen nach Infektion charakterisiert.
Zusammenfassend deuten die Ergebnisse dieser Arbeit stark darauf hin, dass durch
die fehlende Expression von IRF4 in CD8+ T Zellen, jedes Signal als ein schwaches
TZR-Signal übermittelt wird, unabhängig von der tatsächlichen Stärke des aktivieren-
den Signals. Das lässt wiederum darauf schlieÿen, dass IRF4-deziente CD8+ T Zellen
einem Schicksal unterliegen, dass dem von normalen CD8+ T Zellen, welche mit einem
schwachen TZR-Signal aktiviert wurden, sehr ähnelt. Beide CD8+ T Zell-Populationen
sind gegenüber Zelltod und Phagozytose anfälliger im Vergleich zu stark TZR-aktivierten
normalen CD8+ T Zellen. Diese Arbeit erweitert schon bekanntes Wissen, da die er-
stmals hier gezeigten Ergebnisse darauf schlieÿen lassen, dass IRF4 als Schlüsselreg-
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ulator der CD8+ T Lymphozyten vermittelten Immunantwort nach einer Infektion
agiert. Seine Expression beeinusst zusätzlich drastisch die Stärke und Kinetik der
Eektor-CD8+ T Zellanwort und diktiert den Beginn der Kontraktionsphase indem
es zu einer Aktivierung verschiedener Tod und Phagozytose induzierenden Signalwege
führt.
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Humans are exposed to a diverse range of bacteria, viruses, fungi, and parasites. If
these microorganisms enter the body, they need to be detected and eliminated. The
central task of the immune system is the protection of the body against all invading
pathogens. The immune system itself can be divided into the adaptive and innate
immune system, which both utilize dierent recognition components, mechanisms and
cells, complementing one another.
The adaptive immune system provides specic recognition of invading microorganisms
and their components, and additionally, immunological memory for life time. This
immune response is mediated by B and T cells with pathogen-specic adapter proteins in
the late phase of infection. The two major types of T lymphocytes are CD8+ cytotoxic
T cells and CD4+ helper T cells. Here, this study focuses on the adaptive immune
response mediated by CD8+ T lymphocytes after Listeria monocytogenes infection in
mice. Thereby, investigate the role of the transcription factor IRF4 on eector CD8+
T cell dierentiation and functionality. Additionally, its impact on the magnitude and
duration of the expansion and the onset of T cell contraction.
Chapter 1
CD8+ T cells
CD8+ T lymphocytes are very important mediators of the immune defense against intra-
cellular pathogens like viruses and bacteria. This cytotoxic T cell population expresses
the dimeric co-receptor CD8, which is composed of two CD8α, forming a homodimer
or made of one CD8α and one CD8β chain. CD8+ T cells recognize pathogenic pep-
tides presented by major histocompability complex (MHC) class I molecules on antigen
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presenting cells (APCs) [3]. Their major function is the killing of infected cells, the
production of cytokines and chemokines to activate other immune cells, and to initiate
anti-infectious mechanisms.
1.1 CD8+ T cell development
Lymphoid progenitors arise in the bone marrow and migrate via the blood into the
thymus where they undergo several dierentiation stages, as they respond to signals
in their micro-environment (Figure 1.1). Early committed T cells lack the expression
of the T cell receptor (TCR), they are not CD4+ nor CD8+ and termed therefore as
double-negative (DN) thymocytes. Double-negative thymocytes can be further subdi-
vided into four stages of dierentiation. With ongoing dierentiation processes, they
express a pre-TCR, which is composed of the non-rearranging pre-TCRα and TCRβ
chain. A transition from the DN to the double-positive (DP) stage occurs, leading
to a substantial cell proliferation of the CD4+ CD8+ thymocytes and a replacement
of the pre-TCR with a complete TCRαβ [243]. The rearrangement of the somatic
deoxyribonucleic acid (DNA) and random chain pairing of the two chains of the TCR
lead to an individual TCR locus in each T cell, ensuring their diversity [202]. The
TCRαβ expressing DP thymocytes have to undergo selective processes to generate a
receptor repertoire, to reduce the risk of autoreactivity and to keep cells alive [67]. The
DP thymocytes interact with cortical epithelial cells in the thymus that express high
density MHCclass I and class II molecules associated with self-peptides. The interac-
tion between the TCR with these self-peptide MHC ligands decides on the cell fate of
the thymocytes, as too strong signaling will result in apoptosis. When the interaction
between the TCRs and the presented self-peptides is too weak, the cells do not get
intracellular signals. Those signals are required to sustain viability and leading to cell
death by neglect. Only a small fraction of cells with an intermediate level of TCR sig-
naling will be positively selected and will undergo maturation [197]. Mature thymocytes
expressing TCRs that bind to self-peptide MHCclass I complexes become CD8+ T lym-
phocytes, whereas those that bind to self-peptides presented on MHCclass II molecules
become CD4+ T cells [62]. Both matured T cell subsets leave the thymus and travel to
peripheral lymphoid organs awaiting an encounter with antigen (ag).
T lymphocytes express dierent TCRs, which are specic against certain foreign
molecules. The TCR consists of multiple chains but it lacks an intracellular domain.
Therefore, the TCR is associated with CD3, which contains an intracellular signaling
domain [45]. The TCR and the CD3 subunit form a complex to assist the transmission
of the signal into the T cell. Thus, leading to activation induced proliferation and dif-
ferentiation [120]. The TCR/CD3 complex is made up of diverse chains. In detail, one
α and β or γ and δ chain, which are additional joined with two ε, two ζ and another δ
and γ chain.
1.2 CD8+ T cell activation and expansion
CD8+ T lymphocytes are very important mediators of the adaptive immunity against
certain viral and bacterial pathogens, as they contribute to resistance against intra-
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Figure 1.1: T lymphocyte development. Lymphoid progenitors arise in the bone
marrow and travel into the thymus where they undergo several dierentiation
stages. Early committed T cells lack the expression of the T cell receptor
(TCR), they are double-negative (DN) thymocytes and express with ongoing
dierentiation a pre-TCR. A transition from the DN to the double-positive
(DP) stage occurs, leading to a substantial cell proliferation and development
of TCRαβ surface expression. All thymocytes have to successfully undergo
TCR gene re-arrangements, positive and negative selection processes. Only a
small fraction of lymphocytes will undergo maturation. Mature thymocytes
that express TCRs that bind to self-peptide MHCclass I complexes become
CD8+ T lymphocytes, whereas those that bind to self-peptides presented on
MHCclass II molecules become CD4+ T cells. Both matured T cell subsets
leave the thymus and become peripheral naïve T lymphocytes. Figure is
adopted from Germain [63].
19
1 CD8+ T cells
cellular infections [24, 254]. Small pathogen-derived peptides are presented to CD8+
T lymphocytes on the surface of professional APCs by MHCclass I molecules. The lig-
ation of the peptide-MHC (pMHC) with the TCR lead to the priming and activation
of naïve CD8+ T cells [66, 174]. The strength of the TCR determines the choice of the
transcriptional and dierential program, which is initiated. The TCR signaling strength
is dependent on the magnitude and the duration of the signal, as well as on the number
of TCR molecules on the T cell surface [123, 187]. Moreover, the amount of peptide
MHCclass I complexes, the TCR anity and avidity inuence the development, dier-
entiation, and the formation of eector and memory CD8+ T cells [112, 264]. Recent
publications have demonstrated that the recruitment of low and high anity clones
lead to a broad TCR diversity of eector and memory cells [12, 41]. However, it has
been shown that strong TCR engagement or prolonged exposure to antigen resulted in
enhanced generation of eector cells [89, 235]. In contrast, although even very weak
TCR ligand interactions are sucient do induce initial proliferation and eector cell
formation, they preferentially trigger memory cell dierentiation [54].
Nevertheless, an ecient priming and activation of T lymphocytes requires 3 signals.
Besides the ag-specic stimulation of the TCR via pathogenic peptides presented on
MHCclass I molecules on professional APCs, two other signals are needed [151]. Sig-
nal 2 is presented by the engagement of co-stimulatory molecules, which can be provided
by the interaction of distinct surface molecules expressed by an APC with its respective
receptor on the T cell surface. Such co-stimulatory interactions occur for example be-
tween the B7 ligands (CD80 and CD86) on dendritic cells (DCs) with the CD28 receptor
on CD8+ T cells, and lead to the generation of Interleukin 2 (IL2) [147]. Reduced co-
signals lead to a lower magnitude of the CD8+ T cells response. Furthermore, as third
signal, the availability of cytokines like interferon (IFN), IL2 and IL12 play additionally
a major role for the tight regulation of the acquisition of cytotoxic functions [36, 204].
They also include IL1 and IL6, which have been shown to be required at dierent stages
of T cell dierentiation and to have distinct eects on the responsiveness to IL2 [194].
Dierent pro- and anti-inammatory cytokines work in opposition to promote terminal
eector or memory precursor formation [100]. It has been shown that in the absence of
specic cytokine signals the T cells fail to develop a full eector function, survive poorly,
and do not form a proper memory population [37].
1.3 Acquisition of cytotoxic functions by CD8+ T cells
Dierent eector mechanisms are initiated after priming of naïve CD8+ T cells to com-
bat an infection (Figure 1.2). One eector mechanism is the cytolysis of infected cells via
the pore-forming molecule perforin [102]. The membrane-bound perforin on cytotoxic
CD8+ T lymphocytes (CTLs) polymerizes and forms pores, which result in an inux of
small molecules, such as Ca2+ or induces osmotic stress, leading to colloid osmotic ly-
sis [244]. Ecient lysis by perforin is dependent on the contribution of granule enzymes,
both secreted by exocytosis and together inducing apoptosis of the target cell [231].
There exist various types of granzymes, such as granzymeA and B, stored within the
granular matrix of CTL lysosomes [53]. CD8+ T cells release cytotoxic granzymes in
the direction of the target cells, aligned along the immune synapse to avoid non-specic
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Figure 1.2: Cytotoxic CD8+ T cells acquire various eector functions. Cy-
totoxic eector CD8+ T cells become activated, as they recognize
pathogen-derived peptides bound to MHCclass I molecules. They express
the pore-forming molecule perforin and granzymes to lyse infected target
cells via cell-induced apoptosis. Furthermore, CTLs upregulation of FASL
(CD95L) molecule, which can lead to activation of the caspase cascade,
thereby initiating programmed cell death by aggregation of FAS (CD95)
on the target cells. Additionally, CTLs express dierent cytokines, like IL2
and TNF, to recruit and activate other cells of the immune system, such as
macrophages. Modied gure from Trapani and Smyth [231] is shown.
damage of surrounding cells. Pores formed by perforin into the membrane of the tar-
get cell allow the cytotoxic granzymes to enter infected cells. These serine proteases
cleave proteins inside the target cell, thereby shutting down the production of bacterial
or viral proteins [11]. Additional, granzymes induce fragmentation and degradation of
DNA at the internucleosomal level, resulting in apoptosis of target cells [79]. Although
granzymes and perforin mostly involved synergistically in cytolysis, granzymes are also
capable of crossing the plasma membrane and entering the target cells in the absence
of perforin [207].
Another killing feature of cytotoxic CD8+ T cells is mediated via the upregulation of
FASL (CD95L). This molecule can lead to an activation of the caspase cascade, thereby
initiating programmed cell death by aggregation of FAS (CD95) on the target cells [208].
The FAS-FASL interaction results in typical apoptosis of the target cells where cytoplas-
mic proteases are involved in the induction of programmed cell death [180].
Additionally, following ag-specic stimulation, CD8+ T lymphocytes produce several
cytokines and chemokines to orchestrate to full wingspread of the immune response.
Eector CD8+ T cells produce IFNγ and tumor necrosis factor (TNF) to recruit other
cells of the immune system like macrophages to the site of infection and inammation,
and additionally increases their anti-microbicidal activity [75].
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1.4 Dierentiation of CD8+ T cells
Naive CD8+ T lymphocytes circulate between the blood and secondary lymphoid organs
where they encounter their cognate antigen. The homing of immune cells to secondary
lymphoid organs is possible due to the expression of a dened set of homing recep-
tors, such as CD62L (L-selectin) and chemokine receptors like CCR7 (CC-chemokine
rezeptor 7). Eector T cells show decreased expression of lymph node homing receptors,
allowing them to circulate and home to non-lymphoid tissues, as they have to migrate
to the side of inamation and infection.
During the early phase of infection, CD8+ T cells upregulate activation markers, like
CD44 and CD11α (integrinα) but downregulate the naïve marker CD127 (interleuk-
in-7Rα) [203]. CD8+ T cells dierentiate into short-lived eector cells (SLEC) and
memory-precursor eector cells (MPEC). Both CTL subsets can be distinguished ac-
cording to their surface marker expression of KLRG1 (killer cell lectin-like receptorG1)
and CD127. SLEC express high levels of KLRG1 and low levels of CD127 [97]. Cells
of this cell subset are not able to establish memory after clearance of infection, as these
cells undergo contraction. In contrast, MPEC express low levels of KLRG1 and high
levels of CD127, CD27, and Bcl-2 (B cell lymphoma 2) [97, 101, 200]. MPEC have the
ability to survive and form long-term persistent memory. However, CD8+ T cells ex-
pressing nor CD127 neither KLRG1 are termed to be early eector cells (EEC), which
are meant to become SLEC or MPEC. Cells expressing both markers at the same time
are termed to be double-positive eector cells (DPEC) and can be detected after infec-
tion [169]. Besides that, another method to distinguish between eector and memory
CD8+ T cells is based on expression of CD27, KLRG1 and CD127 [217].
Environmental factors, such as cytokines like IL2 [253], IFNγ [251], type I IFN (IFNα
and IFNβ) [38, 116], and IL12 [111, 257] promote the generation of eector cells and
longevity, as well as the function of memory CD8+ T cells. IFNγ not only contributes
to the pathogen clearance through its activation of antimicrobial mechanisms, it also
plays a role in T cell homeostasis and might participate in the selection of the memory
pool by increasing the expression of self-MHC complexes [7]. IL2 promotes eects on
lymphocyte cell survival and proliferation. Furthermore, IL2 can directly regulate the
cytotoxicity of CD8+ T cells via direct impact on the perforin and granzyme gene
expression during primary activation of CD8+ T cells upon activation [94]. Like IL2,
also IL15 utilizes the common gamma (γc) and IL-2Rβ chain, has been shown to have
co-stimulatory features and to be crucial for maintaining CD8+ T cell homeostasis
and basal proliferation [64, 68, 133]. Additionally, IL4, IL7, IL9, and IL21 cytokines
use also the γc subunit for signaling playing a role in the survival and proliferation of
thymocytes [221, 238]. Taken together, all these dierent cytokines participate in the
immune response to intracellular bacteria and there are more or less capable to promote
anti-pathogenic resistance, are associated with phagocyte inux or support activation
and proliferation.
CD122, the IL-2Rβ chain, is a part of the IL-15R complex and is highly expressed
by memory CD8+ T cells. In the absence of CD4+ T cell help, CD8+ T cells express
lower CD122 and show declined numbers, as well reduced functionality. It has been
shown that the transcription factor (TF) T-box transcription factor, T-box21 (Tbet)
and eomesodermin (EOMES) are linked to the CD122 expression, a receptor that confers
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cellular responsiveness to IL15.
Dierent regulators, like T-bet and EOMES among others, were shown to be essential
key mediators for the cell fate decisions of CD8+ T cells [91, 97, 181]. Both transcription
factors, Tbet and EOMES control IFNγ expression and the generation of cytokine
producing CD8+ T cells, which additionally have acquired cytolytic functionality. They
have a partially redundant activity. Furthermore, Blimp-1 (B lymphocyte activator
protein 1) and Bcl-6 (B cell lymphoma 6) play a role for the balance between eector
and memory cell formation [88, 103].
Memory CD8+ T cells can be further divided into two subsets dependent on their
distinct phenotypic and functinal properties, as there is a cellular heterogeneity within
the pool of memory T cells. Based on the categorization made by Sallusto and col-
leagues [199], memory CD8+ T cells can be divided into TEM and TCM. TCM reside
in secondary lymphoid organs, as they highly express CD62L but do not express imme-
diately lytic functions. In contrast, TEM are mainly located in non-lymphoid tissues.
They do not express CD62L but they display certain eector functions and cytotoxic
functionality.
Several potential models exists to explain how the heterogeneous pool of memory cells
arise during the cause of infection [100]. Nevertheless, there are several controverse pub-
lications claiming dierent models to be true. It is well possible that multiple pathways
lead to the generation of a memory T cell pool where cells having distinct genotype,
potential, and functions.
1.5 Expansion, contraction, and memory phase
Upon initial antigen encounter, naive CD8+ T cells pass 3 dierent phases, namely
expansion, contraction, and memory phase, which is illustrated in Figure 1.3. CD8+
T cells bearing TCRs specic for several pathogen-derived antigens leave the naïve stage
and undergo clonal expansion, thereby increasing in numbers and dierentiating into
eector cells gaining a variety of eector functions [25]. The naïve CD8+ T lymphocyte
repertoire is comprised of small numbers of precursors ranging from 10 to 10.000 cells,
which are specic for a single antigen [15]. Therefore, if a naïve CD8+ T cell becomes
activated, it must undergo a massive proliferative expansion to reach a sucient number
of eector cells. Clonal expansion requires a high energy supply, which is achieved due
to an alteration of the metabolic program, characterized by a switch to aerobic glycolysis
and higher rates of biosynthesis [140].
The goal of the clonal expansion of ag-specic CD8+ T cells is to combat the invad-
ing pathogen eciently via their cytotoxic capacities, and to contribute to its clearance.
After the peak of proliferation concluding the expansion phase, most of the cells die
by apoptosis in a contraction phase, which often correlates with the clearance of acute
infection. CD8+ T cells then decline in numbers in all tissues to a memory level, where
just a small heterogeneous population be maintained at 5-10% of the initial numbers
and persisting for life [93]. The size of the memory population resulting due to the con-
traction phase is substantially bigger than the naïve precursor pool. Dierent memory
CD8+ T cell subsets arise from the contraction phase having dierent tissue homing,
self-renewal, and eector recall potentials. In case of reinfection, upon second antigen
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Figure 1.3: Graphic illustration of the CD8+ T cell development during acute
infection. Naïve CD8+ T cells undergo massive proliferation after en-
counter their cognate antigen and dierentiate into cytotoxic CD8+ T lym-
phocytes (CTLs). CTLs acquire cytolytic eector functions, which con-
tribute to pathogen clearance. After the peak of response, CTL decline
in numbers during the contraction phase due to apoptosis to a memory
level leading to long-live protection. Modied gure from Williams and Be-
van [252] is shown.
encounter, memory CD8+ T cells mobilize very rapid their eector functions [125] and
are less dependent on co-stimulatory signals, which are required for priming of naive
ag-specic T cells [89].
There are dierent mediators and signaling pathways that maintain the memory pool,
such mediators like antigen persistence [89, 157] and the activation of the TCR via MHC
or the inuence of various cytokines [228]. The cytokine milieu additionally shapes CD8+
T cell responses, as these environmental factors inuence the clonal expansion, eector
function acquisition, contraction phase, and memory formation. IL2 stimulation of
CD8+ T cells during their priming phase is critical for CD8+ T cell memory formation.
1.6 Dierent molecules, receptors, and death pathways
mediate contraction
T cell contraction is mediated via intrinsic and extrinsic pathways of apoptosis, includ-
ing caspase-dependent and -independent death programs, which initiate morphological,
biochemical, transcriptional, and metabolic changes [58]. CD8+ T cells cannot evade
apoptotic pathways if an engagement of death receptors and eat-me signals, cytokine
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derivation or inhibition of cytokine signaling occurs [43, 118, 144]. The intrinsic pathway
is mediated by the mitochondria and is tightly regulated via members of the Bcl-2 su-
perfamily [39]. The inammatory environment [97], as well as the engagement of death
receptors due to the expression pattern of pro- and anti-apoptotic molecules can trigger
apoptosis.
The balance between dierent molecules dictates whether eector T cells survive and
expand, or go into contraction as consequence of initiated apoptotic pathways. It is
challenging to detect apoptosis of cells, as rapid clearance of dying cells by phagocytes
takes place [8] and as it is dicult to dene the exact moment in which contraction
begins. T cell proliferation and cell death might occur simultaneously till one gain
the upper hand. Dying cells are quickly recognized and removed by phagocytes, like
macrophages, which can be either neighboring cells or cells especially recruited to the
sites where increased cell death occurs. Furthermore, the location of T cell contraction,
whether T cells preferentially die in lymphoid organs or in infected tissue, might vary
based on the infection model [148, 247].
Several inhibitory molecules have been linked to an impaired T cell function or an
exhausted T cell phenotype [250]. Some belong to the B7 family (CTLA4, PD-1) [28],
immunoglobulin family (Tim3, CD160, LAG3) or CD2/SLAM family (2B4) [26].
The death receptor-mediated pathway is triggered by certain mediators, which regu-
late apoptosis and lead to the activation of caspases, if the interplay of pro- and anti-
apoptotic molecules is in imbalance. Recent publications provided evidence that at the
onset of contraction, eector CD8+ T cells express lower levels of anti-apoptotic proteins
like Bcl-2 [126] but increase their co-expression of pro-apoptotic molecules like CD160,
PD-1, 2B4, CTLA4, BIM, and LAG3, all being associated with functional impairment
and disease progression [170, 171].
During the early stage of apoptosis, dying cells release nd-me signals or exposure
eat-me signals on their surfaces (Figure 1.4), which facilitate their recognition by recep-
tors expressed on professional phagocytes, such as macrophages, monocytes, dendritic
cells, and neutrophils [182, 191, 192]. Viable cells actively expose don't eat-me signals,
which deliver a negative engulfment signal to prevent their recognition and uptake by
phagocytes [50]. Don't eat-me signals, such as CD46 [51], CD47 [59], and CD31 [20] are
not longer expressed which further favor the uptake of those cells.
Additionally, apoptotic cells secret soluble factors acting as chemoattractant, which
in turn recruit monocytes and macrophages migrating to their proximity and lead to
phagocytic activation and cell clearance [193]. Just to mention some signaling molecules,
phosphatidylserine (PS) exposure on the outer surface of the cell membrane can be
detected by phagocytosing cells, removing all cells targeted with this early apoptotic
surface marker [145]. The regulated release of triphosphate nucleotides like ATP and
UTP [49] or shingosine 1-phosphate (S1P) [249], lipid lysophosphatidylcholine (LPC),
and the fractalkine CX3CL1 [232], or ICAM-3 [70] from early apoptotic cells attract
macrophages towards cells undergoing apoptosis and lead to cell clearance. Furthermore,
some molecules like fractalkine are shown to induce the production of bridging molecules
like milk fat globule EGF factor 8 (MFG-E8) and thereby upregulate the engulfment
machinery components and facilitates recognition [152]. PS binds with high anity to
the bridging molecule MFG-E8 on activated macrophages, which in turn promotes the
clearance of the apoptotic cell, as it enables the recognition by engulfment receptors [72].
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Figure 1.4: Release of nd-me signals and exposure of eat-me signals on the
apoptotic cell surface. Cells prone to death release several nd-me sig-
nals, such as nucleotides, lysophatidylcholine (LPC), shingosine 1-phosphate
(S1P), and fractalkine. Additionally, as apoptotic cells undergo programmed
cell death they expose a variety of eat-me signals on their surface, such as
phosphstidylserine (PS), complement activating molecules C1q and C3, al-
tered sugars and ICAM-3, among others. Molecules like GAS6 and MFG-E8
bridge the interaction between eat-me signals on target cells and the phago-
cytic receptors on phagocytes. Modied and merged gure from Ravichan-
dran [193] and Hochreiter-Huord and Ravichandran [82] is shown.
Another bridging molecule is Gas6, which also binds to PS and mediates the recognition
of the apoptotic cells by receptors on phagocytes [132].
Furthermore, antibodies and other mediators such as IgM, IgG, and SAP can act as
bridging molecules to induce apoptotic pathways or to facilitate binding of complement
components, like IgM facilitates C1q binding. Thus, leading to the activation of the
classical component pathway [172]. Taken together, the presentation of eat me signals
on the cell surface of an early apoptotic cell attract phagocytic cells, followed by a
rapidly engulfment, leading to digestion in phagocytic lysosomes, and cell death.
Extrinsic apoptotic pathways can be initiated by membrane bound receptors. Death
receptors like FAS (also known as CD95), TNFa receptor 1 (TNFR1) and TRAIL
(CD262/DR5) induce extrinsic apoptosis by binding to their respective ligand. TRAIL
death receptor expressed on T cells renders cells susceptible to caspase-8-mediated apop-
tosis. During the contraction phase, CD8+ T cells can express both FAS and FASL
molecules [237]. Via the interaction of FAS-FASL [161], CD8+ T cells can kill each
other to eliminate eector cells at the end of an immune response, when the immune
system combated the invading pathogens. Therefore, the FAS-FASL pathway oers
an additional lytic ability of CTL to control T cell proliferation by the initiation of
apoptosis-induced cell death (AICD). The surface molecule FAS (CD95 or APO-1) con-
sists of an intracellular death domain, which initiates signaling to death after ligand
binding [92], either lead directly to caspase-mediated death by the activation of the
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procaspase cascade or direct cells to necrosis [81, 240].
The complement system is composed of over 30 soluble and membrane bound proteins
generated primarily in second lymphoid tissue and the liver, which than circulate in
the blood and mediate distinct biochemical pathways involved in innate and adaptive
immune responses [30]. It includes additionally several pathway components, receptors
as well as certain regulators. The complement system can be activated by three dierent
pathways (Figure 1.5), namely the lectin, the classical, and the alternative pathway [156].
The activation of the lectin complement pathway through mannose-binding lectin
(MBL)- associated serine protease (MAPS) mediates mainly pathogen removal, as MBL
can recognize carbohydrates on microbial surfaces. Furthermore, it is able to interact
with nucleic acids and phospholipids, among others [223]. It has been shown that MBL
clusters in dying cell surfaces to trigger phagocytosis [219].
The major molecule of the classical pathway is the C1 component, which is composed
of C1q and the proteases C1r and C1s [57]. The protease C1s cleaves the C4 component
into C4a and C4b followed by the C4b deposition on the microbe or cell surface where
it triggers opsonization and leading further to the cleavage of C2 into Cs2 and C2b.
This pathway generates a common C3 convertase known as C4b2a [245]. The C3 com-
ponent also serves as central molecule for the alternative complement pathway being
spontaneous activated by hydrolysis of the internal C3 thioester bond [179]. Its cleav-
age result in the C3 convertase complex C3bBb creating an ecient cycle of C3 cleavage
and convertade assembly [74].
The activation of the C3 molecule is a shared step in all three pathways, which leads
to a terminal pathway with the generation of C3 and C5 convertase enzyme complexes.
Those complexes cleave C3 and C5 into the opsonins C3b and C5b and additional gen-
erate anaphylatoxins, namely C3a and C5a [196]. These very potent chemoattractants
and inammatory mediators play a crucial role in the complement cascade. In detail,
C3 convertase promotes the further cleavage of C3 into C3a and C3b. C3b remains
bound on the cell surface of the microorganism or the target cell forming a complex
namely C4b2a3b generated by the classical or lectin pathway or C3bBb3b complex when
the generation occurred via the alternative pathway. Nevertheless, both complexes are
known as C5 convertase, which promotes the cleavage of C5 into C5b and C5a [114].
C5b participates in the assembly of the MAC while the generated anaphylatoxins C3a
and C5a are released and signal through their cognate G-protein-couples receptors [52].
The generation of these key anaphylatoxin molecules after the activation of the complex
cascade initiates chemotaxis of phagocytic cells and induces strong pro-inammatory
signaling [210]. The deposition of the C5b molecule induces assembly of the other com-
plement proteins C6, C7, C8 and C9. This terminal pathway leads to the formation of
the lytic membrane attack complex initiating target lysis [155].
The main functions of the complement system are diverse. First, it promotes opsoniza-
tion and phagocytosis through the release of C3b and C5b peptides leading to direct
cell lysis. Second, the clearance of invaded microorganisms and deletion of apoptotic
cells through assembly of the membrane-attack complex (MAC) by C5-C9, and third to
trigger inammation through fragments of the complement cascade such as C3a, C4a,
and C5a.
Furthermore, the generation of chemotactic and inammatory peptides promote phago-
cytosis through their interaction with several complement receptors coupled to G-proteins
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Figure 1.5: The complement cascade. Activation of the complement cascade can
be induced via (1) the lectin pathway initiated via mannose-binding lectin
(MBL) to carbohydrates on target surfaces, (2) via the classical pathway
initiated by the C1 component, and (3) by the alternative pathway by hy-
drolysis of internal C3. All three pathways leading to the activation of C3
and C5 convertases and to the formation of anaphylatoxin C3a and C5a.
Additional, to the generation of C3b and C5b serving as opsonins. The C5b
deposition induces the assembly of the other complex proteins C6-C9, lead-
ing to the formation of the lytic membrane attack complex (MAC) initiating
target lysis. Modied gure from Józsi [98] and Murray et al. [160].
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mostly present on macrophages, namely CR1 (CD35), CR2 (CD21), C3a receptor (C3aR),
and C5a receptor (C5aR, also called CD88) having distinct but synergistic functions [134,
198, 236, 255]. For example, CD88 (also known as C5aR1) is expressed on myeloid, en-
dothelial and epithelial cells. C5ar1 binds the activated complement anaphylatoxin C5a
and triggers chemotaxis of phagocytosing cells and the release of pro-inammatory me-
diators. There are many regulators being involved in those complex processes, such as
CD46 being a co-factor for serum factor I inactivating C3b and C4b components, CD55
(also known as DAF) leading to dissociation of C3 convertase, CD59 inhibiting the MAC
formation or Serpin G1 inhibiting the C1 component of the classical pathway. Viable
cells express several complement regulators to inhibit the deposition of the complement
components such as C3 and C4, and the activation of the complement cascade.
Chapter 2
Listeria monocytogenes
In 1926, the gram-positive bacteria Listeria Monocytogenes (LM ) was rst described
in animals by Murrey and colleagues [159]. Three years later in 1929, the foodborne
pathogen was also described in humans [168]. This ubiquitous organism can be found in
diverse environments, such as soil but it also contaminates water, food products, and col-
onizes humans and animals. After ingestion of Listeria contaminated food, this bacteria
is able to cross several barriers inicting gastroenteritis via passing the intestinal barrier
and thereby invade the intestinal epithelium. It also crosses the blood-brain barrier
causing meningitis and encephalitis [71], as well as abortion in pregnant woman [128].
2.1 Pathogenesis
Listeria monocytogenes is a gram-positive, facultative intracellular rod-shaped bacterium
that is widely used as model system to investigate cell-mediated immunity against in-
tracellular pathogens [108]. The pathogenesis of this intracellular bacterium is based on
various virulence factors (Figure 2.1).
Following intravenous (i.v.) injection into mice, LM accumulates rapidly in the spleen
and liver, which serves as sites of infection and bacterial replication. The bacteria is
then phagocytosed by macrophages and neutrophils in these organs. Most of the bac-
teria are destroyed but some can escape from the phagosome into the cytoplasm of
the infected cell, thereby escaping the arm of the complement and their detection by
neutralizing antibodies [71]. This process is highly dependent on the secreted viru-
lence factor listeriolysin (LLO), a pore-forming toxin, which lyses the phagosomal mem-
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brane [60, 186], and two phospholipaseC enzymes (PlcA and PlcB) [212].
Additionally, several other virulence factors of LM are expressed, which are instrumen-
tal in invasion and intracellular replication of the bacterium. Bacterial surface proteins
such as internalin A and B enable the entry into non-phagocytic cells, such as hepa-
tocytes, epithelial and endothelial cells [18, 129]. Once in the cytoplasm, the bacteria
multiplies and initiate movement, as LM can polymerizes host-derived F-actin to spread
from cell to cell without leaving the intracellular space [34].
The bacterium starts its lifecycle again, once internalized by neighboring cells. The
escape from autophagy and its actin-based mobility within the cytosol is mediated by
the virulence factor actin-assembly-inducing protein (ActA) [211]. Both, LLO and ActA
play a critical role for the survival of LM in phagocytic cells, the dissemination within
tissue and the pathogenicity. The importance of many virulence factors has been shown
by the demonstration that mutant strains having a single or a combinatorial defect in
these factors, compared to wild type stain, are avirulent or attenuated in their capability
to induce systemic infection [69, 263].
2.2 Murine listeriosis model
Listeria monocytogenes infections in animal models have become a useful tool to inves-
tigate host-pathogen interaction, cell-mediated immune responses, mechanisms of bac-
terial clearance, and the subsequent acquisition of life-long protective immunity. The
murine model of systemic listeriosis, via an intravenous inoculation of LM into mice,
represents an adequate model system to investigate the pathophysiology of a complex
intracellular bacterial infection and to study the host defense mechanisms against in-
tracellular pathogens. Oral inoculation of LM into mice, which would be closer to the
natural root of infection through the gastrointestinal tract in humans, is not ecient as
only small numbers of LM cross the mouse intestinal barrier due to a mutation of the
murine E-cadherin [46]. The intravenous infection of mice provides a suitable infection
model resulting in a systemic listeriosis.
Some advantages, beside many others, are the possibility to generate LM with attenu-
ated pathology as this bacterium can easily genetically manipulated. Other advantages
are the alteration of the infection duration with antibiotic treatment and the knowledge
of T cell specic epitopes. Early studies of CD8+ T cell responses were hampered by
the lack of knowledge of specic CD8+ T cell epitopes. But nowadays, many dierent
CD8+ T cell specic natural and constructed epitopes are known, which are presented
either on H-2Kd or H-2Kb restricted MHCclass I molecules, making it possible to an-
alyze CD8+ T cell-mediated immune responses in mice from BALB/c or C57BL/6J
background, respectively [23, 233].
The rst MHCclass I restricted bacterial pathogen-derived epitopes recognized by
CD8+ T cells were the listeriolysin derived epitope LLO91-99 [177], and the hydro-
lase p60 derived epitope p60217-255 [175] in Balb/c mice. This study has focused on
the MHCclass I restricted CD8+ T cell response of mice with BL/6J background. Since
natural Listeria derived epitopes are mainly for H-2Kd mice, a recombinant Listeria
monocytogenes stains expressing Ovalbumin (OVA) or altered peptide ligands (APL) to
enable the detection of CD8+ T cells recognizing H-2Kb- class I restricted determinant
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Figure 2.1: The pathogeneses of the intracellular bacterium Listeria mono-
cytogenes (LM) is dependent on various virulence factors. Lis-
teria express bacterial surface proteins such as internalinA and B, which
enable the entry into non-phagocytic cells such as hepatocytes, epithelial
and endothelial cells. The secreted pore-forming toxin listeriolysin (LLO)
lyses the phagosomal membrane and two phospholipaseC enzymes (PlcA
and PlcB) enable the bacterium to escape from the autophagy. The actin-
based mobility within the cytosol is mediated by the virulence factor actin-
assembly-inducing protein (ActA). Therefore, LM is capable of spreading




derived from OVA, such as SIINFEKL (SI) or SIYNFEKL (Y3) and SIITFEKL (T4)
were used in this study, respectively. Additionally H-2Kb- peptide tetramer staining was
used to examine the generation, dierentiation and memory formation of OVA-specic
CD8+ T cells after systemic Listeria infection in H-2Kb mice.
2.3 Cell-mediated immune response against Listeria
A large variety of cytokines and a wide range of cell types are involved in the immune
response against Listeria monocytogenes (LM). Although, LM has evolved clever ways to
manipulate the host cell to its advantage and to escape dierent protective mechanisms
by the host cell via remarkable adaptation. Its presence within the cytosol can be
recognized by the immune system and induces a potent cell-mediated immune response.
The host response against LM is a complex interplay between innate and adaptive
immune elements. Several cytokines like IFNγ, IL2 and TNFα play a major role for a
proper immune response together with the cooperation of various cell types including
neutrophils, natural killer cells (NK), macrophages, and cytotoxic CD8+ and helper
CD4+ T lymphocytes [108].
The bacterium penetrates the epithelial cell membrane and disseminates in the blood
stream through the whole body and into the organs. During the early phase of infection,
T cell independent mechanisms cause remarkable reduction of bacterial numbers. Never-
theless, these mechanisms can not completely eliminate the pathogens. In the liver and
spleen, two of the main target organs of the bacteria, the pathogen is rapidly internalized
by splenic and hepatic macrophages. During the initial stage of infection, IFNγ and
TNFα secreting cells like NK and neutrophils play a crucial role in controlling bacterial
growth, especially in liver [32, 47]. The rapidly triggered innate immune response is es-
sential for the survival of the host [234]. As in liver, also in spleen, neutrophils together
with macrophages rapidly accumulate as rst line defense of the host [33]. Furthermore,
at the cell surface also toll-like receptors have been implicated in the recognition of LM
as they transmit signals to activate innate immune defenses [224].
After cellular invasion, bacteria escape from the double-membrane-bound vacuole,
gain access, and multiplies intracellular within the cytosol of the host cell. Therefore,
foreign peptides secreted by the bacterium are mostly processed by the endogenous
MHCclass I antigen processing pathway (Figure 2.2) and presented to CD8+ cytotoxic
T lymphocytes [178]. Due to this process, CD4+ T cells play a minor role for the
protective immunity [124] and CD8+ T cells are the most eective mediators of anti-
listerial immunity. Nevertheless, class II-restricted CD4+ T cells promote help for CD8+
T cells, among others, produce IL2 and IFNγ.
However, activated CD8+ T cells are involved in the primary response to Listeria, as
they produce a broad range of cytokines upon antigen encounter. CD8+ T cell responses
to LM reach peak frequencies after approximately 7 days after intravenous infection.
They are especially important for the protective immune response to secondary LM
infections as the protection is dependent on IFNγ production by CD8+ T cells. Secreted
cytokines, like IFNγ and TNFα, also produced by other cells, are very important for
the resistance of mice to this pathogen [22, 77]. Additionally, a pore-forming perforin
exclusively produced by cytotoxic CD8+ T cells, play thereby the major role in the T cell
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mediated resistance to LM together with the FAS-dependent cytolysis of the infected
cells. Once in the cytoplasm, the bacterium multiplies and polymerizes host-derived
F-actin, thereby initiating movement from cell to cell without leaving the intracellular
milieu. This is the reason why it has been shown that neither antibodies nor B cells
participate in the immunity against Listeria. Mainly, CD8+ T cells promote anti-listerial
resistance in naive mice and mediate clearance of this bacteria.
Figure 2.2: Pathogenic peptides secreted by Listeria monocytogenes are
mostly processed by the MHCclass I antigen processing pathway.
After cellular invasion, Listeria bacteria escape from the double-membrane-
bound vacuole and gain access to the cytosol of the host cell. Therefore,
foreign peptides secreted by the bacterium are mostly processed by the en-
dogenous MHCclass I antigen processing pathway. Pathogenic-derived pep-
tides are then presented on MHCclass I molecules to CD8+ T cells. Modied
gure from Pamer [176].
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Chapter 3
Interferon regulatory factor 4
The interferon regulatory factor 4 (IRF4) is a member of the interferon regulatory factor
(IRF) family comprising several transcription factors, rst described as downstream
regulators of interferon signaling. Unlike other family members, IRF4 is not induced by
interferon, but rather by antigen receptor engagement. IRF4 is a critical transcriptional
regulator for the development and functionality of the immune system, as its expression
is mainly restricted to several lymphoid and myeloid cell types. It can act either as
activator or repressor on its target genes, dependent on its interaction partner.
3.1 IRF4 is a member of the IRF family
The IRF family consists of 9 members (IRF1-IRF9) in mammals, sharing homologue
sequences but have distinct functions in several cell types. IRFs were rst described as
downstream regulators of interferon signaling but nowadays it has been shown that they
are also involved in cytokine signaling, cell growth regulation and homeostasis, and they
control the dierentiation and functionality of dierent immune cells [226]. Furthermore,
IRFs are key mediators against anti-viral responses.
The rst members of this family, IRF1 and IRF2, were found to bind to enhancer
elements in the promoter region of genes that encode for IFN [73, 154]. Because both
IRF family members bound to a common DNA motif namely IRF enhancer [227]. Later,
similar sequences were also detected in the promoters of genes that are regulated by IFNs,
this motif was then dened as interferon stimulatory response element (IRSE) [40].
Additional family members show sequence homology and all share a DNA binding
domain (DBD), which is localized in the rst 115 amino acids of the amino-terminal
region. It contains a helix-turn-helix motif, consisting of 5 tryptophan residues that
are each separated by 10-18 amino acids [73]. This motif recognizes a 5'-GAAA-3'
core sequence and mediates IRF binding to the ISRE. Furthermore, all IRF family
members, except IRF6, contain a carboxy (C)-terminal IRF-associated domain (IAD),
enabling heterodimerization between family members [150] and mediating heterodimeric
interactions with other transcription factors.
3.2 IRF4 and its structural features
The IRF4 is one member of the IRF family of transcription factors. It was rst investi-
gated by distinct research groups with dierent contexts and has therefore several names.
IRF4 is also called Pip as it is a PU.1 interaction partner [19, 48, 185], and LSIRF as
it is characterized as a lymphocyte specic IRF [146]. IRF4 was additionally named
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Figure 3.1: Domain structure of the transcription factor IRF4. IRF4 is composed
of a N-terminal DNA-binding domain (DBD; blue), which consists of ve
conserved tryptophan (W) residues that are each separated by 8-18 amino
acids. The IRF-association domain (IAD type 1; green) facilitates het-
ero-dimerization with other family members or co-regulators. The repressor
domain (orange) alters the function from activation to suppression and vice
versa of the IRF4 molecule dependent on its interaction partners. A nuclear
localization signal (red) enables IRF4 to not only reside in the cytoplasma,
it can translocate in the nucleus where it exerts its function through regu-
lation of its transcriptional target genes. Modied gure from Loho and
Mak [137].
interferon consensus sequence-binding (ICSAT) protein in adult T cell leukemia [260]
and MUM1 because of its role in oncogenesis of multiple myeloma [90]. Its expression
is restricted to cells of the adaptive immune system, like macrophages [143], T and
B cells [153]. In T cells, its expression can be initiated via TCR stimulation.
IRF4 is similar to IRF8, as they are highly homologous proteins, which can interact
with each other exercising transcriptional regulatory functions [209]. Both, IRF4 and
IRF8, unlike other family members, they do not activate the transcription of Type I
interferon genes or positively regulate interferon-induced gene expression, as they have
a weak anity to the 5'-GAAA-3' motif of the ISREs.
The IRF4 protein is composed of a single polypeptide chain [185] with a N-terminal
DBD and a C-terminal regulatory domain, composed of a nuclear-localization signal, a
C-terminal IAD type 1, and a repressor domain [127], shown in Figure 3.1.
The DBD of the IRF4 enables its binding on the DNA at the ISRE. Its DNA binding
specicity depends on its cell lineage-specic co-regulators. Many of this co-regulators
have been identied depending on the cellular context, such as PU.1 [185], BATF [135,
158], STAT3 [122], NFAT [195], and PGC-1a [117], among others. In CD8+ T lym-
phocytes, IRF4 binds to its co-regulator BATF and both form a complex binding to
a composite DNA element called AICE (AP-1-IRF composite element) in their target
genes [65].
Due to its IAD, IRF4 can form homodimers or heterodimers with IRF8 or other
family members. Furthermore, IRF4 can also form heterodimers with members of the
Ets family [105] or activator protein 1 (AP-1) family [65] of transcription factors. The
repressor domain facilitates an alteration of the function of an IRF molecule in the
presence of particular binding partners. Depending on its interacting partner, IRF4
serves as suppressor or activator. The nuclear-localization signal enables IRF4 to not
only reside in the cytoplasma, it additional can translocate in the nucleus. It exerts its
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Figure 3.2: IRF4 has pivotal functions in several immune cells. IRF4 plays a wide
variety of roles for the formation, dierentiation, and function in dierent
cells of the immune system, like dendritic cells (DCs), macrophages, B cells,
and T lymphocytes.
function through regulation of its transcriptional target genes.
3.3 IRF4 has pivotal functions in dierent immune cells
IRF4 plays a wide variety of roles for the formation, dierentiation and function in
dierent cells of the immune system, as shown in Figure 3.2. IRF4 is required for a
proper formation of germinal centers and plasma cell dierentiation to produce high
titers of ag-specic antibodies [113, 206]. It is together with BLIMP-1 (B lymphocyte-
induced maturation protein 1) the master regulator of class-switch recombination [5].
This TF promotes M2 polarization of macrophages [201], acts as negative regulator
of TLR (toll-like receptor) signaling, as it negatively regulates the production of pro-
inammatory cytokines [164]. IRF4 has been shown to be essential for dierent dentritic
cell (DC) subsets [225], especially for the development of CD8- CD11b+ DCs [200,
222]. It has critical functions within the T cell compartment, as IRF4 is essential for
T cell dierentiation and functionality [138]. IRF4 is important for the development of
various CD4+ T cell subsets like Th1, Th2 [230], Th9 [215], Th17 [21, 87], follicular
Th cells [17, 167], and regulatory T cells [35, 173]. IRF4 has additionally pivotal roles




Aim of the study
Interferon regulatory factor 4 is one of the key transcription factors, which have been
shown to be very fundamental for the development and functionality of several immune
cells, such as B cells, dendritic cells, macrophages, and several CD4+ T lymphocyte
subsets [21, 113, 139, 201, 216, 222, 225, 267]. However, it has remained an open question
whether IRF4 expression additionally plays an essential role for the dierentiation and
functionality of CD8+ eector T cells.
Hence, this current work aimed to investigate in detail the inuence of IRF4 on the
CD8+ T lymphocyte response regarding activation, dierentiation, and formation of a
functional anti-pathogenic eector CD8+ T cell population. Therefore, in this study
a new transgenic mouse model was used, where the IRF4 gene is exclusively excised
in mature peripheral CD8+ T cells, other cell types being not aected. To investigate
the role of IRF4 expression for the CD8+ T cell fate decision upon primary infection,
mainly the murine listeriosis model was used as infection system to study CD8+ T cell
responses.
Additionally and most important, this present study further wanted to examine in
detail whether IRF4 inuences the initiation, kinetic, and magnitude of the clonal CD8+
T cell expansion upon primary infection and its impact on the initiation of T cell con-









cell culture plates (48-, 24-well at bottom,
96- well round bottom)
Greiner/Costar
1ml cuvettes (PMMA) Carl Roth
reaction tubes (0.5, 1.5 and 2ml) Eppendorf
conical FALCON tubes (15ml, 50ml) Corning Life Sciences
cell strainer (40 µm, 70 µm) BDBioscience
sterile cell trics lter (30 µm) Partec
syringes and needles of dierent sizes BDBioscience
FACS tubes (5ml) with/without lid BDBioscience
FACS tubes (5ml) with lter (40 µm) lid BDBioscience
MACS LS-separation columns Miltenyi Biotec






Aria II cell sorter BDBioscience
ow cytometer LSR II BDBioscience
Casy® cell counter Innovartis
incubator innova co-170 NewNew Brunswick Scientic
pipettes Eppendorf




Vortexer Genie2 Scientic Industries
ow cytometer MACSQuant Miltenyi Biotec
Herasafe lamina ow Thermo Scientic
autoclave (Serie EC) Webco
incubator New Brunswick Scientic
Allegra X-15R centrifuge Beckman Coulter
Allegra X-22 centrifuge Beckman Coulter
centrifuge 5810R Eppendorf
photometer (UV-3100PC) VWR
midiMACS magnet Miltenyi Biotec
QuadroMACS TM Seperator Magnet Miltenyi Biotec
Magnetic MultiStand Miltenyi Biotec
Table 5.2: Laboratory equipment.
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5.3 Chemicals and reagents
CHEMICALS/REAGENTS COMPANY
ACK lysing buer Gibco
bovine serum albumin (BSA) PAA
brefeldinA Sigma Aldrich
brain heart infusion (BHI) Oxoid
brain heart infusion agar (BHI-agar) Oxoid
CD8α MicroBeads, mouse Miltenyi Biotech
CD90.1 MicroBeads, mouse Miltenyi Biotech
dimethyl sulfoxide (DMSO) Sigma Aldrich
erythrocyte lysis buer Qiagen
ethanol, absolute Roth
Easycoll Biochrom
fetal calf serum (FCS) Lonza
gelantine veronal buer Sigma Aldrich
ionomycin (Iono) Sigma Aldrich
isourane Abbott
isopropanol (2-Propanol) Roth
penicillin/ streptomycin (P/S) Biochrom
phorbol 12-myristate 13-actetate (PMA) Sigma Aldrich
phosphate buered saline (PBS) Gibco
RPMI 1640 + GlutaMAX-I










Table 5.3: Chemicals and reagents.
5.4 Media, buer and solutions
5.4.1 Media
Rosewell Park Memorial Institute (medium) (RPMI)
RPMI was purchased from Gibco in 500ml bottles. RPMI 1640 with GlutaMAX-I was
supplemented with heat inactivated fetal calf serum (FCS) (10%), β-ME (50 µM nal)
and a mixed solution (P/S) of penicillin (100U/ml nal) and streptomycin (100µg/ml
nal). Media were stored at 4 °C and pre-warmed in a 37 °C water bath before usage.
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Brain heart infusion (BHI)
For the solid BHI media, 9.25 g of the Oxoid brain heart infusion (CM1135) was dissolved
in 250ml dH2O and autoclaved (20min at 121 °C). The BHI media was stored at 4 °C
until usage.
brain heart infusion (BHI)-Agar
Brain heart infusion agar (Oxoid,#CM1136) was made by solving 23.5 g of brain heart
infusion agar in 500 g dH2O. The media was autoclaved (20min at 121 °C) and after
cooling down to 40-50 °C, 2ml streptomycin (stock 50mg/ml in dH2O, nal 200 µg/ml)
and 75 µl chloramphenicol (stock 50mg/ml in ethanol, nal 7.5 µg/ml) was added if
needed. Under sterile conditions, 12ml of the liquid BHI media was poured into cell
plates. After the agar cooled down and solidied, the plates were sterile packaged and
stored at 4 °C until usage.
5.4.2 Buer and solutions
FCS
Fetal calf serum (FCS) was purchased from Lonza and long-term stored at -20 °C. Before
usage, thawed serum was heat inactivated at 56 °C for 30minutes and aliquoted as
needed. Aliquots were additionally stored at -20 °C and re-warmed in a 37 °C water
bath before usage.
PBS
Phosphate buered saline was purchased from Gibco. The 10X phosphate buered
saline (PBS) solution was diluted with dH2O and the pH value was adjusted to 7.2
and autoclaved. PBS/BSA was made by adding 0.2% bovine serum albumin (BSA)
(PAA) into the PBS solution. All buers were stored at 4 °C and used ice-cold for cell
preparation.
dH2O
Demineralized water was made in house via TKA GenPore.
GVB
Gelantine veronal buer (GVB) was purchased from Sigma Aldrich containing CaCl2
and MgCl2, to study all three pathways of the complement cascade.
5.5 Antibodies
All antibodies, which were used in these experiments for immunouorescence staining,
are listed in Table 5.4. For optimal staining, all antibodies were titrated before usage.
Antibodies bound to dierent uorochromes were used to stain for cell linage markers,
cytokines, dierentiation status, and transcription factors of murine cells. For surface
staining and intracellular staining, cells were incubated in 100µl total antibody mixture,



























CD95 (FAS) BDBioscience Jo2
CD107a Biolegend 1D4B
CD127 Biolegend A7R34
CD152 (CTLA4) Biolegend UC10-4B9
CD160 Biolegend 7H1
CD178 (FASL) Biolegend MFL3
CD233 (LAG3) eBiosciences eBioC9B7W
CD244 (2B4) eBiosciences eBio244F4
CD279 (PD-1) Biolegend RMP1-30




















To identify, enrich or analyze antigen-specic CD8+ T cells by ow cytometry uorescent
tetramers of MHC I peptide complexes were used in this study. In detail, MHCclass I
H-2Kb tetramers loaded with the Ovalbumin peptide SIINFEKL, containing the Strep-
tag® anity tag and coupled to Strep-Tactin PE or APC, were used to label SIINFEKL-
specic CD8+ T cells after LM-OVA infection. All reagents are listed in Table 5.3.
CD8+ T cells of interest, which are specic for the SIINFEKL peptide expressed by
LM-OVA, were labeled based on their binding specicity of their cell surface receptors
for these particular MHC-peptide complexes and could be analyzed without altering the
qualitative and quantitative parameters of the cells due to restimulation or other in vitro
manipulation.
REAGENT MANUFUCTURER
Strep-Tactin PE IBA Lifescience (Cat#6-5000-005)
Strep-Tactin APC IBA Lifescience (Cat#6-5010-005)
MHCclass I H-2Kb tetramers
with SIINFEKL (Ovalbumin peptide)
IBA Lifescience (Cat#6-7015-005)
Table 5.5: Reagents for tetramer staining.
5.7 Kits
BDFixation and Permeabilization Kit
REAGENT MANUFACTURER
BDFACS Lysing solution (10X solution) BDBiosciences (Cat#349202)
BDFACS Perm solution 2 (10X solution) BDBiosciences (Cat#347692)
Table 5.6: Fixation and permeabilization buers (intracellular staining)
BDCytoFix/CytoPerm Kit
REAGENT MANUFACTURER
BDCytoFix/CytoPerm solution BDBiosciences (Cat#512090KZ)
BDPerm/Wash Buer (10X solution) BDBiosciences (Cat#5122091KZ)
Table 5.7: Fixation and permeabilization buers (BrdU staining).
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Dead cell apoptosis Kit
REAGENT MANUFACTURER
AnnexinV PE antibody Biolegend (cat#640908)
AnnexinV-Binding-Buer Biolegend (cat#422201)
cell staining buer Biolegend (cat#420201)
Table 5.8: Reagents of the dead cell apoptosis kit.
5.8 Stimulation of CD8+ T cells
Murine cells were stimulated either polyclonal with aCD3/aCD28 in culture or with
PMA/Iono for restimulation of ex vivo CD8+ T cells. All reagents, which were used for
short and long-term stimulation, are listed in the Table 5.9 below.
REAGENT MANUFACTURER CONCENTRATION
Brefeldin A Sigma Aldrich 5mg/ml in 70% ethanol
usage: 10µg/ml
PMA Sigma Aldrich 1mg/ml in ethanol
usage: 10 ng/ml nal














Table 5.9: Reagents for short and long-term stimulation of murine cells.
5.9 Live-dead discrimination
Dierent viability dyes were used to discriminate between live and dead cells in ow









Table 5.10: Live-dead discrimination reagents.
DAPI
4', 6-diamidino-2-phenylindole (DAPI) is a blue uorescent nucleic acid dye used for the
identication of cell cycle and in this study to distinguish between viable and dead cells,
as DAPI specically stains nucleic double stranded DNA (dsDNA) in dead cells, which
leads to an increased uorescence with approximately 20-fold.
PI
Fluorescent staining with propidium iodide (PI) was used to evaluate cell viability in ow
cytometry, as it stoichiometrically binds to nucleic acids. The cell membrane integrity
excludes PI from staining viable and apoptotic cells. Additionally, PI was used as
counterstaining in multicolor uorescent assays together with anti-AnnexinV antibody
staining, which is specic for cellular structures to distinguish between viable cells or
cells that are early or late in the apoptosis process. In this apoptosis assay, PI detects
phosphatidylserine (PS) on the cytoplasmic surface of the cell membrane and membrane
integrity.
Annexin V
In viable cells, PS is predominantly located along the cytosolic side of the plasma mem-
brane. The cell membrane integrity excludes viability dyes such as PI in healthy cells or
at early stages of apoptosis. Therefore, cells displaying only AnnexinV staining are in
the early stage of apoptosis, where the PS loses its asymmetric distribution and translo-
cates to the extracellular membrane, where it is detectable with uorochrome coupled
AnnexinV antibody. In the late stages of apoptosis, cells are stained with both, An-
nexinV antibody and PI, as AnnexinV can bind to the accessible PS because an uptake
of PI into the cell occurs.
LD-Red
Live-Dead Red Fluorescent Reactive Dye (LD-Red) was used to label dead cells before
xation. The reactivity of this xable viability dye is restricted to the cell-surface amines.
In viable cells, the dye can exclusively bind to extracellular amines resulting in a less
intensive uorescence. If cells having compromised membranes, the dye reacts with the
free amines both inta- and extra-cellular, yielding intense uorescent staining typically
greater than 50-fold. This procedure makes it possible to distinguish between viable
and dead cells also after xation and permeabilization of the cells to enable intracellular




Depending on the experimental setup, dierent reagents were used to monitor cell pro-
liferation. All reagents are listed in Table 5.11 and further details are described below.
PROLIFERATION DYE COMPANY STOCK FINAL CONC.
BrdU Sigma Aldrich 1mM in PBS 1 µM/ml
CFDA-SE Molecular Probes 5mM in DMSO 10 µm in PBS
Cell ProliferationDye
eFluor® 450
eBioscience 10mM in DMSO 20µM in PBS
Table 5.11: Proliferation dyes.
Bromdeoxyuridine
bromdeoxyuridine (BrdU) is an analog of the nucleoside thymidine, which is permanently
incorporated into replicating DNA of dividing cells during DNA synthesis. It allows
the identication of cells that were dividing during the period of BrdU exposure. For
in vivo administration, 1mg/ml BrdU was given in drinking sugar water from day 5
till day 8 after infection. A combination of BrdU with phenotypic markers allowed to
determine between proliferated and non-proliferated cells during the period of BrdU
administration. The cellular incorporation of BrdU was detected by anti-BrdU specic
antibodies following membrane permeabilization by ow cytometry.
Carboxyuorescein succinimidyl ester
carboxyuorescein diacetate succinimidyl ester (CFDA-SE) incorporate stably within
the cells via covalently binding to free amines. This permeable cell permanent dye
is converted into carboxyuorescein succinimidyl ester (CFSE), which is a uorescein-
based tracer for long-term cell labeling, both in vivo and in vitro. It is used to monitor
cell proliferation, as progressive halving of CFSE uorescence intensity within daughter
cells occurs following each cell division.
Cell Proliferation Dye eFluor® 450 staining
The Cell ProliferationDye eFluor® 450 (eBioscience, cat#65-0842) is used to monitor
cell proliferation over the long-term. This uorescent dye binds to amines on the surface
and inside the cell and, as the cell divides, the dye is distributed equally between the
daughter cells and thereby successive halving the uorescent dye with each cell division.
5.11 Cytokines
Recombinant murine cytokines, listed in Table 5.12 were used for culturing of murine
cells. Of interest, IL2 was used in dierent concentrations dependent on the experimental
setup. A nal IL2 concentration of 10 ng/ml equals 50U.
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CYTOKINE MANUFACTURER ORIGIN STOCK FINAL
IL2 Miltenyi Biotech rec. murine 10µg/ml 10 ng/ml
IL7 Miltenyi Biotech rec. murine 10µg/ml 10 ng/ml
IL12 Miltenyi Biotech rec. murine 10 µg/ml 10 ng/ml
IL15 Miltenyi Biotech rec. murine 10 µg/ml 10 ng/ml
Table 5.12: Cytokines used for cell culture experiments.
5.12 Listeria infection
For infection experiments, recombinant strains of Listeria monocytogenes expressing
dierent peptide ligands of ovalbumin were used to analyze CD8+ T cell responses
after bacterial infection. If not indicated otherwise, the recombinant Listeria strain N4
(LM-OVA or LM-OVAN4) was used. Bacteria belonging to this strain express the native
but high TCR anity OVA ligand SIINFEKL257-264(N4). Other recombinant bacteria
strains, which were used in this study, express altered peptide ligands (APL), which
dier in their stimulatory potency to activate OT1 cells, as they dier in their TCR
anity/avidity. In this study, a recombinant Listeria expressing OVA protein containing
the epitopes SIYNFEKL (Y3) or SIITFEKL (T4) were used. All recombinant Listeria
monocytogenes strains were kindly provided by Dietmar Zehn [264]. For both, primary
and secondary infection, independent of the Listeria strain which was used, mice were
infected with Listeria through the tail vein (i.v.) with 2000 CFU LM-OVA in 200 µl
PBS.
5.13 Mouse strains
C57BL/6J and CD45.1 congenic wild type mice and OT1 mice (on C57BL/6 back-
ground) were purchased from the Jackson Laboratory or Charles River Laboratories.
OT1 transgenic mice have MHCclass I-restricted, ovalbumin-specic, CD8+ T cells [110].
Those cells have a transgenic T cell receptor (TCR), which expresses the Vα2 and Vβ5
variable regions of the TCR [78]. OT1 cells can recognize ovalbumin residues 257-264
(SIINFEKL), as well as altered peptide ligands with lower anity, in the context of
H-2Kb. IRF4ox mice were kindly provided by Ulf Klein [113]. Ulf Klein and col-
logues generated a transgenic mouse strain carrying a lox-P-anked IRF4 allele. They
additionally placed a gene encoding for enhanced green uorescent protein (eGFP) in
an opposite orientation upstream of the IRF4 promoter region, leading to its expression
in IRF4-decient cells after CRE-mediated recombination.
The transgenic mice E8Icre (on C57BL/6 background) were kindly provided by Ichiro
Taniuchi. Those mice express CRE recombinase driven by a combination of the core
E8I enhancer and the CD8α promoter [141].
IRF4ox.E8Icremice (in this study termed as IRF4KOCD8 mice) with CD8+ T cells
lacking the transcription factor IRF4 were generated by crossing. Therefore, IRF4ox
(heterocygote) conditional mice with loxP-anked IRF4 alleles were crossed with E8Icre
transgenic mice, thereby initiating IRF4 deletion in the thymus in all CD8α expressing
T cells. E8Icre is specically expressed in CD8α+CD8β+ αβT cells and CD8αα+
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Figure 5.1: Generation of the conditional knockout mouse strain
IRF4ox.E8Icre. In these transgenic mice, only the mature periph-
eral CD8+ T lymphpcytes lack the expression of the transcription factor
IRF4.
CD8β- αβT cells and therefore IRF4ox.E8Icre mice lack IRF4 expression in peripheral
CD8+ T cells but not in other cells (Figure 5.1).
The OT1.IRF4ox.E8Icre mice (in this study termed as OT1.IRF4KOCD8) are
TCR transgenic mice, which have IRF4-decient CD8+ T cells with a specic TCR
recognizing ovalbumin derived epitopes, such as SIINFEKL (SI), were obtained by
cross-breeding of OT1 mice with IRF4ox.E8Icre mice.
All mice were bred and maintained in the research institute for Experimental Medicine
(FEM) at the Charité-Universitätsmedizin Berlin. All animal experiments were ap-
proved by the LAGeSo-Berlin (Landesamt für Gesundheit und Soziales) and were per-
formed in accordance with the German law for animal protection. All mice were used






6.1 Isolation and preparation of murine cells
All organs were dissected from sacriced mice, which were anesthetized with Isourane
before cervical dislocation. After disinfection of the fur, all desired organs and both
hind legs were explanted and stored in appropriate containers with PBS on ice or at
4 °C until further processing.
6.1.1 Extraction from spleen, lymph node and thymus
Single-cell suspension of either spleen (SP), thymus (THY) or lymph node (LN) were
obtained by meshing the organs through a 70µm cell strainer using a syringe plunger.
After a centrifugation step (500xg, 5min), the supernatant was aspirated and the cell
pellet was resuspended in 1ml ACK buer (Gibco) and incubated for 3minutes at room
temperature (RT) to lyse erythrocytes. After stopping the erythrocyte lysis reaction by
adding PBS/BSA, the cell preparation was nalized by an additional washing step with
PBS/BSA. Cell suspensions were stored at 4 °C until further usage.
6.1.2 Extraction from liver
In brief, murine livers (LI) (without gall bladder) were meshed through a 70µm cell
strainer using a syringe plunger to generate a single cell suspension in PBS. After cen-
trifugation (500xg, 5min), the cell pellet was resuspended in 5ml of 40% Easycoll
(Biochrom) diluted in RPMI and layered on 5ml 70% Easycoll solution. A gradient
centrifugation (580xg, 20min, acceleration 5, deceleration 0) without brake was per-
formed. After removing carefully the uppermost layer containing mostly hepatocytes,
the thin interface with the lymphocytes was harvested carefully and transferred into a
new tube. After washing the cells twice with PBS/BSA (500xg, 5min), the erythrocytes
were removed by a lysis reaction. Therefore, the cell pellet was resuspended in 1ml ACK
buer (Gibco) and after incubation of 3minutes at RT, an additional washing step with
PBS/BSA was performed to stop the lysis reaction. Cell suspensions were stored at 4 °C
until further usage.
6.1.3 Extraction from bone marrow
After sacricing mice, the bones of the hind extremities (tibia and femur) were collected
by removing all muscles and tissue. Bones were kept in PBS till the preparation pro-
cedure continued and stored at 4 °C or on ice. Using a syringe, the bone marrow (BM)
was ushed out of the bone and a single cell suspension was generated by passing the
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suspension through a 70µm cell strainer using the plunger of a syringe. To remove any
erythrocytes, the cell pellet was resuspended in 0.5ml ACK buer (Gibco) and after
incubation of 3minutes at RT, an additional wash step with PBS/BSA was performed
to stop the erythrocyte lysis reaction. Cell suspensions were stored at 4 °C until further
usage.
6.1.4 Extraction from blood
After warming the mouse prior with an infrared lamp, blood was drawn from the tail
vein and collected into a MiniCollect Tube K3EDTA (Greiner Bio-one). Erythrocytes
were lysed via erythrocyte lysing buer from Qiagen for 10 minutes at RT. Lysis reaction
was stopped by adding PBS/BSA. After centrifugation (500xg, 5min), the cell pellet
was washed another time with PBS/BSA and stored at 4 °C until further usage.
6.2 Enrichment of cells via magnetic beads
Manual cell separation with the column-based method of magnetic labelling was used
to enrich or purify CD8+ T cells from heterogeneous cell suspensions made of murine
secondary lymphoid organs. The basic principle of the magnetic-activated cell sort-
ing (MACS) cell separation technology (Miltenyi Biotech) is a magnetic-based cell sep-
aration. Therefore, desired cells that express specic antigens on their cell surface are
targeted with magnetic antibody-conjugated MicroBeads (Miltenyi Biotech). The cell
suspension with the labeled target cells is passed over a column, which is placed in a
magnetic eld. The column matrix composed of ferromagnetic spheres induces a high
magnetic gradient within the column, when it is placed in the magnetic eld. This
enables that non-labeled cells pass through while the magnetically labeled target cells
remain within the column. After rinsing to wash non-labeled cells away, the column is
removed out of the magnetic eld and the remaining target cells are eluated by ushing
the column. Positive selection was performed in these experiments, where the target cells
were magnetically labeled and the ow through with the unwanted cells was discarded.
Magnetic MicroBead- conjugated highly specic antibodies against CD8 (mouse CD8α
MicroBeads, Miltenyi Biotech) or CD90.1 (mouse CD90.1 MicroBeads, Miltenyi) were
used to purify or enrich CD8α or CD90.1 expressing T cells from lymphoid organ cell
suspensions, respectively. The separation took place according to the manufacturer's
protocol.
In detail, the cell suspension with the target cell population was incubated with Mi-
croBeads of the desired specicity for 15minutes at 4 °C, followed by adding PBS/BSA
and a centrifugation step (500xg, 5min). The cell pellet was resuspended in 2ml
PBS/BSA and the cell suspension was ltered with a 30µm lter and applied onto
an LS-column (Miltenyi Biotech) placed in the strong permanent magnetic eld of the
separator. The magnetic eld retains MicroBead-bound cells while non-labeled cells
ow through the column. After rinsing the column three times with 3ml PBS/BSA, it
was removed from the magnetic eld and the retained target cells were eluated in 4ml




6.3 T cell transfer
Wild type OT1 T cells express a transgenic TCR specic for the ovalbumin epitope
SIINFEKL in the context of H-2Kb. For T cell transfer experiments, WT OT1 cells were
compared to OT1 cells that lack the transcription factor IRF4. IRF4-decient OT1 cells
were generated by crossing wild type OT1 mice with IRF4ox.E8Icre resulting in the
generation of OT1.IRF4ox.E8Icre mice. Spleen and lymph node cells from donor mice
were puried using a positive CD8 purication kit from Miltenyi (6.2), according to
the manufacturer's instructions. Equal numbers (in all experiments, unless indicated
otherwise) of donor T cells were transferred i.v. into sex-matched C57BL/6J or CD45.1
wild type mice. Always, the volume of the inoculum was 200 µl. Transferred wild type
or IRF4-decient OT1 cells were distinguished from recipient CD8+ T cells via congenic
marker expression of CD90.1, CD90.2, CD45.1 and CD45.2.
6.4 Culturing and stimulation of T cells
Murine primary cells were generated, as described in Section 6.1, from lymphoid or-
gans of mice of the desired mouse strain. In vitro and ex vivo, cells were cultured
or stimulated in supplemented RPMI 1640 media (see Section 5.4.1 for details). De-
pending on the experimental setup, additionally to the FCS, β-ME, and antibiotics
penicillin/streptomycin (P/S), dierent cytokines (listed in Table 5.12) or stimulating
reagents (listed in Table 5.9). If FACS measurement was intended, the murine golgi-
inhibitor brefeldinA (Sigma Aldrich) was added into to culture or stimulation sample
and incubated for 4-6 hours at a nal concentration of 10µg/ml to enrich the amount of
intracellular cytokines and prevent internalization or secretion.
6.4.1 T cell culture
T cell cultures were done with naïve CD8+ T cells. Therefore, lymphoid organ cell
suspension were generated as described in Section 6.1.
After pre-enrichment of CD8 T cells via the MACS technology from Miltenyi Biotech
(Section 6.2) using magnetic MicroBead-conjugated antibodies against CD8 (mouse
CD8α MicroBeads, Miltenyi Biotech), cells were labeled with anti CD3, CD4, CD8,
CD44 and CD62L antibodies. Naïve CD8+ T cells (CD3+ CD4- CD8+ CD44- CD62L+)
were sorted using the Aria II sorter from BD. For some experiments, naïve CD8+ T cells
were labeled with CFDA-SE (Molecular Probes) or additionally incubated for a certain
time window with BrdU (Sigma Aldrich) to track proliferation (Section 5.10). For cul-
ture, cells were resuspended in RPMI media supplemented with FCS, β-Mercaptoethanol
and antibiotics (P/S) (Section 5.4.1). Polyclonal T cell stimulation was induced by cul-
turing the cells in a 96-well plate. The plate was coated with plate-bound 3µg/ml αCD3
(BDBioscience, clone 17A2) and 1µg/ml αCD28 (BDBioscience, clone 37.51) antibod-
ies. Those antibodies mimic the stimulation via TCR and co-stimulatory molecules,
respectively. This in turn leads to a strong T cell activation and proliferation of T cells
but is independent of the TCR specicity. The 96-well U-bottom plate (Greiner) was
coated with the antibodies in PBS for at least 2 hours at 37 °C and rinsed with PBS
before further usage. Additionally, cells were incubated in the absence or presence of
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dierent cytokines (as listed in Table 5.12), like murine recombinant IL2 or IL12 in their
indicated concentrations (see Table 5.12). From day 2 on, cells were resuspended and
transferred into bigger at-bottom well plates (48-, 24-, 12-well plate), depending on
their growth rate, and new media supplemented with cytokines was added as required.
From day 3 on, all cells, independent of the initial culture conditions, were cultured in
media containing IL2 (10 ng/ml) to enable viability and proliferation. At the end of a
culture after 3-7 days, cells were taken out of the wells and transferred into a FACS tube
by adding PBS to wash media and cytokines away. Afterwards cells were counted either
by CASY or MACSQuant (Section 6.8) and restimulated (Section 6.4.2) for further
analysis.
6.4.2 (Re-) stimulation of T cells
Polyclonal with PMA/Iono
Cell suspensions of the dierent organs were generated as described in Section 6.1. For
polyclonal short-term activation or re-activation cells were resuspended in supplemented
RPMI (Section 5.4.1), with the certainty that the maximum of the cell concentra-
tion with 2x106 cells/ml was not exceed. Restimulation was performed at 37 °C and
5%CO2 for 4-6 hours with 10 µg/ml PMA (Sigma Aldrich) and 1 µg/ml Ionomycin
(Sigma Aldrich) in a total volume of 1ml. Additionally, brefeldinA (10 µg/ml) was
added to enrich the amount of intracellular cytokines and prevent internalization or
secretion.
OVA-specic with SIINFEKL
In vitro stimulation of naive T cells or restimulation of in vivo primed T cells during
an LM-OVA infection were performed with the native N4 (SIINFEKL) peptide or with
altered peptide ligands, namely SIYNFEKL (Y3) or SIITFEKL (T4). All three class I
(Kb)-restricted peptide epitopes are presented by the MHCclass I molecule H-2Kb, but
having dierend TCR anity. For restimulation of in vivo primed CD8+ T cells, single-
cell suspensions of dierent organs (cell numbers can range from 1-2x106 cells/ml) were
generated, as described in Section 6.1. Cells were resuspended in supplemented RPMI
1640 media and cells were incubated for 6 hours with peptide and further analyzed via
ow cytometry. For stimulation experiments of transgenic CD8+ T cells expressing
an OVA-specic T cell receptor (OT1), naive cells were incubated with either N4, Y3,
or T4 peptide, all resulting in an activation but with dierent strength of the TCR
engagement.
6.5 Live-dead discrimination
Dierent methods were used to analyze cells while discriminating dead cells and debris
from viable cells.
DAPI and PI
To discriminate between viable and dead cells in non-xed samples, DAPI (0.4µM -




Annexin V and PI staining for apoptosis detection
Cells were resuspended at a concentration of 1x106 cells/ml. After the surface staining
(Section 6.7.1) was performed, cells were washed by centrifugation (500xg, 5min) in
cold Biolegend cell staining buer (Biolegend). Next, cells were resuspended in 50µl
AnnexinV Binding Buer (Biolegend). After adding 1µl uorochrome conjugated An-
nexinV PE antibody and 2.5 µl PI solution the cells were gently vortexed and incubated
for 15minutes at RT in the dark. Afterwards, 200µl AnnexinV Binding Buer was
added and the samples were analyzed on the ow cytometer.
LD-Red
Cells to be stained were washed by centrifugation (500xg, 5min) in PBS to remove
any protein contaminations. The cell pellet was resuspended in 100 µl PBS and 2µl of
LD-Red uorescent dye was added. After an incubation for 20minutes at 4 °C in the
dark, the cells were washed again with PBS by another centrifugation step and processed
further.
6.6 Proliferation dyes and reagents
BrdU
To label cells in vitro with 5-bromo-2'-deoxyuridine (BrdU), a nal concentration of
1 µM BrdU was added into the media to access proliferation of the CD8+ T cells during
culture with a density limited to 2x106 cells/ml. Cells from the same population and
culture conditions without BrdU treatment were used as a negative control to deter-
mine background staining levels of the anti-BrdU antibody. Before the whole staining
procedure, cells were washed in PBS and pelleted (500xg, 5min). After 10minutes sur-
face staining (Section 6.7.1), cells were washed by centrifugation (500xg, 5min) in PBS.
All centrifugation steps thereafter were performed at 500xg for 10minutes. Cells were
xed with BDCytox/Cytoperm solution for 20minutes at 4 °C and washed once with
1X Perm/Wash Buer (BDBiosciences). Thereafter, cells were incubated for 10minutes
on ice with 100 µl of Triton-X100 (0.01% in PBS/BSA) and then washed once with
1X Perm/Wash Buer. A re-xation followed via an additional incubation of the cell
pellet in 100 µl Cytox/Cytoperm solution for 5minutes at room temperature and one
additional washing step with 1XPerm/Wash Buer thereafter. Because a denaturation
of the nuclear DNA into single-stranded DNA form is necessary to allow antibodies to
bind to the incorporated BrdU, a DNAse treatment was performed. Therefore cells were
exposured to 30µg DNAse I (Sigma) for 1 hour at 37 °C. Next, incubation was stopped
by adding 1XPerm/Wash Buer and pelleting the cells. The cells were stained with
anti-BrdU antibody for 30minutes at 4 °C and afterwards washed by centrifugation in
1XPerm/Wash Buer before analysis via ow cytometry.
CFSE
Cells were washed two times with PBS (490xg, 5min) to remove protein contamination
and resuspended at a density of less than 5x107 cells/mL. CFDA (Molecular Probes,
5mM in DMSO) was pre-diluted to 10µM in PBS. The CFDA pre-dilution and the
single cell suspension were mixed in equal volumes and incubated for 10minutes at room
temperature. Afterwards, cells were washed two times with PBS/BSA and resuspended
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in medium to proceed further.
Cell ProliferationCell Proliferation Dye eFluor® 450
Cells were washed two times with PBS (490xg, 5min) to remove any protein contamina-
tion and afterwards resuspended in 1ml pre-warmed PBS. Note that the nal concentra-
tion of cells should not exceed 1x107 cells/mL. Cell Proliferation Dye eFluor® (10mM
in DMSO) was pre-diluted to 20 µM in PBS. The Cell ProliferationDye eFluorV450
pre-dilution and the single cell suspension were mixed with equal volumes by vortexing
and incubated for 20minutes at RT in the dark. The labeling was stopped by adding
4-5 volumes of cold PBS/BSA and incubated on ice for 5minutes. Afterwards, cells




Expression of surface molecules was veried by ag-specic uorescent-labeled antibody
staining. Before staining with antibodies, cells were washed once with PBS to remove
any protein contamination. Thereafter, cells were incubated for 15minutes at 4 °C
with the desired antibodies and afterwards washed with PBS/BSA to remove unbound
antibodies. Analysis was performed using FACS LSR II machine.
6.7.2 Intracellular staining
After surface staining the cells were xed and permeabilized with BDFixation Permeabi-
lization Kit. Therefore, cells were washed with PBS to remove any proteins. Afterwards,
the cell pellet was resuspended in 1ml BD Fixation Buer and incubated for 10minutes
at room temperature, which was followed by 490xg centrifugation for 10minutes. Super-
natant was aspirated and the cell pellet was resuspended in 0.5ml BDPermeabilization
Buer and incubated for another 10minutes at RT. Reaction was stopped by adding
PBS/BSA followed by analysis by ow cytrometry using FACS LSR II machine.
6.7.3 Tetramer staining
To analyze ag-specic CD8+ T cell responses after bacterial infection with the recom-
binant Listeria monocytogenes expressing OVA, MHCclass I tetramers were used to
exclusively label peptide-specic CD8+ T cells. The tetramer complexes consists of
four major histocompatibility complex (MHC) molecules loaded with a specic pep-
tide and bound to uorescently-labeled uorochromes. In the present experiments, the
MHCclass I H-2Kbtetramers were loaded with SIINFEKL, an ovalbumin peptide (IBA
Lifescience; Cat#6-7015-005). Peptide-loaded MHC molecules were combined with
Strep-Tactin PE (IBA Lifescience; Cat#6-5000-005) or Strep-Tactin APC (IBA Life-
science; Cat#6-5010-005). CD8+ T cells, which are specic for the respective peptide-
loaded MHC molecule, were stained and further labeled with antibodies for cell lineage,
functionality, and dierentiation pattern analysis. Tetramer staining was performed
prior surface and intracellular staining. For each tetramer staining reaction, 1-2x106 cells
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were incubated with peptide-MHC tetramers bound to uorochromes. Therefore, 0.8µl
MHC I-Strep H-2Kb molecules, containing the Strep-tag anity tag and loaded with the
Ovalbumin SIINFEKL, and 1 µl Strep-Tactin uorochrome (PE or APC) were added
to 3.7 µl PBS and incubated over night at 4 °C. Next day, this mixture was added
to 1-2x106 cells (in 45 µl PBS) of a lymphoid organ and mixed by pipetting up and
down. After an incubation of 45minutes at 4 °C in the dark, cells were washed by
adding 3-4ml PBS. After centrifugation at 500xg for 5minutes (4 °C), supernatant was
aspirated. Thereafter, cells were resuspended in 100 µl PBS and cell surface labeling
(Section 6.7.1) and intracellular staining (Section 6.7.2) were performed.
6.7.4 Complement staining
To analyze for complement deposition, splenocytes were prepared from organs like de-
scribed in Section 6.1.1. Prior staining, the cell pellet was washed once with gelantine
veronal buer (GVB) [SigmaAldrich] and centrifugated (500xg for 5minutes, at 4 °C)
and supernatant was discarded. Afterwards, the cell pellet was resuspended in GVB and
incubated for 1 hour at 37 °C thereafter, cells were washed with RPMI (500xg, 5 min,
4 °C) and complement staining was performed for 45 min and additional surface staining
for 15 min, both performed at 4 °C in RPMI. Cells were washed with RPMI to remove
unbound antibody and analysis was performed directly using MACSQuant analyzer.
6.8 Determination of cell numbers
Counting of cells was performed using the CASY cell counter from Innovartis or the
MACSQuant ow cytometer from Miltenyi Biotech. For both applications, an aliquot
of the cell suspension was added into an appropriate buer of dened volume. Abso-
lute cell counts were determined volumetrically and were automatically calculated as
events/volume for every sample. The cell number, which was determined in an aliquot,
was used to calculate the absolute cell number of the original sample.
CASY
The CASY cell counter (Innovartis) was used to determine cell concentration and via-
bility of cells in a single-cell suspension. This method is based on non-invasive electrical
current exclusion and pulse area analysis, which allows quantication of cell concen-
tration, determining the cell viability by excluding cell aggregations and debris. A cell
aliquot is added into a special electrolyte solution (CASYton from Roche). This mixture
is aspirated through a precision pore of dened geometry with a constant ow speed and
a pulse low voltage eld is applied. The electrolyte-lled measuring pore represents a
dened electrical resistance where the cells displace a quantity of electrolyte correspond-
ing to their volume. Living cells behave like an isolator as the electric current cannot
go through the cellular membrane and in contrast, can go through the broken cellular
membrane of dead cells, which are recorded by the size of their cell nucleus. Absolute
cell number is given as viable cells per ml.
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MACSQuant
The MACSQuant analyzer (Miltenyi Biotech) is a ow cytometer, which can combine
multisample and multiparameter analysis. Due to volumetric measurement one can
achieve simultaneous quantication of absolute target cell numbers. Because this ana-
lyzer is equipped with three lasers, two scatters and 8 uorescent channels, a multicolor
cell analysis is also possible. The absolute cell count of a sample was either based on the
size, granularity, and viability of the cells or based on the expression of surface markers,





Table 6.1: MACSQuant conguration details.
6.9 Flow cytometry and cell sorting
Flow Cytometry was used as a technique for counting, examining, and sorting of cells
suspended in a stream of uid. Light is used to illuminate the cells and a series of
sensors detect the dierent types of light that are refracted or emitted from the dierent
cells. Each will be assigned in its own channel. Every cell that passes through the ow
cytometer is detected and classied as a distinct single event. In most applications of
the ow cytometry the cell is sent to the waste after is exits the laser beam.
Flow Cytometry
In detail, a beam of a light with a single wavelength is directed onto a hydro-dynamically
focused stream of uid where cells are passed sequentially through a nozzle. At the
point where the stream of the uid passes through the light beam a series of dierent
detectors are aimed. One detector is in line with the light beam (forward scatter or
FSC) and several perpendicular to it (side scatter or SSC) and additionally a series of
uorescent detectors. Some of the laser light is scattered by the cells, which makes cell
counting possible and to distinguish cell size. The extent to which light scattering occurs
depends on the physical properties of the cell, meaning size and internal complexity. In
detail, forward-scattered light (FSC) is proportional to cell-surface area and correlates
with the cell volume or size. The side-scattered light (SSC) is proportional to cell
granularity or internal complexity, i.e. shape of the nucleus or the amount and type of
cytoplasmic granules. Using FSC and SSC, one can distinguish dierent cell subsets in
a heterogeneous population. Additionally, for doublet exclusion height can be selected
using FSC-H and FSC-A or by using a dump channel one can avoid false positive cells
by doublet exclusion. Cells are stained with uorochrome-conjugated antibodies that
bind specic to cell surface and intracellular molecules. Dierent antibodies with distinct
uorochromes can be used simultaneously to distinguish separate subpopulations of cells.
The laser beam excites the uorochromes and the emitted light, which is proportional
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to the antigen density, is measured via a series of detectors or by a photomultiplier
tube. The acquired data by the sensors is compiled and integrated to build a picture
of the sample. Each event will be plotted independently. Data are presented as one-
dimensional (single parameter) histograms or two-dimensional dot plots with logarithmic
axes, representing cells with uorescent values, where each cell is shown as a dot in
the plot. To dene the characteristics of a subset of cells, a numerical or graphical
boundary is set, namely gate. For analysis, individual cell data events are grouped into
discrete populations via a set region, dependent on the similarities in light scattering and
uorescence. When this set region is used to limit the cells, which are drawn in a plot,
is termed as 'gate'. Gating allows analysis of various parameters simultaneously across
several dierent scatter-plots and histograms. In the present experiments, samples were
acquired using the LSR II cytometer from BDBioscience to perform multi-parameter
detection of proteins and cellular status, such as proliferation, exhaustion or apoptosis
of single cells.
FACS
Fluorescence-activated cell sorting (FACS) is a specialized type of ow cytometry. Some
cytometers can not only analyze cells, they additionally can capture and collect the cells
of interest out of a heterogeneous uid mixture of cells according to their characteristics
(size and uorescence). First, the cells of interest are identied by setting a sort gate
around the target cell subpopulation on the data acquisition plot. Once the population
to be separated has been identied, only cells of interest are sorted out of the stream
and collected into a tube dependent on their size and morphology. As the cell passes
through the laser beam, the Sorter determines if this cell is a target cell according to the
pre-selected sort mode. Sorting of cells is accomplished by electrical charge. Therefore,
an electrical charge is applied on the cell within the uidic drop. The charged drop is
then deected by charged electrodes and thereby sorted into dierent collection tubes
or sent to the waste tube, which is dependent on the characteristics of the cell. In the
present experiments, after magnetic bead sorting to pre-enrich the cells of interest to
reduce both the number of cells that need to be sorted and the required sorting time,
cell sorting was carried out on a FACS Aria Cell Sorter (BDBiosciences).
For some experiments, naive CD8+ T cells or OT1 cells either from wild type or condi-
tional knock out mice were prepared by FACS sorting. Therefore, after pre-enrichment
of CD8+ T cells via MACS technology (Section 6.2) and uorescent surface staining
(Section 6.7.1) naive CD8+ T cells were sorted CD3+ CD4- CD8+ CD44- CD62L+
with the Aria Cell Sorter. The purity was always higher than 98%, checked as standard
practice after each cell sorting. Cells were washed in cold PBS via centrifugation at
500xg for 5min (4 °C) and resulting supernatant was discarded. Cell pellet was resus-
pended in the required volume and naive CD8+ T cells were transferred in 200 µl i.v.
per mouse.
For the described ex vivo experiments, after MACS pre-enrichment, initially trans-
ferred wild type and IRF4-decient OT1 cells were isolated via FACS Sorter according
to their congenic marker expression from infected spleens of recipient mice.
58
6.10 Infection model - Listeria monocytogenes
6.10 Infection model - Listeria monocytogenes
Recombinant Listeria monocytogenes expressing dierent ovalbumin derived ligands
were used to infect mice initially or one day after adoptive transfer of T cells. Mice
were infected intravenously (i.v.) with 2000 CFU Listeria, expressing either the ova
derived peptide N4, Y3 or T4, in PBS for primary and secondary infection. Mice were
sacriced at dierent time points to analyze the CD8+ T cell response in dierent organs
after bacterial infection.
6.10.1 Listeria infection
For infection, the bacterial stock was thawed and a small amount was directly added
into BHI liquid media (Section 5.4.1) and grown at 37 °C and 5% CO2 on a shaker.
The growth was observed by measuring the optical density at 600 nm (OD600) with a
spectrophotometer. After an incubation time of 3-4 hours, when the exponential growth
phase was achieved, bacteria were diluted as required in fresh PBS to 1x104 CFU/ml.
Next, mice were infected intravenously with 200µl containing 2000 CFU of LM-OVA. To
make injection into the tail vein feasible, the mice were warmed with an infrared lamp.
Actual CFU were calculated following infection by plating dilutions of the inoculum on
BHI agar plates, described in detail in Section 6.10.3. For quantication from bacterial
titers of homogenized organs, cell suspensions were diluted 1:10 in 1% TritonX-100 in
PBS and dilutions were plated on BHI agar plates with or without C/S. After 2 days
of incubation, grown colonies were counted and the initial concentration of the bacteria
solution was calculated.
6.10.2 Stock preparation
To keep virulence of the Listeria stock, in vivo passaging is necessary as continued in vitro
growth of the bacteria lead to a selection of less virulent organisms. For stock prepa-
ration, one C57BL/6J mouse was infected i.v. with 5000 CFU in 200µl PBS. After
2 days of infection, the mouse was sacriced and the spleen was harvested. After sin-
gle cell preparation (6.1) of the organ, 150µl of the cell suspension mixed 1:10 in 1%
TritonX-100 in PBS was spread out on a BHI agar plate with antibiotics (C/S) and
incubated for another 2 days at 37 °C. Following, 3 colonies were picked and separately
incubated in 0.5 ml BHI liquid media for 4 hours. Afterwards, 250 µl of each Listeria
culture was combined into a 50 ml Falcon tube containing 30ml BHI media. The mixed
culture was expanded until an OD600 of 0.3 was achieved. Then, 15ml of 50% Glycerol
(in BHI) was added, mixed well and 500 µl was aliquoted into cryovials. For long-term
storage of the bacteria, Listeria were kept at -80 °C.
6.10.3 Determination of bacterial load
The concentration of the bacteria solution was veried by counting the total number of
colony forming units, made by viable bacteria. Therefore, the bacteria solution to be
injected was further diluted and a certain amount of this solution was spread out with a
spatula on a BHI agar plate. The plate was incubated for 2 days at 37 °C in a humidied
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5% CO2 atmosphere. Grown single colonies were counted and initial concentration of
the bacteria solution was calculated.
6.11 LCMV infection
To examine whether IRF4 plays a dierent role for the CD8+ T cell response during
viral infection compared to bacterial infection with Listeria monocytogenes, addition-
ally lymphocytic choriomeningitis virus (LCMV) infections in mice were administered.
LCMV infections were conducted by injecting mice i.p. with 2x105 plaque forming unit
(PFU) of LCMV, Armstrong strain. Therefore, the stock was diluted in an appropriate
volume to generate an infection mix with 2x105 PFU within 200 µl PBS. The virus stock
was kindly provided by Dr. Sibel Dulanik.
6.12 Statistics
For in vivo experiments, each group contained 3-5 animals and the mean was calculated
out of at least two independent experiments. In the graphs are shown mean values plus
standard error of the mean (SEM). For in vitro experiments, the mean of at least two
independent experiments was calculated, each consisting of 2-3 values. If two groups
were analyzed, the statistical signicance of the experimental results was analyzed via
the paired Student's t test. Signicance was dened by a variation coecient of at least
*p<0.05, whereas **p<0.01, and ***p<0.001 were set as highly signicant. Graphs,




The interferon regulatory factor 4 has been shown to play a crucial role for the dieren-
tiation and function of several cell types of the immune system, such as B cells, CD4+
T lymphocytes, and macrophages, among others. Previous studies have further evalu-
ated that IRF4 expression correlates with T cell receptor signaling and its absence lead
to abnormal immune responses upon infection [146, 153, 259]. To examine in detail the
inuence of IRF4 on the CD8+ T lymphocyte responses regarding activation, dieren-
tiation, and formation of a functional anti-pathogenic eector CD8+ T cell population,
bacterial and viral infections were performed in a mouse model based on the Cre-Lox
recombination technology.
In this study, IRF4ox.E8Icre (IRF4KOCD8) mice and OT1.IRF4ox.E8Icre mice
with a transgenic TCR were used, both mouse strains have a conditional deletion of the
transcription factor IRF4 exclusively in mature CD8+ T cells, other cell types being
not eected. This mouse model oers many advantages compared to the other mouse
models, used in recent published studies on the role of IRF4 expression in the CD8+
T cell responses [86, 142, 162, 163, 166, 188, 262]. The present study further wanted to
investigate the impact of IRF4 expression on the quality, quantity, and kinetic of the
clonal expansion and its inuence on the initiation of contraction of the eector CD8+
T cells upon primary infection.
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Chapter 7
Special features of the
IRF4ox.E8Icre mice
To determine the role of IRF4 in the CD8+ T cell development in vivo, a transgenic
mouse strain carrying loxP-anked alleles of IRF4 (kindly provided by U. Klein [113])
was breed. These mice were crossed to mice expressing Cre recombinase, driven by the
E8Icre enhancer region and Cd8α promoter, in peripheral CD8+ T cells (kindly provided
by I. Taniuchi [76]). In IRF4ox.E8Icre mice (termed as IRF4KOCD8 mice in this study),
the Cre-mediated recombination of the loxP sites occurs in cells that normally express
Cd8α, and goes along with eGFP expression in those cells being decient for IRF4.
First, the expression of the transcription factor IRF4 in IRF4KOCD8 and wild type
(IRF4ox mice termed as WT) mice in CD4+ and CD8+ T lymphocyte subsets (Fig-
ure 7.1A/B) was analyzed. As expected, in IRF4KOCD8 mice only mature CD8+ T cells
lacked IRF4 expression tested on splenocytes at day 7 after LM-OVA infection, while
CD8+ T cells of WT mice expressed IRF4 up to over 60% (Figure 7.1C). In both, WT
and IRF4KOCD8 mice, the CD4+ T cell compartment and the CD3 negative compart-
ment were capable to express IRF4 after activation similarly (Figure 7.1B/C). Therefore,
in IRF4KOCD8 mice, only CD8+ T lymphocytes do not express IRF4 after activation,
while CD4+ T lymphocytes and other cell types were not aected from the IRF4 de-
ciency. The simultaneous activation of eGFP expression upon Cre-mediated recom-
bination was observed via ow cytometric analysis. The majority of peripheral CD8+
T cells of the IRF4KOCD8 mice was positive for eGFP expression (Figure 7.1D). In sum,
IRF4ox.E8Icre mice have a conditional deletion of IRF4 in CD8+ T cells, correlating
with simultaneous eGFP expression.
To determine whether there are any initial dierences between untreated wild type
and IRF4KOCD8 mice, the size of the CD4+ and CD8+ T cell compartment was ana-
lyzed. Furthermore, an examination of the dierentiation pattern of the CD8+ T cell
subset in dierent organs of untreated 6-8 weeks old mice was performed. A normal
ratio between CD4+ and CD8+ T cells was noted in IRF4KOCD8 mice with no dier-
ences in lymphocyte numbers and frequencies compared to age-matched wild type mice
(Figure 7.2). This was true for peripheral lymphocytes in blood (Figure 7.2C), as well
as in all the other organs (thymus, spleen, and lymph nodes) tested (Figure 7.3). CD4+
and CD8+ T cell compartments were normal, with no signicant dierences in CD8+
T cell subset distribution. In particular, in IRF4KOCD8 mice the majority of CD8+
T cells were in the naïve compartment, while the eector and memory compartment
were only small fractions, very similar to CD8+ T cells from WT mice (Figure 7.4B).
These results conrm that the initial generation of T lymphocytes is not altered in
IRF4KOCD8 (IRF4ox.E8Icre) mice.
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Figure 7.1: IRF4ox.E8Icre mice have a conditional deletion of IRF4 in
CD8+ T cells and simultaneously express eGFP. Immunouores-
cence analysis of IRF4 expression in splenocytes (gated on CD3+ T lym-
phocytes) on day 7 after LM-OVA infection in IRF4ox.E8Icre mice (termed
as IRF4KOCD8) and wild type mice (WT). (A) Exemplary dot plots of in-
tracellular expression of IRF4 in splenic CD8+ T cells of IRF4KOCD8 and
WT mice. (B) Histograms of IRF4 expression in CD4+ and CD8+ T cell
subsets gated on viable splenic CD3+ T lymphocytes and in the CD3 neg-
ative compartment of the indicated mouse strain. (C) Frequency of IRF4
expressing CD4+ (circles) and CD8+ (squares) T cells of WT (blue) and
IRF4KOCD8 (red) splenocytes. Each symbol represents an individual mouse.
Small horizontal lines indicate the average. (D) Representative histogram of
the eGFP expression on CD8+ T cells; blue lled line represents WT mice
and empty red line represents IRF4KOCD8 mice. IRF4ox mice were used
as WT controls. Data in graph (C) are representative of two independent
experiments with similar results. Each group containing 5 mice. ns indicates
statistically not signicant; ***p<0.0001 (Student's t test).
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Figure 7.2: The generation of T lymphocytes is not altered in IRF4ox.E8Icre
mice. Blood were taken from untreated 6-8weeks old wild type (WT) and
IRF4ox.E8Icre (termed as IRF4KOCD8) mice. Frequencies of T cell subsets
of the CD4+ and CD8+ compartment were analyzed. (A) Exemplary dot
plots with the gating strategy are shown. Viable CD3 expressing T lympho-
cytes were further divided into CD4+ and CD8+ T cells. (B) Exemplary
dot plots of the CD4+ and CD8+ T cells subsets in blood of the indicated
mouse strain. (C) Frequency of CD4+ (circles) and CD8+ (squares) T cells
pre-gated on CD3+ T lymphocytes in blood of 6-8 weeks old untreated mice
of the indicated phenotype. Results in (C) show the mean + SEM. IRF4ox
mice were used as WT controls. Data show no statistical signicance (Stu-
dent's t test). Data represents two independent experiments with 4 mice per
strain.
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Figure 7.3: Total numbers and organ distribution of T cell subsets are in
IRF4KOCD8 mice similar to WT mice. Spleen (SP), mesenteric lymph
nodes (LN), and thymus (THY) were taken from untreated 6-8weeks old
wild type (WT) and IRF4ox.E8Icre (termed as IRF4KOCD8) mice. Total
numbers per organ of the CD4+ and CD8+ T lymphocytes were analyzed.
(A) Total numbers of CD4+ and CD8+ T cells in the thymus (THY), spleen
(SP), and lymph nodes (LN) of untreated 6-8week old WT (IRF4ox mice)
and IRF4KOCD8 mice. Data represent two independent experiments with
8-9 mice per group.
IRF4-decient mouse models from previous publications showed a spontaneous al-
teration in the genotype and homeostasis of peripheral CD8+ T cells, an enlarged
B cell compartment, and disease patterns (lymphadenopathy) in old (12-14 week) un-
treated mice [153, 162]. Therefore, this present study analyzed whether old IRF4KOCD8
(IRF4ox.E8Icre) mice stay healthy with age. To do so, the present analysis checked
whether IRF4-decient CD8+ T cells maintain a wild type phenotype in 12-16weeks old
IRF4KOCD8 mice. Furthermore, the conditional KO mice were analyzed for abnormal
cell proliferation of the B cell compartment.
The frequencies of the CD4+ and CD8+ T cell compartment, as well as their dieren-
tiation pattern in dierent organs of untreated 12-16weeks old IRF4KOCD8 mice with
their aged matched wild type controls (Figure 7.4C) were compared. A normal ratio
between CD4+ and CD8+ T cells was noted in IRF4KOCD8 mice with no dierences
in lymphocyte numbers and frequencies. This was true for peripheral lymphocytes in
blood (BL), as well as in spleen (SP), and mesenteric lymph nodes (LN). The CD4+ and
CD8+ T cell compartment in old IRF4KOCD8 mice was comparable to young healthy
WT mice with no signicant dierences in CD8+ T cell subset distribution, as shown
in Figure 7.4D. In particular, in old IRF4KOCD8 mice the majority of IRF4-decient
CD8+ T cells exhibited a naïve phenotype, similar to their aged matched wild type
controls. As expected, the eector and memory compartment was rather small in both
untreated mice strains. Additionally, present results could not detect dierences in the
size of the B cell compartment comparing IRF4KOCD8 mice with their aged matched
counterparts (Figure 7.5).
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Figure 7.4: IRF4-decient CD8+ T cells share a wild type phenotype in un-
treated mice. Spleen (SP), mesenteric lymph nodes (LN), blood (BL), and
thymus (THY) were taken from untreated 6-8weeks old and 12-16weeks old
untreated wild type (WT) and IRF4ox.E8Icre (termed as IRF4KOCD8)
mice. Additionally, the dierentiation pattern of the CD8+ T cell subset
was analyzed on the basis of their surface marker expression. (A) Exemplary
dot plots of CD62L, CD44, KLRG1, and CD127 (IL7Ra) surface expression
on CD8+ T cells in blood of 6-8weeks old mice. (B) Percentage of naïve
(CD44low CD62L+, shown in circles), memory (CD44+ CD62L+ shown in
squares) and eector (CD44+ CD62L- shown in triangles) CD8+ T cell sub-
sets in blood of 8 weeks old WT and IRF4KOCD8 mice, as assed by ow
cytometry. Data show no statistical signicance (Student's t test). (C) Per-
centage of naïve (CD44low CD62L+), memory (CD44+ CD62L+), and eec-
tor (CD44+ CD62L-) CD8+ T cell subsets in THY, SP, and LN of 6-8weeks
old WT and IRF4KOCD8 mice. (D) Percentage of naïve (CD44low CD62L+),
memory (CD44+ CD62L+), and eector (CD44+ CD62L-) CD8+ T cell
subsets in spleen of 12-16weeks old WT and IRF4KOCD8 mice. Data are
representative of two independent experiments with similar results. Each
symbol in (B) and (D) represents an individual mouse and small horizontal
lines indicate the average. IRF4ox mice were used as WT controls. Data
show no statistical signicance. (Student's t test). Results in (C) show the
mean + SEM.
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Figure 7.5: IRF4ox.E8Icre mice show no altered B cell compartment. Spleen
(SP) were taken from untreated 12-16weeks old wild type (WT) and
IRF4ox.E8Icre (termed as IRF4KOCD8) mice. The size of the B cell subset
was analyzed on the basis of the CD19 and B220 cell surface expression on
B cells. (A) Percentage of splenic B cells (viable CD3- CD19+ B220+) of the
non-T lymphocytes of 12-16weeks old WT and IRF4KOCD8 mice. Data are
representative of two independent experiments with similar results. IRF4ox
mice were used as WT controls. Results in (A) show the mean + SEM. There
were no statistical signicant dierences determined (Student's t test).
In conclusion, no abnormal dierentiation or cell development could be detected ini-
tially in young or old IRF4ox.E8Icre (IRF4KOCD8) mice, which were used in this study.
IRF4-decient CD8+ T cells from this conditional knock out mice maintained a naive
phenotype and even with ongoing age, mice stayed healthy showing no disease patterns.
Chapter 8
The importance of IRF4 in eector
CD8+ T cells during infection
8.1 Induction of IRF4 expression
To examine the induction of the IRF4 expression after TCR engagement, stimulations
of naïve CD8+ T cells of wild type mice with anti-CD3 and the co-stimulatory molecule
anti-CD28 were performed. IRF4 was not expressed in naïve CD8+ T cells but its
expression was rapidly induced following activation after TCR signaling, examined via
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Figure 8.1: Naïve CD8+ T cells upregulate IRF4 expression after TCR en-
gagement. (A) CD8+ T cells from untreated wild type mice were rst
naïve sorted (viable CD3+ CD4- CD44- CD62+) and in vitro stimulated
with plate-bound aCD3/aCD28 antibody. IRF4 expression levels were de-
termined at the indicated time points of in vitro cultured cells by intracel-
lular staining via ow cytometry. Frequencies of IRF4 expression in CD8+
T cells are shown. Data are representative of two independent experiments
with similar results.
intracellular staining and further ow cytometric analysis. IRF4 expression peaked
between 24-36 hours after TCR stimulation and declined to lower levels for the following
days (Figure 8.1).
8.2 The importance of IRF4 for the eector CD8+ T cell
generation
IRF4 expression is upregulated in naive CD8+ T lymphocytes upon bacterial or vi-
ral infection after TCR-mediated activation of ag-specic cells. Therefore, this study
examined whether IRF4 has a role in regulating the eector CD8+ T cell generation
and thus the immunological response in vivo. WT (IRF4ox mice termed as WT) and
IRF4KOCD8 (IRF4ox.E8Icre) mice were infected with a recombinant strain of Listeria
monocytogenes expressing the ovalbumin-derived peptide SIINFEKL (N4), termed as
LM-OVA or LM-OVAN4. In Figure 8.2A, a schematic graph of the tetramer staining is
shown. A tetramer staining to identify H-2Kb-restricted cytotoxic CD8+ T cells specic
for ovalbumin (OVA) was used. Exemplary ow cytometry plots of ag-specic CD8+
T cells are shown in Figure 8.2B. At the peak of eector response on day 7 after in-
fection, the present analysis observed a signicant reduction of SIINFEKL (SI)-specic
CD8+ T cells (SITet+) in the spleen of IRF4KOCD8 mice (mean: 5,5%) compared to
WT mice (mean: 0.39%) (Figure 8.2C left). These dierences were drastic in frequen-
cies, as IRF4KOCD8 mice showed a 14-fold reduction in the percentage of SI-specic
CD8+ T cells compared to WT control mice. This dramatic reduction was further
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demonstrated in reduced total numbers of CD8+ T cells in IRF4KOCD8 mice compared
to WT mice.
Additionally, WT and IRF4KOCD8 mice were intraperitoneal (i.p.) infected with the
Armstrong strain of the lymphocytic choriomeningitis virus (LCMV). On day 8 after in-
fection being the peak of the T cell reaction, the resulting CD8+ T cell response to the
LCMV epitope GP33 (GP33Tet+) via tetramer staining was measured. As expected,
this analysis observed similar severely reduced levels of splenic ag-specic CD8+ T cells
in IRF4KOCD8 mice (mean: 5.5%) compared to WT control mice (mean: 1,3%) (Fig-
ure 8.2C right). Consistent with these results, at the peak of the CD8+ T cell response,
results shown in this study found that the total number of CD8+ T cells was dramat-
ically diminished within the spleen in IRF4KOCD8 mice after infection (Figure 8.2E),
where normally ag-specic CD8+ T cells should be enriched at that time point, like in
wild type mice.
To determine whether the drastically decrease of ag-specic CD8+ T cells in the
absence of IRF4 expression occurred already early after infection, SI-specic CD8+
T cells in WT and IRF4KOCD8 mice were examined via tetramer staining on day 5 after
LM-OVA infection. Not surprisingly, IRF4-decient SI-specic CD8+ T cells showed
drastically reduced frequencies (mean: 0.4%) on day 5 after infection (Figure 8.2), when
normally the clonal expansion phase of CD8+ T cells led to the generation of a robust
eector cell population with increasing numbers, as detected in WT mice (mean: 2.5%).
In summary, the dramatically reduced overall quantity of ag-specic eector CD8+
T cells after bacterial and viral infection observed in IRF4KOCD8 mice suggests a general
defect of IRF4-decient CD8+ T cells to develop a robust anti-pathogenic CD8+ T cell
response during infection. These results support the assumption that IRF4 expression
plays an essential role in the generation and maintenance of ag-specic CD8+ T cells
during an eector CD8+ T cell response upon primary infection.
During the primary CD8+ T cell response to acute bacterial or viral infection, naïve
lymphocytes dierentiate into eector CD8+ T cells. To generate a robust eector
cell population, primed CD8+ T cells need to proliferate after antigen encounter to
increase in numbers, not only in secondary lymphoid tissue, but also in the local sites
aected by the infection. To examine the reason for the reduced magnitude of the CD8+
T cell response in the absence of IRF4 expression, this study analyzed whether their
proliferative capacity was altered. Therefore, the total CD8+ T cell compartment and
the OVA-Kb-specic CD8+ T cell population of IRF4KOCD8 (IRF4ox.E8Icre) and WT
(IRF4ox termed as wild type) mice were analyzed. Because it was shown that Ki-67
antigen is present in all proliferating cells, we used Ki-67 as a representative proliferation
associated marker [61].
Wild type (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre) mice were intravenously
(i.v.) infected with LM-OVA. The intracellular expression of Ki-67 within the CD8+
T cell compartment was analyzed at dierent time points upon bacterial infection. Seven
days after Listeria infection, markedly reduced frequencies of Ki-67+ CD44+ cells among
SI-specic CD8+ T cells in IRF4KOCD8 mice compared to WT mice were observed, ana-
lyzing the secondary lymphoid organ spleen (Figure 8.3A) with up to 4.5 -fold reduction
and liver as a target organ of Listeria infection with up to 2 -fold reduction (Figure 8.3B).
Additionally, an acquisition of the proliferative capacity of the CD8+ T cell com-
partment on day 5 after Listeria infection was performed. Comparing the total CD8+
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Figure 8.2: IRF4 is required for the generation of antigen-specic CD8+ T cell
after bacterial and viral infection. (A) Schematic graph of the ex-
perimental setup. IRF4KOCD8 mice (IRF4ox.E8Icre mice) having IRF4-
decient CD8+ T cells or wild type (IRF4ox mice termed as WT mice)
having IRF4-sucient CD8+ T cells were infected with Listeria monocyto-
genes expressing ovalbumin (LM-OVA) or with the Armstrong strain of the
lymphocytic choriomeningitis virus (LCMV). Antigen-specic CD8+ T cells
were identied via tetramer staining at the peak of the CD8+ T cell re-
sponse. (B) Exemplary ow cytometry plots of ag-specic CD8+ T cells.
Frequency of SIINFEKL (SI)-specic CD8+ T cells on day 7 after infection
with LM-OVA (upper row), or LCMV epitope GP33-specic CD8+ T cells
on day 8 after LCMV infection (lower row) of the indicated mouse strain.
(C) Frequencies of SI-specic CD8+ T cells after LM-OVA infection on day 7
after infection (left), and LCMV epitope GP33-specic CD8+ T cells on
day 8 after LCMV infection (right) of the indicated mouse strain. (D) Fre-
quencies of SI-specic CD8+ T cells on day 5 after LM-OVA infection are
shown. (E) Total numbers of CD4+ and CD8+ T cells in spleen on day 7
after LM-OVA infection were calculated. Data are representative of two inde-
pendent experiments with similar results (4-5 mice per group). Each symbol
in (C) represents an individual mouse and small horizontal lines indicate the
average. Data show statistical signicance with ***p<0.0001 and *p<0.05
(Student's t test). Results in (D) and (E) are presented as mean + SEM.
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T cell subset of both mice strains, present analysis could determine dierences in the
proliferative activity on day 5 after infection. The frequency of Ki-67+ CD8+ T cells
was examined with around 13% in IRF4KOCD8 mice, whereas in WT mice total CD8+
T cells reached a frequency of up to 20% expressing Ki-67. Although, the mean u-
orescence intensity (MFI) was similar comparing total CD8+ T cells from WT and
IRF4KOCD8 mice, as shown in Figure 8.3C.
Of interest, the proliferative activity, dened by Ki-67 staining, of IRF4-decient
SI-specic CD8+ T cells was found drastically reduced (mean: 18.7%) already on 5 days
after infection, compared to their WT counterparts (mean: 52.8%) (Figure 8.3D). This
reduction of the proliferative fraction of CD8+ T cells was examined for the quantity
and quality of Ki-67 expression, as IRF4-decient SI-specic CD8+ T cells showed
additionally reduced MFI values for the proliferation marker Ki-67 in IRF4KOCD8 mice.
Further determination of 5-bromodeoxyuridine (BrdU) incorporation within IRF4-
decient CD8+ T cells of IRF4KOCD8 mice and IRF4-sucient CD8+ T cells from
WT mice after LCMV infection, additionally showed drastic dierences in the prolifer-
ative activity. Exemplary histograms in Figure 8.4A show the BrdU incorporation into
CD8+ T cells during the early stage of infection. In detail, the BrdU incorporation by
total IRF4-decient CD8+ T cells between day 5 and day 8 was signicant lower com-
pared to their counterparts in WT mice. More than double the CD8+ T cells in WT
mice were BrdU+, compared with that by IRF4-decient CD8+ T cells in IRF4KOCD8
mice. Additionally, CD8+ T cells expressing CD69, an activation marker [229], which
has been shown to be rapidly expressed on mature T cells after TCR-mediated ac-
tivation [189], showed the same reduced proliferative capacity. This was indicated by
drastically reduced BrdU incorporation within IRF4-decient CD8+ T cells by analyz-
ing their proliferation between day 5 and day 8 after LCMV infection (Figure 8.4B).
In summary, these results suggest reduced proliferation of IRF4-decient CD8+ T cells
compared to their WT counterparts at this stage of infection. Based on these results,
it can be assumed that IRF4 expression is crucial for a proper proliferative capacity
of CD8+ T cells after antigen encounter. These data showed that IRF4 deciency in
CD8+ T cells led to a reduced proliferative activity after an initial expansion. Thus,
IRF4 expression in CD8+ T cells is required for maintained proliferation during the
clonal expansion phase.
8.3 IRF4 impacts the dierentiaton of eector
CD8+ T cells
Besides aecting the size of the CD8+ T cell response upon primary infection, this study
wanted to investigate whether the absence of IRF4 expression in CD8+ T cells also impli-
cates in shaping the phenotypic and functional properties of CD8+ T cells. To compare
the cellular phenotype of wild type and IRF4-decient CD8+ T cell populations after
bacterial infection, WT mice (IRF4ox) and IRF4KOCD8 mice (IRF4ox.E8Icre) were
i.v. infected with LM-OVA. Splenocytes were stained for CD44 and CD62L to distin-
guish between naïve, eector, and memory cell populations. After antigen encounter
during Listeria infection, present results observed no dierence in surface expression
of CD44. Wild type and IRF4-decient CD8+ T cells expressed similar high levels of
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Figure 8.3: IRF4-decient CD8+ T cells show less proliferative capacity. The
level of intracellular Ki-67 expression was analyzed to examine the growth
fraction of the total and SI-specic CD8+ T cells. Therefore, WT and
IRF4KOCD8 mice were intravenously infected with LM-OVA and splenocytes
were analyzed on day 5 or day 7 after bacterial infection. (A) Frequencies
of SI-specic CD8+ T cells were identied via tetramer staining in spleens
from WT (in blue) and IRF4KOCD8 mice (in red) on day 7 after Listeria in-
fection, labeled for CD44 and Ki-67 marker expression. (B) Flow cytometric
prole of SI-specic CD8+ T cells in liver, identied via tetramer staining,
from WT (in blue) and IRF4KOCD8 mice (in red). Seven days after Listeria
infection, tetramer+ CD8+ T cells were labeled for CD44 and Ki-67 marker
expression. (C) Exemplary histogram of Ki-67 expression on total splenic
CD8+ T cell population pre-gated on viable CD3+ T lymphocytes of the
indicated mouse stain on day 5 prior infection (left) are shown. Frequencies
of Ki-67 expressing cells (middle graph) and MFI values (right graph) were
measured on day 5 after Listeria infection. (D) Exemplary histogram of the
Ki-67 expression on splenic SI-specic CD8+ T cell population, pre-gated
on viable CD3+ T lymphocytes of the indicated mouse stain, on day 5 prior
infection (left) are displayed. Frequencies of Ki-67 expressing cells (mid-
dle graph) and mean uorescence intensity (MFI) values (right graph) were
measured after Listeria infection (d5 p.i.). IRF4-decient CD8+ T cells are
shown in red and WT CD8+ T cells are shown in blue. Data are represen-
tative of two independent experiments with similar results. Each symbol in
(A) and (B) represents an individual mouse and small horizontal lines indi-
cate the average. Data show statistical signicance with ***p<0.0001 and
*p<0.05 (Student's t test). Results in (C) and (D) show the mean + SEM.72
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Figure 8.4: IRF4-decient CD8+ T cells exhibit altered rates of proliferation.
Wild type (IRF4ox mice termed as WT) and IRF4KOCD8 (IRF4ox.E8Icre)
mice were infected with the Armstrong strain of LCMV. BrdU was given in
drinking sugar water from day 5 till day 8 after infection. On day 8 at the
peak of CD8+ T cell response, splenic CD8+ T cells were analyzed for BrdU
incorporation. (A) Representative histogram of BrdU incorporation by to-
tal CD8+ T cells (left) and CD69+ CD8+ T cells (right) of wild type mice
(shown in blue) and IRF4KOCD8 mice (shown in red). Data are represen-
tative of four mice per strain. (B) Graph shows the frequencies of BrdU
incorporation by total CD8+ T cells and CD69+ CD8+ T cells of WT mice
(shown in blue) and IRF4KOCD8 mice (shown in red). Graph in (B) shows
the mean + SEM. Data show statistical signicance with **p<0.001 and
*p<0.01 (Student's t test).
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CD44, as shown in Figure 8.5, indicating that an initial activation of both cell subsets
occurred. Nevertheless, dierent to WT CD8+ T cells, which downregulated CD62L
expression after antigen encounter, the majority of IRF4-decient CD8+ T cells did not
cleaved CD62L from their cell surface. Instead, IRF4-decient CD8+ T cells maintained
a high CD62L expression, as shown on day 7 after bacterial infection (Figure 8.5A/B).
Thus, the acquisition of the CD62Llow CD44high eector phenotype was drastically im-
paired (3.7-fold decreased) in the absence of IRF4 expression in CD8+ T cells, com-
pared to their WT counterparts (Figure 8.5C). WT CD8+ T cells showed drastically
higher frequencies (mean: 83.3%) of CD44high CD62Llowag-specic CD8+ T cells, com-
pared to IRF4-decient CD8+ T cells (mean: 22.2%). Therefore, a greater proportion
of IRF4-decient CD8+ T cells acquired a TCM phenotype being CD44
high CD62Lhigh
(mean: 35.2%) compared to their WT counterparts (mean: 7.8%), leading to an over
4-fold dierence.
The present study then analyzed CD8+ T cells for the expression of markers charac-
teristically expressed on short-lived eector cells (SLEC) or memory-precursor eector
cells (MPEC). The few remaining ag-specic IRF4-decient CD8+ T cells on day 7
after Listeria infection were pre-dominantly KLRG1 negative (Figure 8.6A/B), consis-
tent with a memory-like phenotype, as KLRG1 is a marker of replicative senescence.
This drastically reduced KLRG1 expression indicated impaired dierentiation into a
SLEC population. Indeed, in IRF4KOCD8 mice, a SLEC population was almost absent
(Figure 8.6C). In contrast, the majority of WT CD8+ T cells expressed high levels
of KLRG1. In WT mice, as expected on day 7 after infection, the majority of CD8+
T cells showed SLEC characterization, according to their marker expression of KLRG1
and CD127.
Furthermore, despite the increase in the MPEC percentage of up to 3-fold among the
SI-specic CD8+ T cells (Figure 8.6C) in IRF4KOCD8 mice on day 7 after infection, the
absolute numbers of MPECs in these mice were decreased (Figure 8.6D), compared to
WT controls.
These results indicated that the absence of IRF4 expression in CD8+ T cells during
Listeria infection resulted in an impaired eector cell dierentiation and in the absence
of a proper SLEC subset. However, this phenotypic alterations in IRF4-decient CD8+
T cell population after an initial activation, led to an enhanced development of CD44high
CD62Lhigh eector memory (TEM) CD8+ T cells. In contrast, a large proportion of WT
CD8+ T cells acquired a CD44high CD62Llow central memory T cell (TCM) phenotype,
which is consistent with the generation of a robust ag-specic CD8+ T cell population.
Therefore, IRF4 deciency promotes the deformation of memory-like CD8+ T lympho-
cytes with detrimental impact on the generation of a proper eector T cell population
after primary infection.
8.4 IRF4-decient CD8+ T cells maintain CD62L
expression
CD62L expression is required for homing of T cells to secondary lymphoid organs. Wild
type eector CD8+ T cells express low levels of CD62L, as a rapid downregulation
of CD62L on activated T cells is required to facilitate the migration to the sites of
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Figure 8.5: Remaining IRF4-decient CD8+ T cells acquire a memory-like
phenotype after infection. Double staining for the surface expression of
CD44 and CD62L on SI-specic splenic CD8+ T cells was performed on day 7
after LM-OVA infection of wild type and IRF4KOCD8 (IRF4ox.E8Icre)
mice. (A) Exemplary dot plots show CD62L versus CD44 surface expres-
sion among splenic SI-specic CD8+ T cells on day 7 after Listeria infec-
tion of the indicated mouse strain. (B) Histograms displaying CD44 and
CD62L surface expression of ag-specic splenic CD8+ T cells pre-gated on
viable CD3+ lymphocytes of the indicated mouse stains on day 7 after infec-
tion. (C) Percentages of naïve (CD44low CD62L+, shown in circles), memory
(CD44+ CD62L+ shown in squares), and eector (CD44+ CD62L- shown
in triangles) CD8+ T cell subsets in splenocytes of Listeria infected WT and
IRF4KOCD8 mice (day 7 p.i.) were measured by ow cytometry. Data are
representative of two independent experiments with similar results. Each
symbol in (C) represents an individual mouse and small horizontal lines
indicate the average. Data show statistical signicance with ***p<0.0001
(Student's t test).
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Figure 8.6: IRF4-deciency in CD8+ T cells inhibits SLEC formation after
infection. Double staining for the surface expression of KLRG1 and CD127
on splenic CD8+ T cells was performed on day 7 after LM-OVA infection of
WT (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre) mice to subdivide CD8+
T cells into SLECs and MPECs. (A) Exemplary dot plots show CD127 versus
KLRG1 surface expression on splenic tetramer+ CD8+ T cells on day 7
after Listeria infection of the indicated mouse strain. (B) Histograms show
CD127 and KLRG1 surface expression on tetramer+ splenic IRF4-sucient
(in blue) and IRF4-decient (in red) CD8+ T cells pre-gated on viable CD3+
T lymphocytes. (C) Percentages of SLECs (CD127low KLRG1high, shown
in triangles) and MPECs (CD127high KLRG1low shown in rectangles) in
spleens of Listeria infected WT and IRF4KOCD8 mice (day 7 p.i.) were
measured by ow cytometry. (D) Graph shows the calculated numbers of
splenic SLECs and MPECs of SI-specic CD8+ T cells in WT (in blue) and
IRF4KOCD8 (in red) mice on day 7 after infection. Data shown are pooled
from 2 independently performed experiments with at least 4 mice per group.
Each symbol in (C) represents an individual mouse and small horizontal
lines indicate the average. Graph in (D) shows the mean + SEM. Data show
statistical signicance with ***p<0.0001 (Student's t test).
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infection [199].
However, IRF4-decient CD8+ T cells do not clear the L-selectin (CD62L) from
their surface after antigen encounter, as they maintain CD62L expression, as shown in
Figure 8.7A on day 7 after Listeria infection. This is in contrast to the normal expression
pattern of CD62L on wild type CD8+ T cells after activation. Therefore, this study
asked whether IRF4-decient CD8+ T cells show dierent homing capabilities compared
to WT CD8+ T cells. To determine the eect of maintained CD62L expression on
IRF4-decient CD8+ T cell inltration of infected tissue, IRF4KOCD8 and WT mice
were infected with LM-OVA. CD8+ T cells in spleen, lymph nodes, and liver were
monitored on day 5 post infection. Listeria-specic CD8+ T cells were identied via the
expression of CD11a, an integrin shown to be upregulated upon antigen encounter via
infection [190].
As expected, CD62L expression on wild type ag-specic CD8+ T cells (Figure 8.7A)
were found to be markedly reduced in secondary lymphoid organs, shown in spleen (SP)
and mesenteric lymph nodes (LN), as well as in liver as a site of infection. In contrast,
ag-specic IRF4-decient CD8+ T cells were CD62Lhigh (Figure 8.7A), in all organs
tested. The eects were greater in spleen where the majority of the WT ag-specic
cells downregulated CD62L, while almost all IRF4-decient CD8+ T cells maintained
CD62L expression. Listeria-specic T cells in mesenteric lymph nodes (LN) and in the
target organ liver (LI) of WT mice also showed a drastic downregulation of CD62L,
while IRF4-decient CD8+ T cells did not clear the molecule from their cell surface
(Figure 8.7A). Nevertheless, the frequency of splenic Listeria-specic CD8+ T cells,
identied via CD11a expression on the cell surface, did not dier in IRF4KOCD8 mice
compared to WT mice (Figure 8.7B). Only a slightly reduced tendency in IRF4-decient
CD8+ T cells could be detected. This observation indicated, that the accumulation of
ag-specic CD8+ T cells in spleen was less aected by the IRF4 deciency.
However, frequencies of Listeria-specic CD8+ T cells (identied as CD11a+) har-
vested from infected livers or the lymphatic organ LN were not similar in both mice
strains. At day 5 after bacterial infection, the frequencies of CD8+ T cells responding
to Listeria infection were decreased in the absence of IRF4 expression, with over 3-fold
in LN and most pronounced with over 4-fold in the target organ liver (Figure 8.7B).
Nevertheless, ag-specic CD8+ T cells were located in LN and the non-lymphoid organ
liver, although frequencies were drastically reduced compared to WT controls.
In summary, these data suggest that IRF4 is required for the correct tissue localization
and moreover necessary for the accumulation of responding ag-specic CD8+ T cells in
infected tissue. Nevertheless, activated IRF4-decient CD8+ T cells, which maintained
CD62L expression, facilitate the migration to the sites of infection, as present results
detected ag-specic CD8+ T cells in the liver of infected IRF4KOCD8 mice, although
frequencies were drastically reduced.
8.5 IRF4 expression aects the CD8+ eector T cell
potential
Furthermore, this study investigated whether the phenotypic dierences could be also
linked to distinct functional and antibacterial protective capacities. The functionality
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Figure 8.7: Maintained expression of CD62L on Listeria-specic IRF4-
decient CD8+ T cells does aect the migration to the site of
infection. WT (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre) mice were
infected with LM-OVA. On day 5 after infection, mice were sacriced and
CD8+ T cells in spleen (SP), liver (LI), and mesenteric lymph nodes (LN)
were analyzed. Cells were pre-gated on viable CD3+ CD4- CD8+ CD11a+
cells to identify ag-activated CD8+ T lymphocytes. (A) Exemplary his-
tograms show CD62L surface expression on CD11a+ antigen-activated CD8+
T cells on IRF4-sucient (in blue) and IRF4-decient (in red) CD8+ T cells
pre-gated on viable CD3+ lymphocytes in spleen (left), liver (middle), and
lymph nodes (right) on day 5 after Listeria infection. (B) Percentage of CD8+
CD11a+ T cells (pre-gated on viable CD3+ CD4- T lymphocytes) in spleen,
liver, and lymph nodes on day 5 after Listeria infection of the indicated phe-
notype. Results in (B) show the mean + SEM. Student's t test was used for
statistical analysis. *p<0.05; ns indicates statistically not signicant.
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of eector CTLs was rst determined by the ability of these cells to produce cytokines,
such as IFNg, TNFa, and IL2. Therefore, WT and IRF4KOCD8 mice were infected
with LM-OVA or LCMV and sacriced on day 7 or day 8 after infection, respectively.
Listeria infected splenocytes were restimulated ag-specic with the OVA peptide SIIN-
FEKL (SI) or polyclonal with phorbol 12-myristate 13-acetate together with Ionomycin
(PMA/Iono), to determine the production of eector molecules. LCMV infected spleno-
cytes were restimulated with GP33 immunodominant peptide. Each restimulation was
performed for 6 hours in the presence of BrefA, which blocks protein segregation and
causes protein enrichment of the produced cytokines. The production of IFNg, TNFa,
and IL2 was determined via intracellular staining followed by ow cytometry analysis.
After primary infection, splenic ag-specic CD8+ T cells fromWTmice produced high
levels of IFNg (mean: 4.1%) after restimulation with SI peptide. In contrast, acquisition
of IFNg production was drastically impaired (mean: 0.2%) in the few remaining IRF4-
decient CD8+ T cells from IRF4KOCD8 mice, which were located in infected spleen
(Figure 8.8A/B). This dramatic reduction in the eector cytokine production could
be detected in ag-specic stimulated IRF4-decient CD8+ T cells in the secondary
lymphatic organ spleen, as well as in the non-lymphoid peripheral organ liver, being a
target organ of Listeria infection (Figure 8.8B). Importantly, the defect of the IRF4-
decient CD8+ T cells to produce IFNg was similar detectable after restimulation with
the immunodominant peptide GP33 of LCMV infected splenocytes from IRF4KOCD8
mice (Figure 8.8B/C). These results suggest that the phenotype of IRF4-decient CD8+
T cells is not dependent on the infection model, rather occurs due to general intrinsic
defects of the remaining ag-specic CD8+ T cells.
Wild type CD8+ T cells showed high percentages of IFNg producing cells and a high
IFNg expression per cell, indicated by the intensity of the IFNg staining (MFI), while
TNFa was also produced in appropriate levels (Figure 8.9A/B). Not surprisingly, high
proportion of IFNg+ wild type CD8+ T cells co-expressed TNFa and IFNg. Of interest,
functional defects in the production of cytokines additionally aected the secretion of IL2
and TNFa in the absence of IRF4 expression in eector CD8+ T cells. Furthermore, the
polyfunctionality was also impaired, as the frequencies of splenic IFNg+ CD8+ T cells
being positive for TNFa or IL2 were dramatically decreased in IRF4-decient CD8+
T cells (Figure 8.9C). Of note, very low cytokine responses were also observed after
non-specic polyclonal restimulation of IRF4-decient CD8+ T cells (Figure 8.9D).
Taken together, the ability of IRF4-decient CD8+ T cells to respond to antigenic
stimulation by cytokine production was severely impaired, in both infection models.
IRF4KOCD8 mice had much lower frequencies of CD8+ T cells responding to infection
specic antigens. Therefore, these results indicate that IRF4 is indispensable for an
eective cytokine production in eector CD8+ T cell.
Wild type (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre) mice were infected with
Listeria monocytogenes and the cytotoxic capabilities of splenic CD8+ T cells on day 7
after infection were analyzed, as the presumption raised that cytotoxic capabilities are
additionally severely restricted in the absence of IRF4 expression and this might result
in an increased pathogen burden. This hypothesis was based on previous results rep-
resented in this present study, showing that IRF4 deciency in CD8+ T cells resulted
in a drastically decreased ag-specic eector cell population with dramatically reduced
eector cytokine production.
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Figure 8.8: IRF4-decient CD8+ T cells show drastically impaired cytokine
production during infection. Dynamics of IFNg production by splenic
ag-specic CD8+ T cells of IRF4KOCD8 (IRF4ox.E8Icre shown in red) and
WT (IRF4ox shown in blue) mice after Listeria or LCMV infection. Mice
were infected with LM-OVA or LCMV and sacriced on day 7 or day 8 after
infection at the peak of CD8+ T cell response, respectively. Lymphocytes
were prepared from infected spleens or livers and analyzed for IFNg produc-
tion by ow cytometry, after 6 hours of ag-specic in vitro stimulation with
the indicated peptide. (A) Representative dot plots of the IFNg expression
in Listeria infected splenic CD8+ T cells after 6 hours of ag-specic stimula-
tion with SIINFEKL (SI) peptide of the indicated mouse strain are shown.
(B) Frequency of IFNg expression in CD8+ T cells after SI stimulation of Lis-
teria infected spleen (left graph, circle symbols) or liver (right graph, triangle
symbols) of the indicated mouse strain. (C) Frequency of IFNg expression
in splenic CD8+ T cells of WT and IRF4KOCD8 mice after LCMV infection
are depicted. Antigen-specic in vitro stimulation was performed with the
GP33 peptide of LCMV. Each symbol represents an individual mouse with
4-7 mice per group. Small horizontal lines indicate the average. Data are
representative of at least two independent experiments with similar results.
Data show statistical signicance with ***p<0.0001 and *p<0.05 (Student's
t test).
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Figure 8.9: IRF4 is indispensable for eective cytokine production and poly-
functionality. WT (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre) mice
were infected with LM-OVA and sacriced on day 7 after infection. Spleno-
cytes were polyclonal restimulated with PMA/Iono to determine the produc-
tion of eector molecules. (A) Frequencies of IFNg and TNFa expression in
splenic IRF4-decient (in red) and IRF4-sucient (in blue) CD8+ T cells
are shown. Splenocytes were harvested on day 7 after LM-OVA infection and
after further 6 hours of in vitro stimulation with PMA/Iono, the expression
of cytokines was determined via intracellular staining. (B) Mean uores-
cence intensity (MFI) values of IFNg+ and TNFa+ CD8+ T cells of the
indicated mouse strain are depicted. (C) Frequencies of CD8+ T cells ex-
pressing IL2, TNFa and IFNg on day 7 after Listeria infection of the indicated
mouse strain. Splenocytes were 6 hours in vitro stimulated with SI peptide.
Cytokine production was determined via intracellular staining using ow cy-
tometry. (D) Exemplary dot plots show IFNg versus TNFa expression in
splenic CD8+ T cells on day 7 after Listeria infection of the indicated mouse
strain. Splenocytes were polyclonal stimulated with PMA/Iono. Results
in (A), (B), and (C) show the mean + SEM. Student's t test was used for
statistical analysis with *p<0.05 and **p<0.005. Data are representative of
at least two independent experiments with similar results with 4-5 mice per
group.
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Indeed, IRF4-decient CD8+ T cells expressed lower levels of the death receptor lig-
and FASL and of the degranulation marker CD107a, than their wild type counterparts.
Accessorily, granzymeB expression was signicantly reduced in IRF4-decient CD8+
T cells after infection (Figure 8.10A). These results indicated that the antibacterial pro-
tective capacities of the IRF4-decient ag-specic CD8+ T cell subset was drastically
diminished, which might lead to a less ecient clearance of the pathogen. To determine
whether there are dierences in the clearance capacity due to the absence of IRF4 in
CD8+ T cells, the bacterial numbers in spleen on day 5 after intravenous Listeria in-
fection in the WT and IRF4KOCD8 mice were examined. Colony forming units (CFU)
observed in spleen were calculated. IRF4-deciency in the CD8+ T cell compartment
resulted in an increase in the bacterial burden in IRF4KOCD8 mice after Listeria infec-
tion, showing higher bacterial numbers per secondary lymphoid organ (Figure 8.10B).
Those ndings provide evidence that IRF4 expression in the CD8+ T cell population is
required to acquire cytotoxic properties to attack and destroy pathogen infected cells,
as IRF4 deciency in CD8+ T cells led to an increased bacterial burden.
8.6 IRF4 deciency alters the transcriptional program of
CD8+ T cells
The fate of the CD8+ T cell population is known to be dependent on the expression
ratio between the two T-box transcription factors, namely Tbet and Eomes. Although,
Tbet and Eomes show expressional overlap, it is claimed that the reciprocal expression
of this master regulators correlate with the functionality and dierentiation of CD8+
T cells into distinct cell subsets [91, 220]. Recent studies show that Eomes promote
memory cell formation [9]. In contrast, Tbet plays a critical role for the dierentiation
into eector cells and contributes to the expression of eector cytokines and cytotoxic
molecules [181, 220]. Additionally, Tbet is known to promote upregulation of KLRG1.
Therefore, the question raised whether IRF4 deciency results in decreased Tbet and
increased Eomes expression. This presumption raised, as IRF4-decient CD8+ T cells
showed a drastic reduction in the terminal eector CD8+ T cell subset with a drastically
impaired KLRG1 expression after activation (Figure 8.6).
As expected, IRF4-sucent CD8+ T cells from day 7 infected WT mice expressed
high levels of Tbet, while the percentage of CD8+ T cells expressing Eomes maintained
low on day 7 after Listeria infection, as shown in Figure 8.11. This observation was
consistent with recent publications determining an increase of Tbet expression after ac-
tivation of naïve CD8+ T cells via TCR engagement [149]. In contrast, IRF4-decient
CD8+ T cells showed higher levels of Eomes expression (Figure 8.11), matching with the
memory-like phenotype (CD44+ CD62L+ CD127+ KLRG1-) recorded on day 7 after
Listeria infection. However, the percentage of Tbet expressing CD8+ T cells revealed
no signicant dierence between both mice strains on day 7 after Listeria infection. Nev-
ertheless, the mean uorescence intensity (MFI) value of Tbet was signicantly reduced
in IRF4-decient CD8+ T cells (Figure 8.11B/C). Because Tbet drives terminal eec-
tor dierentiation and correlates with KLRG1 expression, the unusual lack of KLRG1
expression in IRF4-decient CD8+ T cells could be linked to the detected increased
Eomes expression and diminished Tbet expression.
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Figure 8.10: IRF4 deciency impairs cytotoxic CD8+ T cell functions to kill
target cells. Diminished protective cytotoxic CD8+ T cell response in
the absence of IRF4 in WT (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre)
mice, which were infected with LM-OVA and sacriced 5 days later. Spleno-
cytes of infected mice were analyzed for their expression of cytotoxic mark-
ers and the bacterial load in the secondary lymphoid organ was examined.
(A) Exemplary overlaying histograms of FASL, CD107a and granzymB ex-
pression in wild type (in blue) and IRF4-decient CD8+ T cells (in red) are
shown. Numbers in the histograms indicate the mean uorescence intensity
(MFI) values and percentages (%) of positive cells of the indicated marker.
(B) Graph shows the numbers of bacteria in the secondary lymphoid organ
spleen, determined by examining the colony forming units (CFU). Results
in (B) show the mean + SEM. Statistical signicance was analyzed by
Student's t test with **p<0.005.
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Examination of Tbet+ Eomes+, Tbet+ Eomes-, and Tbet- Eomes+ populations of
WT and IRF4-decient ag-specic CD8+ T cells on day 7 after Listeria infection re-
vealed lower proportions and numbers of Tbet+ Eomes- CD8+ T cells in IRF4KOCD8
mice (Figure 8.12A/B). IRF4-decient CD8+ T cells showed higher frequencies in the
Eomes+ Tbet- and Eomes+ Tbet+ proportion. In contrast, in WT mice higher fre-
quencies of CD8+ T cells expressed Tbet alone or together with Eomes (Figure 8.12A).
Although, frequencies of Tbet- Eomes+ and Tbet+ Eomes+ CD8+ T cells were higher
in IRF4KOCD8 mice compared to WT mice, total numbers revealed a drastic reduction
of these populations (Figure 8.12B), in agreement with overall drastically reduced num-
bers of ag-specic CD8+ T cells in the absence of IRF4, which were examined on day 7
after infection (Figure 8.2).
In conclusion, recent data suggest that IRF4 expression inhibited Eomes expression
and positively regulated Tbet expression in WT CD8+ T cells. Represented results
indicate that an abnormal transcriptional programming of IRF4-decient CD8+ T cells
might be the reason for the drastic functional impairment and successive loss of their
proliferative capacity and reduced existence and survival. The untypical dierentiation
pattern of IRF4-decient eector CD8+ T cells, that present results observed on day 7
after Listeria infection in IRF4KOCD8 mice, suggest a dierent underlying transcrip-
tional prole of those few remaining ag-specic CD8+ T cells compared to their WT
counterparts. This indicates that IRF4 is mandatory for the cell fate decision of CD8+
T cells after infection and important to balance the expression of the key transcription
factors Tbet and Eomes.
8.7 Importance of IRF4 for CD8+ T cell memory formation
and recall
Previous experiments in this study demonstrated that on day 7 after Listeria infec-
tion eector CD8+ T lymphocytes showed a memory-like phenotype (CD44+ CD62L+
CD127+ KLRG1-) in mice having IRF4 deciency in the CD8+ T cell compartment.
Thus, the question came up whether IRF4KOCD8 mice show an increase of ag-specic
CD8+ T cells in the memory pool and if they similarly show an impaired CD8+ T cell
response after secondary infection. To investigate the contribution of IRF4 expression
to the formation of a robust memory CD8+ T cells subset, mice having IRF4-decient
CD8+ T cells (IRF4ox.E8Icre mice termed as IRF4KOCD8) and wild type (IRF4ox)
mice were infected with the Armstrong strain of lymphocytic choriomeningitis virus
(LCMV). The experimental setup is shown in Figure 8.13A.
Tetramer staining was used to examine the resulting ag-specic CD8+ T cell response
to the LCMV GP33 epitope (GP33 Tet+ cells) upon acute viral infection. Splenic
GP33-specic CD8+ T cells were analyzed on day 8 and day 60 after LCMV Armstrong
infection, and on day 68, 8 days after antigen reencounter. Time points were chosen
to analyze the eector CD8+ T cell compartment at the peak of eector response,
to examine the memory formation, and to analyze the eector T cell response after
secondary infection.
Not surprisingly, IRF4-deciency changed the magnitude of the CD8+ T cell response
after viral infection. Consistent with the present previous observations during primary
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Figure 8.11: IRF4-decient CD8+ T cells in Listeria infected IRF4KOCD8
mice express high levels of Eomes. WT (IRF4ox) and IRF4KOCD8
(IRF4ox.E8Icre) mice were infected with LM-OVA and on day 7 sacriced.
Splenocytes were surface stained with viability dye, anti-CD3, CD4, and
CD8 antibody and intracellular stained for Eomes and Tbet expression.
(A) Overlaying histograms of Eomes and Tbet expression in wild type and
IRF4-decient CD8+ T cells. (B) Histograms showing the expression of
Tbet and Eomes in WT (in blue) and IRF4-decient CD8+ T cells (in red).
(C) Frequencies of splenic CD8+ T cells expressing Eomes or Tbet on day 7
after Listeria infection of the indicated mouse strain are shown. Transcrip-
tion factor expression was measured via intracellular staining using ow
cytometry. (D) Frequencies show the mean uorescence intensity (MFI)
values of Tbet and Eomes expression in splenic CD8+ T cells on day 7 af-
ter Listeria infection. Wild type mice are shown in blue and IRF4KOCD8
mice in red. Data are representative of two independent experiments with
3-6 mice per group with similar results. Result in (C) and (D) show the
mean + SEM. Statistical signicance was analyzed by Student's t test with
*p<0.05, **p<0.005 and ***p<0.0001.
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Figure 8.12: IRF4 expression ensures the balance between Tbet and Eomes ex-
pression in CD8+ T cells. Splenocytes from LM-OVA infected WT and
IRF4KOCD8 mice were harvested on day 7 post infection and stained with
viability dye, OVA-specic H-2Kb-SI tetramer, and antibodies for CD3,
CD4, CD8, Tbet, and Eomes. (A) Graph shows proportions of Tbet+
Eomes+ (left), Tbet+ Eomes- (middle), and Tbet- Eomes+ (right) pop-
ulations of WT (in blue) and IRF4-decient CD8+ T cells (in red) on
day 7 after LM-OVA infection. (B) Graph shows calculated numbers of
Tbet+ Eomes+ (left), Tbet+ Eomes- (middle), and Tbet- Eomes+ (right)
populations of WT (in blue) and IRF4-decient CD8+ T cells (in red) on
day 7 after LM-OVA infection. Data are representative for two indepen-
dent experiments with 3-6 mice per group. Results in (A) and (B) show
the mean +SEM. Statistical signicance was analyzed by Student's t test
with ***p<0.0001.
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Listeria infection, IRF4KOCD8 mice showed a severely decrease in the GP33-specic
CD8+ T cell population at the peak of CD8+ T cell response after primary infec-
tion (Figure 8.13B). Interestingly, present results found similarly reduced numbers of
LCMV GP33-specic CD8+ T cells on day 68, 8 days upon rechallenge with LCMV,
compared to 8 days after primary infection. Comparison of the formed memory frac-
tion of ag-specic CD8+ T cells in WT and IRF4KOCD8 mice on day 60 after infection
showed no signicant dierences in frequency. LCMV GP33-specic CD8+ T cells were
not reduced at this later time point (day 60 p.i.) in IRF4KOCD8 mice, suggesting a
memory formation in WT and IRF4KOCD8mice to a similar extent.
Additionally, the phenotype of ag-specic CD8+ T cells in IRF4KOCD8 mice was
dierent during the acute infection phase (d8 and d68 p.i.) compared to WT mice, as
shown in Figure 8.14. In detail, at the peak of T cell response on day 8 after primary
LCMV infection, GP33-specic CD8+ T cells in WT mice were assigned into the eector
cell compartment, being KLRG1+ CD127- CD62L- and CD44+. Similar to the primary
virus infection, after secondary antigen encounter, IRF4-decient CD8+ T cells showed
an altered surface expression of CD62L and KLRG1 compared to CD8+ T cells from
WT mice (Figure 8.13). A similar phenotype of IRF4-decient CD8+ T cells was also
found in IRF4KOCD8 mice on day 68, 8 days after rechallenge with LCMV. In contrast,
IRF4-decient CD8+ T cells showed a memory-like phenotype maintaining CD62L on
their surface and expressing CD127 and CD44, but lacked KLRG1 expression. Inter-
estingly, IRF4-decient memory CD8+ T cells (day 60 post primary infection) were
qualitative and qualitatively not dierent from their counterparts in WT hosts. Just
minor dierences could be detected, comparing WT and IRF4-decient CD8+ T cells,
as both cell subsets acquired a similar phenotype in the surface marker expression of
CD44, CD62L, KLRG1, and CD127.
Taken together, these data indicate that IRF4 is necessary for a proper expansion and
dierentiation of eector CD8+ T cells during the onset of the immune response upon
primary and secondary infection, but did not impact later (memory) T cell homeostasis
or the generation of long-lived pathogen-specic CD8+ T cells.
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Figure 8.13: Similar memory formation but impaired eector and eector re-
call CD8+ T cell response in the absence of IRF4. (A) Schematic
graph of the experimental setup. Wild type (WT) and IRF4KOCD8 mice
were infected with lymphocytic choriomeningitis virus (LCMV) Armstrong.
Splenocytes were surface stained with viability dye, anti-CD3, CD4, and
CD8 antibody. Splenic GP33-specic CD8+ T cells were analyzed via
tetramer staining on day 8 and day 60 after LCMV Armstrong infection,
and on day 68 (8 days after second antigen reencounter). (B) Antigen-
specic CD8+ T cells were determined using tetramer staining, at the peak
of the eector CD8+ T cell response (day 8 p.i.), at a memory time point
(day 60 p.i.), and day 68 after second antigen encounter (recall at day 60
after primary infection). (C) Exemplary ow cytometry plots of CD44 and
CD62L expression on splenic CD8+ T cells, at day 60 after LCMV infec-
tion. Data are representative of two independent experiments with similar
results (4-5 mice per group). Each symbol in (B) represents an individual
mouse and small horizontal lines indicate the average. Data show statistical
signicance with ***p<0.0001 and *p<0.05 (Student's t test).
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Figure 8.14: IRF4 deciency impacts the dierentiation pattern of ag-specic
CD8+ T cells after primary and secondary viral infection. Wild
type (IRF4ox termed as WT) and IRF4KOCD8 mice were infected with
lymphocytic choriomeningitis virus (LCMV) Armstrong and analyzed on
dierent time points (TP). Mice were sacriced on day 8 (eector TP)
or day 60 (memory TP) after primary infection. To analyze the CD8+
T cell response after antigen reencounter, secondary infection was per-
formed 60 days after rst infection and mice were sacriced 8 days later.
Splenocytes were surface stained with viability dye, anti-CD3, CD4, and
CD8 antibody. GP33-specic CD8+ T cells were analyzed via tetramer
staining on day 8 (eector) and day 60 (memory) after LCMV Armstrong
infection, and on day 68 (recall TP being 8 days after second antigen reen-
counter). (A) Exemplary histograms display the surface expression of
CD62L, CD44, CD127, and KLRG1 on splenic ag-specic CD8+ T cells
of WT (in blue) and IRF4KOCD8 mice (in red) at the indicated time point.
Data are representative of two independent experiments with similar results
(4-5 mice per group).
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Chapter 9
IRF4-decient CD8+ T cells have an
increased apoptotic potential
9.1 IRF4 deciency leads to increased susceptibility to
apoptosis
Present results in this study could observe a drastically decrease in numbers and fre-
quency of ag-specic CD8+ T cells and less proliferative capacity in the absence of
IRF4 expression already on day 5 after infection. Additionally, transfer experiments
(Section 10.2) gave proof that IRF4-decient CD8+ T cells, upon initial activation
and clonal expansion, suer from diminished proliferation capacity and are almost dis-
appeared on day 7 after bacterial infection. Therefore, the question came up whether
IRF4 deciency leads to an increase of apoptosis and/or phagocytosis at the early clonal
expansion phase and therefore to an early onset of contraction.
The decline in numbers of ag-specic CD8+ T cells during the contraction phase
is controlled via several mechanisms, such as changes in the transcriptional program,
exposure of eat-me molecules on the cell surface, and the expression of death inducing
receptors, which all lead to the initiation of intrinsic or extrinsic apoptosis pathways.
FAS-mediated cell death pathways result in activation induced cell death (AICD) and
occurs via expression of death receptors on the cell surface. Phagocytosis is initiated
via the exposure of nd-me and eat-me signals on the target cell leading to complement
activation and cell-mediated phagocytosis.
As already mentioned, apoptotic cell death can occur as a result of engagement of the
death receptor FAS (known as CD95 or APO-1) on the surface of a cell prone to die.
When the FAS receptor bind to its ligand, it induces extrinsic apoptosis due to signaling
via an intracellular domain, the recruitment of FAS-associated death domain (FADD),
and the formation of a death inducing signaling complex (DISC). These processes result
in a recruitment of pro-caspases and to an activation of several caspases [29]. To deter-
mine whether IRF4-decient CD8+ T cells are prone to cell death via the FAS-FASL
mediated death pathway this study analyzed the expression of FAS on the cell surface on
day 5 after Listeria infection. Wild type (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre)
mice were infected with Listeria and analyzed the expression of the death receptor FAS
on the surface of splenic CD8+ T cells via ow cytometry. IRF4-decient CD8+ T cells
expressed signicant higher levels of FAS on their surface than their wild type counter-
parts, as shown in Figure 9.1A/B.
These results suggest that IRF4-decient CD8+ T cells are more susceptible to apop-
tosis than their WT counterparts on day 5 after bacterial infection and that the cell
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Figure 9.1: IRF4 deciency led to FAS-mediated apoptosis of eector CD8+
T cells. WT (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre) mice were in-
fected with LM-OVA and on day 5 sacriced. Splenocytes of infected mice
were surface stained with viability dye, anti-CD3, CD4, and CD8 anti-
body. CD8+ T cells were analyzed for their expression of FAS (CD95).
(A) Exemplary histogram of FAS staining on WT (indicated in blue) and
IRF4-decient CD8+ T cells (indicated in red). (B) Frequency of FAS+
CD8+T cells in the indicated mouse strain. Cells were pre-gated on viable
CD3+ CD4- CD8+ T cells. Results in (B) show the mean + SEM. Data
show statistical signicance with ***p<0.0001 (Student's t test).
death might be mediated via the FAS-FASL pathway.
In addition, analysis of the exposure of eat-me and nd-me singals on the cell surface
of eector CD8+ T cells in wild type (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre)
mice after bacterial infection was performed. To do so, mice were infected with Listeria
and the splenic CD8+ T cells were analyzed for their expression of phosphatidylserine
(PS) [145], which can be detected via AnnexinV staining and further ow cytometry
analysis [241]. Five days after infection, IRF4-decient CD8+ T cells exposed signi-
cantly higher levels of PS on their cell surface, indicated by AnnexinV staining, than
IRF4-sucient CD8+ T cells of infected WT mice. This result in shown in Figure 9.2
and indicates that in the absence of IRF4, eector CD8+ T cells are more suscepti-
ble to phagocytosis mediated by monocytes and macrophages, or granulocytes, due to
increased exposure of eat-me signals on their cell surface.
The major task of the complement system is to defend against invading microor-
ganisms. In addition, is facilitates the elimination of early apoptotic cells due the
recruitment of phagocytes. Therefore, this analysis wanted to determine whether IRF4
deciency leads to an activation of the complement cascade to support the apoptotic
process of for the premature termination of the clonal expansion phase of eector C8+
T cells. A schematic overview of the complement pathway is illustrated in Figure 1.5.
The activation of the complement system can be iniciated via three dierent pathways,
all resulting in the formation of C3 and C5 convertase, inducing the terminal lytic path-
way of the complement cascade. Dierent regulatory mechanisms and several molecules
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Figure 9.2: IRF4 deciency leads to increased phoshatidylserine (PS) expo-
sure on CD8+ T cell surfaces. WT (IRF4ox) and IRF4KOCD8
(IRF4ox.E8Icre) mice were infected with LM-OVA and on day 5 sacriced.
Splenocytes of infected mice were surface stained with viability dye, anti-
CD3, CD4, and CD8 antibody. CD8+ T cells of both infected mice strains
were analyzed for their exposure of phosphatidylserine (PS) on the cell sur-
face via AnnexinV staining. (A) Exemplary dot plots of AnnexinV stain-
ing on the surface of WT and IRF4-decient CD8+ T cells. Numbers in
each quadrant indicate the frequency of cells being positiv or negative for
the indicated marker. (B) Frequency of PS exposure on the cell surface
of CD8+T cells according to their AnnexinV staining. Wild type CD8+
T cells are shown in blue and IRF4-decient CD8+ T cells in red. Cells
were pre-gated on viable CD3+ CD4- CD8+ T cells. Data in (B) show the
mean + SEM and are representative of two independent experiments with
similar results. Data show statistical signicance with **p<0.001 (Student's
t test).
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Figure 9.3: Increased complement deposition of C3 examined on IRF4-
decient CD8+ T cells. WT (IRF4ox) and IRF4KOCD8
(IRF4ox.E8Icre) mice were infected with LM-OVA. On day 5 after infec-
tion, splenic CD8+ T cells of infected mice were analyzed for complement
factor deposition, such as C1q, C3 and C4. (A) Frequency of cells with depo-
sition of the indicated complement factor in WT and IRF4-decient CD8+
T cells. Wild type CD8+ T cells are shown in blue and IRF4-decient CD8+
T cells in red. Cells were pre-gated on viable CD3+ CD4- CD8+ T cells.
Graph shows the mean + SEM and data show statistical signicance with
**p<0.001 (Student's t test).
act together to induce the complement cascade triggering opsonisation and phagocytosis
of the target cell.
Again, wild type (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre) mice were infected
with Listeria and the deposition of complement mediators on the cell surface of splenic
CD8+ T cells were examined on day 5 after Listeria infection. First, the present analysis
checked whether IRF4-deciency in CD8+ T cells leads to an activation of the classical
pathway of the complement system. Therefore, the C1q deposition was examinded, C1q
being a subunit of the C1 component and leading to further cleavage processes and
triggering of opsonization. On day 5 after infection, results could not nd signicant
dierences between both cell subsets (Figure 9.3A). To determine the contribution of
C4, its aviability on the cell surface was analyzed. Similar to C1q, present results
could not detect signicant dierences between WT and IRF4-decient CD8+ T cells
of the complement protein C4. However, signicant higher levels of C3 convertase could
be detected in IRF4-decient CD8+ T cells compared to their wild type counterparts
analyzed via ow cytometry (Figure 9.3A).
Results from ow cytometry analysis of this study give hints, that IRF4 deciency
in CD8+ T cells led to a deposition of C3 on the cell surface, which is a molecule
being shared of all 3 pathways of the complement cascade. It initiates the terminal
complement pathway, which induces the generation of anaphylatoxins and the assembly
of the MAC.
It is very likely that CD8+ T cells cannot evade apoptotic pathways, if an engag-
93
9 IRF4-decient CD8+ T cells have an increased apoptotic potential
ment of the death receptor FAS, an increased exposure of the eat-me signals, such as
phosphatidylserine, and the deposition of complement factors occurred. All these mecha-
nisms are indicators of early apoptotic cells, which lead to the recruitment of phagocytes
and facilitate apoptotic cell recognition and uptake. This study therefore further ana-
lyzed the composition of the myeloid cell subsets in WT (IRF4ox) and IRF4KOCD8
(IRF4ox.E8Icre) mice in infected spleens. On day 5 after Listeria infection, frequencies
of the DC and macrophage population were increase with over 2-fold in IRF4KOCD8
mice compared to WT mice. Furthermore, an increase of the monocyte subset could also
be detected in infected spleens of IRF4KO mice on day 5 post infection. Moreover, for
the granulocyte subset, an increase with over 4-fold could be detected in IRF4KOCD8
mice compared to their WT counterparts. These results suggest that IRF4-decient
CD8+ T cells might be more prone to cell death by phagocytes, as they showed an
increase of markers, which identify apoptotic cells. Additionally, in increase recruit-
ment of phagocytes could be detected, which facilitates the recognition and promote
the clearance of the apoptotic cells.
9.2 IRF4-deciency does not enhance the expression of
inhibitory molecules
Several co-inhibitory receptors and molecules were described to be important in inhibit-
ing T cell responses and promoting programmed cell death [14]. Therefore, quanti-
cation of inhibitory receptor expression was performed at an early time point (day 5)
after primary Listeria encounter to search for an explanation for the huge impairment
observed in functionality and dierentiation of ag-specic CD8+ T cells. The expression
of inhibitory molecules could be one reason for the drastic reduction of SI-specic CD8+
T cells detected already on day 5 after infection, when the peak of normal CD8+ T cell
response is not yet achieved. To test this hypothesis, WT and IRF4KOCD8 mice were
sacriced on day 5 after Listeria infection and spleenocytes were processed to examine
the expression of dierent inhibitory markers on ag-experienced CD8+ T cells. Flow
cytometric analysis was performed to determine the expression of B cell lymphoma 2
(Bcl-2), 2B4 (CD244), programmed cell death 1 (PD-1), glycoprotein CD160, T cell
immunoglobulin domain and mucin domain 3 (TIM3), lymphocyte activation gene 3
(LAG3), and cytotoxic T lymphocyte-associated protein 4 (CTLA4).
No dierence in the expression of any of the analyzed inhibitory molecules could be
detected in ag-unexperienced CD8+ T cells from WT or IRF4KOCD8 mice, as shown in
Figure 9.5 in the upper row. Interestingly, ag-experienced IRF4-decient CD8+ T cells
and WT CD8+ T cells upregulated their expression of Tim3, 2B4, and LAG3 com-
pared to ag-unexperienced T cells (Figure 9.5 lower row). Although, no dierence could
be detected between ag-experienced IRF4-decient and IRF4-sucient CD8+ T cells
for the expression of 2B4 and LAG3 on day 5 after Listeria infection. But there was
a slightly increase in the expression of Tim3 in ag-experienced IRF4-decient CD8+
T cells compared to their WT counterparts (Figure 9.5 lower row). An increase in
TIM3 expression on T cells has been shown to negatively regulate T cell activation
and eector responses [95, 268]. Further analysis of the inhibitory molecules PD-1,
CD160, and CTLA4 showed no increase in the expression level after ag-encounter on
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Figure 9.4: Increased myeloid cell subsets in mice having IRF4-decient CD8+
T cells on day 5 after infection. WT (IRF4ox shown in blue)
and IRF4KOCD8 (IRF4ox.E8Icre shown in red) mice were infected with
LM-OVA. On day 5 after infection, spleens of infected mice were analyzed
for their composition of myeloid cell subsets. First total cells were pre-
gated on viable cells, additionally excluding lymhocytes (CD3+), B cells
(CD19+), and natural killer cells (NK1.1+). Total myeloid cells were than
identied based on their expression of CD11b and further separated into
macrophages, monocytes, granulocytes and dendritic cells (DCs), depen-
dent on their marker expression. (A) Exemplary histograms of macrophages
(CD11b+ F4/80+), monocytes (CD11b+ Ly6C+), granulocytes (CD11b+
Ly6G+), and DCs (CD11b+ CD11c+). (B) Quantitative analysis of splenic
macrophages (CD11b+ F4/80+), monocytes (CD11b+ Ly6C+), granulo-
cytes (CD11b+ Ly6G+), and DCs (CD11b+ CD11c+). Data show 3 mice
per group and graph shows the mean + SEM.
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Figure 9.5: No alteration in the expression of exhaustion markers in IRF4-
decient CD8+ T cells. WT (IRF4ox) and IRF4KO (IRF4ox.E8Icre)
mice were infected with LM-OVA and on day 5 sacriced. Splenic CD8+
T cells of infected mice were analyzed for their expression of several in-
hibitory receptors and molecules, including B-cell lymphoma 2 (Bcl-2), 2B4
(CD244), programmed cell death 1 (PD-1), glycoprotein CD160, T-cell im-
munoglobulin domain and mucin domain 3 (Tim3), lymphocyte-activation
gene 3 (LAG3), and cytotoxic T-lymphocyte-associated Protein 4 (CTLA4).
(A) Exemplary overlaying histograms of Bcl-2, 2B4, PD-1, CD160, Tim3,
LAG3 and CTLA4. Numbers in each histogram indicate the mean uores-
cence intensity (MFI) values for the indicated marker. Antigen-experienced
wild type (in blue) and IRF4-decient CD8+ T cells (in red) were pre-gated
for viable CD3+ CD4- CD8+ T cells. Not ag-experienced IRF4-decient
CD8+ T cells are shown in yellow and WT CD8+ T cells in green.
the CD8+ T cell subset of IRF4KOCD8 or WT mice compared to their control cells
(not ag-experienced), neither any dierences between both CD8+ T cell subsets from
infected WT and IRF4KOCD8 mice. Taken together, IRF4-deciency did not result in
an increased expression of pro-apoptotic molecules on CD8+ T cells. These results sug-
gest that the huge impairment in the quality and quantity of ag-speccic CD8+ T cells
already early during the eector phase of the T cell response against invading pathogens
is not due to enhanced exhaustion.
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Chapter 10
IRF4 expression levels dictate the
onset of CD8+ T cell contraction
10.1 Regulation of the IRF4 expression
To determine whether the levels and maintenance of IRF4 expression were aected
by the strength of the TCR signaling, naïve OT1 TCR-transgenic CD8+ T cells were
stimulated with three dierent anity peptides, T4, Y3, and N4, leading to a weak,
intermediate, or strong TCR stimulation, respectively. IRF4 expression levels were
examined by intracellular staining. The stimulation with all three peptides induced
IRF4 expression in OT1 cells and increased to similar MFI values after 24 hours of
stimulation (Figure 10.1). Nevertheless, activation with the high-anity OT1 TCR
ligand peptide N4 maintained the IRF4 expression level high for several days, while
OT1 T cells stimulated with the intermediate and low-anity peptides (Y3 and T4)
showed an anity-dependent decline in the IRF4 expression already after 48 hours after
stimulation. Nevertheless, also the expression of IRF4 via strong TCR signaling was
only transient.
10.2 Strong TCR signaling and normal environment could
not rescue IRF4-decient CD8+ T cells
Represented results of this study show (in Chapter 8) that mice with IRF4-decient
CD8+ T cells generate drastic lower numbers of ag-specic eector cells after bacterial
and viral infection compared to that of control mice. Therefore, the present analysis
wanted to investigate whether strong TCR signals combined with a wild type environ-
ment might rescue the IRF4-decient phenotype.
To test this, an adoptively transfer experimental setup based on OT1 TCR transgenic
CD8+ T cells was performed, with CD8+ T cells expressing an H-2Kb OVA-specic
T cell antigen receptor. Bacterial infections were performed with a recombinant Liste-
ria monocytogenes strain expressing the high TCR anity ovalbumin derived SIINFEKL
epitope (N4). Thus, on day -1, puried naïve WT and IRF4-decient OT1 cells, both
cell subsets having a transgenic TCR for ovalbumin, were mixed in equal proportions
and adoptively transferred i.v. into naïve wild type CD45.1 recipient mice that were
infected with OVA expressing Listeria (LM-OVA) 24 hours later, illustrated in Fig-
ure 10.2A. Of interest, transferred OT1 cells could be distinguished from endogenous
CD8+ T cells via the congenic marker expression of CD45.1 and CD45.2 on T cells.
Wild type OT1 cells being CD45.1- CD45.2+ CD90.1+ could be easily distinguish from
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Figure 10.1: Changes in the kinetic of the IRF4 expression is TCR strength-
depend. Ovalbumin-specic TCR-transgenic CD8+ T cells from un-
treated OT1 mice were naïve sorted (viable CD3+ CD4- CD44- CD62+)
and invitro stimulated with SIINFEKL derived altered peptide ligands of
Ovalbumin that vary in their potency to activate OT1 cells. (N4, Y3,
and T4). IRF4 expression levels were determined at the indicated time
points of invitro cultured from N4 (high anity), Y3 (intermediate an-
ity), and T4 (low anity) stimulated cells by intracellular staining via ow
cytometry. (A) Frequencies of IRF4 expression in CD8+ T cells are shown.
Data are representative of two independent experiments with similar re-
sults.
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IRF4-decient OT1 cells being CD45.1- CD45.2+ but CD90.1 negative.
The expansion of both transferred cell populations, each congenically dierent marked,
was equal till day 3 after Listeria infection, as the ratio between both cell subsets main-
tained 1:1 (Figure 10.2C), as initially transferred (Figure 10.2B). Of note, from day 4
on, the proportion of IRF4-decient OT1 cells in spleen was dramatically declined to
almost not detectable levels on day 7 after infection. Present results speculated, that
this drastic observed discrepancy might be due to dierent homing capacities, as IRF4-
decient CD8+ T cells did not clear the L-selectin molecule CD62L from their cell
surface. But despite their maintained CD62L expression, IRF4-decient CD8+ T cells
were not found enriched in secondary lymphoid organs, like spleen and lymph nodes,
and were detected in drastically lower numbers in the same organs as WT CD8+ T cells
being CD62Llow. These results give the evidence that strong TCR signaling combined
with a normal environment can not rescue IRF4-decient CD8+ T cells. The results of
this study suggest that IRF4-decient CD8+ T cells have intrinsic defects, which could
not be rescued via strong TCR signaling activation or wild type environment.
10.3 IRF4 deciency impacts the kinetic of T cell expansion
Results, obtained in this study and also by other investigators [27, 86, 142, 162, 262],
could show that IRF4 expression is induced in naïve CD8+ T cells after TCR ligand
interaction (Section 8.1). Additionally, its expression kinetic and magnitude in CD8+
T cells is tightly linked to the strength of the TCR activation signal. Measurements
performed in this study to analyze the IRF4 expression kinetic after stimulation with
dierent anity epitopes of ovalbumin (N4, Y3, T4) in transgenic CD8+ T cells (ex-
pressing an H-2Kb OVA-specic TCR), are in agreement with recently published similar
ndings [163]. Therefore, this study wanted to examine whether IRF4 deciency mimics
low TCR signaling and therefore leads to a false translation of the strong TCR signal-
ing, which actually induced the activation of the naïve CD8+ T cell. This has led us
to ask if IRF4-decient CD8+ T cells in the end just suer the same fate as wild type
CD8+ T cells, which has been activated via weak TCR ligand interaction. As it has
been shown that low anity activated CD8+ T cells display an earlier termination of
the expansion phase [264]. Furthermore, Zehn and colloquies [264, 265] have demon-
strated that those low anity T cells go through fewer cell divisions or even disappear,
and acquire reduced eector potential, as they acquire a more memory-like phenotype
(KLRG1-) and being CD62Lhigh, a characteristic of central-memory T cells.
To test this hypothesis, naïve wild type OT1 and IRF4-decient (IRF4KOCD8) OT1
TCR transgenic CD8+ T cells were adoptively co-transferred into CD45.1 wild type
recipient mice. One day later, recipient mice were i.v. infected with a recombinant Lis-
teria monocytogenes strain expressing OVA protein, either containing the low anity
epitope SIITFEKL (T4) or the high anity epitope SIINFEKL (N4). The low anity
peptide T4 leads to weak TCR engagement and the high anity peptide N4 to strong
TCR engagement. Of interest, transferred OT1 cells could be distinguished from en-
dogenous CD8+ T cells via the congenic marker expression of CD45.1 and CD45.2 on
T cells. Wild type OT1 cells being CD45.1- CD45.2+ CD90.1+ could be easily distin-
guish from IRF4-decient OT1 cells being CD45.1- CD45.2+ without CD90.1 expres-
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Figure 10.2: Strong TCR signaling and normal environment could not rescue
IRF4-decient eector CD8+ T cells. (A) Scheme of the experimental
setup of the cell transfer experiment. On day -1, WT (CD45.2+ CD90.1+)
and IRF4-decient (CD45.2+ CD90.1-) OT1 cells were adoptively trans-
ferred with equally numbers into wild type CD45.1 recipient mice. One
day later, recipient mice were infected with LM-OVAN4 and transferred
cell subsets were analyzed on day 2, 3, 4 and 7 after infection. (B) Exem-
plary plot of the WT and IRF4-decient OT1 mixture for the cell transfer.
(C) The graph depicts the ratio of transferred WT (shown in blue) and
IRF4-decient CD8+ T cells (shown in red) in spleen on day 2, 3, 4, and
7 after infection. Transferred and endogenous CD8+ T cells were distin-
guished from each other via their congenic marker expression.
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sion (Figure 10.3A). On day 5 after infection, mice were sacriced and the proportions
of transferred WT OT1 and IRF4-decient OT1 TCR transgenic CD8+ T cells from
spleen of recipient mice were analyzed. Not surprisingly, in recipient mice, which have
been infected with LM-OVA expressing the high anity TCR epitope N4 (SIINFEKL),
the majority of transferred OT1 cells consists of WT OT1 cells (Figure 10.3A upper
row). In contrast, IRF4-decient OT1 cells were greatly outnumbered, as they repre-
sented just one quarter of the transferred cell population (Figure 10.3A, lower row).
These results are in agreement with the present results in Section 10.2 of this study
showing that IRF4-decient OT1 cells initially proliferate after LM-OVAN4 infection
but already drastic decline in numbers from day 4 on after infection. Of great interest,
in recipient mice, which have been infected with LM-OVA expressing the low anity
TCR epitope T4 (SIITFEKL), both transferred cell populations expanded equally, as
the ratio between both cell subsets maintained 1:1, as initially transferred (Figure 10.3A,
lower row).
As already indicated by the approximately 1:4 ratio of transferred WT OT1 cells
to IRF4-decient OT1 cells from spleen of recipient mice, which have been infected
with LM-OVAN4, determination of the total numbers of transferred OT1 cells per
10.000 endogenous CD8+ T cells revealed drastically reduced numbers of IRF4-decient
OT1 cells compared to WT OT1 cells with up to 5-fold dierences (Figure 10.3B). This
result suggests that IRF4-decient OT1 cells could not translate the strong activating
TCR signal into an appropriate developmental and transcriptional program, as the WT
OT1 cells did, which formed a proper population after strong TCR engagement.
Additionally, analysis of the total numbers of transferred OT1 cells from spleen of
recipient mice was performed, which have been infected with the LM-OVAT4, inducing
an activation via weak TCR signaling. On day 5 after transfer, very similar numbers of
WT and IRF4-decient OT1 cells per 10.000 endogenous CD8+ T cells were detected
in spleens of recipient mice (Figure 10.3B). This was not surprising, as this equal distri-
bution was already indicated by the maintained 1:1 ratio of the transferred OT1 cells
from spleen of recipient mice, which were observed after LM-OVAT4 infection.
Of great interest, determination of the total numbers of transferred OT1 cells popula-
tions per 10.000 endogenous CD8+ T cells revealed very similar numbers comparing the
numbers of IRF4-decient OT1 cells from recipient mice, which have been infected with
LM-OVAN4, and WT or IRF4-decient OT1 cells from recipient mice, which have been
infected with LM-OVAT4. These results suggest that the dierentiation and expansion
of the IRF4-decient OT1 cells were similar to WT OT1 cells, which have been activated
via low TCR engagement. Therefore, these results strongly suggest that IRF4-deciency
mimics weak TCR signaling, independent of the actually signaling strength, leading to
a developmental and transcriptional program very similar to the one being initiated in
WT CD8+ T cells, which have been activated via weak TCR signaling.
Present analysis further examined whether both transferred cell populations show the
same increased susceptibility to death when the activation was induced via weak TCR
engagement. As in fact, weak TCR signaling activation in wild type T cells has been
shown to result in an earlier termination of the clonal expansion and an earlier onset
of contraction [264]. This study therefore suggest that IRF4 deciency translates any
TCR signal into a weak TCR activation signal, which in turn triggers the premature
onset of contraction due to initiation of death and phagocytosis of those cells. In line
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Figure 10.3: IRF4 deciency impacts the CD8+ T cell fate decision. Wild
type OT1 and IRF4-decient OT1 TCR transgenic CD8+ T cells were
adoptively co-transferred into CD45.1 wild type recipient mice. One day
later, recipient mice were i.v. infected with a recombinant Listeria mono-
cytogenes strain expressing OVA protein, either containing the low anity
epitope SIITFEKL (T4) or the high anity epitope SIINFEKL (N4). On
day 5 after infection, mice were sacriced and the proportions of trans-
ferred WT OT1 and IRF4-decient OT1 TCR transgenic CD8+ T cells
from spleens of recipient mice were analyzed. Cells were distinguished,
from each other and endogenous CD8+ T cells, via their congenic marker
expression. (A) Exemplary plots (left) show CD90.1 and CD45.2 stain-
ing of transferred WT OT1 (shown in blue) and IRF4-decient OT1 cells
(shown in red). Histograms display the ratio of transferred OT1 cells and
numbers indicate the frequencies of WT OT1 (shown in blue) and IRF4-
decient OT1 cells (shown in red). (B) Total cell numbers of transferred
WT and IRF4-decient OT1 cells per 10.000 endogenous CD8+ T cells.
Each symbol in (B) represents an individual mouse and small horizontal
lines indicate the average.
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with this hypothesis, presented previous data of this study already have been shown that
IRF4-decient CD8+ T cells suer from several apoptotic inducing pathways, leading
to programmed cell death or clearance via phagocytosis, on day 5 after infection of
IRF4KOCD8 mice. Thus, the present study analyzed the surface expression of the anti-
apoptotic molecule Bcl-2, the death receptor expression of FAS, and the exposure of
phosphatidylserine on the cell surface, which act as an eat-me signal for phagocytic
cells, on both transferred cell populations.
Indeed, as shown in Figure 10.3A, WT OT1 cells, which have been activated via
strong TCR engagement (N4) expressed high levels of Bcl-2 on their cell surface (line
in dark blue). In contrast, IRF4-decient OT1 cells (shown in orange), as well as WT
OT1 cells (shown in light blue), which have been activated via weak TCR ligand inter-
action by T4, similarly expressed much lower levels of the Bcl-2 molecule, which has
been shown to prevent cells to undergo cell death [80, 144]. Additionally, the expose
of phosphatidylserine (PS) on the cell surface of both transferred cell populations was
analyzed. Surprisingly, WT OT1 cells (shown as light blue line) and IRF4-decient
OT1 cells (shown in orange), which have been activated by low anity peptide T4,
exposed similarly high levels of PS on their cell surface, as determined by the An-
nexinV staining on day 5 after LM-OVAT4 infection (Figure 10.3B). Analysis of the
frequency of AnnexinV positiv WT OT1 (shown in blue) and IRF4-decient (shown
in red) OT1 cells, which have been activated via low TCR signaling, showed similar
frequencies of CD8+ T cells, which showed a increased PS exposure on their cell sur-
face, as indicated via AnnexinV staining (Figure 10.3C). This indicates that both cell
types are highly endangered by recognition and uptake by phagocytes. In contrast, WT
OT1 cells, which have been primed via the high anity epitope N4 exposed almost none
PS on their surface, as shown by the low AnnexinV staining in Figure 10.3A (as dark
blue line).
Furthermore, measurements of the FAS expression levels on the cell surface of WTOT1
and IRF4-decient OT1 cells were performed, which have been primed via low anity
epitope T4 (Figure 10.3D). Interestingly, both cell subsets activated via weak TCR en-
gagement, displayed very high death receptor expression (Figure 10.3E), which led to
higher susceptibility to programmed cell death, mediated via caspase activation.
In sum, these results give evidence that IRF4 deciency mimics low anity and weak
TCR engagement, which in turn leads to a premature termination of the expansion
phase and a drastically decrease of the eector cell subset. Furthermore, these results
show that IRF4 deciency initiates, independent of the strength of the TCR ligand
interaction, an early contraction of the eector CD8+ T cell population, similar to the
fate that occurs to weak TCR signaling activated wild type CD8+ T cells. Interestingly,
present results could show that IRF4-decient CD8+ T cells, similar to weak TCR
signaling activated wild type CD8+ T cells, are eciently eliminated via the activation
of multiple death inducing pathways.
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Figure 10.4: IRF4 deciency mimics weak TCR activation signaling. Wild type
OT1 and IRF4-decient OT1 TCR transgenic CD8+ T cells were adop-
tively co-transferred into CD45.1 wild type recipient mice. One day later,
recipient mice were i.v. infected with a recombinant Listeria monocytogenes
strain expressing OVA protein, either containing the low anity epitope SI-
ITFEKL (T4) or the high anity epitope SIINFEKL (N4). On day 5 after
infection, mice were sacriced and the proportions of transferred WT OT1
and IRF4-decient OT1 TCR transgenic CD8+ T cells from spleens of re-
cipient mice were further analyzed. Cells were distinguished, from each
other and endogenous CD8+ T cells, via their congenic marker expres-
sion. Transferred cell polulations were analyzed for their Bcl-2 and FAS ex-
pression, and for their exposure of phosphatidylserine (PS) via AnnexinV
staining. (A) Exemplary overlaying histogram of the Bcl-2 expression on
transferred OT1 cells of the indicated cell subset. (B) Exemplary over-
laying histogram of AnnexinV staining on the cell surface of transferred
OT1 cells of the indicated cell subset, representing PS exposure on the cell
surface. (C) Frequency of PS exposure on OT1 cells of the indicated cell
subset, according to their AnnexinV staining. (D) Exemplary overlaying
histogram of the FAS expression on transferrred OT1 cells of the indicated
cell subset. (E) Frequency of FAS expression on OT1 cells of the indicated
cell subset. Cell subsets in (A), (B), and (D) represent LM-OVAN4 acti-
vated WT OT1 cells in dark blue, LM-OVAT4 activated WT OT1 cells in
light blue and LM-OVAN4 IRF4-decient OT1 cells in orange. Cell subsets
in (C) and (E) represent LM-OVAN4 activated WT OT1 cells in red and
IRF4-decient OT1 cells in blue. Graph show the mean + SEM.
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Chapter 11
Cytokines impact the IRF4-decient
CD8+ T cell phenotype
11.1 The inuence of interleukins on IRF4-decient CD8+
T cells
It is well known, environmental factors, such as cytokines and chemokines, are impor-
tant for CD8+ T cell proliferation and dierentiation. Furthermore, cytokines like IL2
and IL12 have an impact on the dierentiation and longevity of CD8+ T cells [253, 257].
Several publication have shown the inuence of IL7 and IL15 to maintain T cell home-
ostasis [64, 238]. Recent results of this studies showed, IRF4 deciency led to diminished
expansion and to reduced viability of eector CD8+ T cells, starting around day 4 after
primary bacteria encounter (Figure 10.2). As IRF4-decient CD8+ T cells could not
be rescued in vivo, neither via strong TCR signaling activation nor due to a wild type
environment (Section 10.2), the question raised whether ex vivo cytokine supply could
support IRF4-decient CD8+ T cells to overcome their proliferation problems and the
increased susceptibility to cell death.
To determine whether IRF4-decient CD8+ T cells can be rescued when such en-
vironmental factors are available, an ex vivo culture of in vivo primed OT1 cells were
performed. Cells were treated with dierent cytokines (listed in Table 5.12). Puried
naïve WT and IRF4-decient OT1 cells (Section 6.9), both cell subsets having a trans-
genic TCR for ovalbumin, were mixed in equal proportions and adoptively transferred
i.v. into naïve wild type CD45.1 recipient mice one day prior infection. Recipient mice
were infected with a recombinant Listeria monocytogenes strain expressing ovalbumin
derived SIINFEKL epitope N4 (illustrated in Figure 10.2A). On day 4 after LM-OVA
infection, both transferred OT1 cell subsets were re-isolated, according to their congenic
marker expression, from infected spleens of recipient mice, and further cultivated under
dierent cytokine conditions.
In detail, transferred OT1 cells (CD45.2+) could be distinguished from endogenous
CD8+ T cells (CD45.1+) via the congenic marker expression of CD45.1 and CD45.2
on T cells. Wild type OT1 cells being CD45.1- CD45.2+ CD90.1+ could be easily dis-
tinguish from IRF4-decient OT1 cells being CD45.1- CD45.2+ but CD90.1 negative.
To monitor cell proliferation, cells were prior labeled with ProliferationDyeV450 (Sec-
tion 5.10). From the start of the culture, the dye was equally distributed between the
daugther cells, as with each further cell division a successive halving the uorescent dye
occurred. Cells were cultured in supplemented RPMI medium with either IL2 (20U),
IL7, IL12, or IL15.
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As shown in Figure 11.1 the division prole between wild type and IRF4-decient
OT1 cells altered between dierent cytokine conditions, on day 3 of ex vivo culture. Al-
most in all treatments, wild type OT1 cells compared to IRF4-decient CD8+ T cells
showed a higher overall proliferation rate, being highest with IL2 treatment and lowest
with IL12, indicated by the reduction of the proliferation dye. Further analysis of the
frequency of cell clones, which showed high proliferation (indicated with orange) addi-
tionally observed highest frequencies of WT and IRF4-decient CD8+ T cells with IL2
treatment. Although, treatment with IL12 showed highest frequencies for intermediate
proliferating clones. Nonetheless, IL12 treatment induced the lowest proliferation of
both cell subsets, as the comparison of the frequencies of not proliferating cells was
highest with IL12 treatment.
Similar to WT OT1 cells, IRF4-decient OT1 cells showed the highest proliferative
capacity when the medium was supplemented with IL2 and the lowest proliferation
capacity with IL12 treatment. However, IRF4-decient OT1 cells proliferated more
than WT when treated with IL15. Nevertheless, the highest increase in the proliferative
capacity after 3 days of ex vivo cultivation could be observed in both cell types with IL2
supplemented medium. These results indicate that the proliferative capacity of in vivo
primed IRF4-decient CD8+ T cells can be inuenced by cytokine treatment, while IL2
had the highest impact on the proliferative capacity and survival.
Previous results in this study indicated a drastically increase in the proliferative capac-
ity of in vivo primed IRF4-decient OT1 cells when they were further ex vivo cultivated
with IL2, as shown in Chapter 11. Therefore, this study wanted to investigate whether
high IL2 concentration leads in turn to a further increase in the proliferative capac-
ity of IRF4-decient CD8+ T cells and may rescue the IRF4-decient phenotype. To
determine whether the enhancement of the proliferative capacity is IL2 concentration
dependent, a similar experiment was performed, as described previously in Chapter 11.
On day 4 after LM-OVA infection, transferred WT and IRF4-decient OT1 cells were
re-isolated to perform an ex vivo culture under dierent IL2 concentrations, ranging
from 0 - 50U. As shown in Figure 11.2A, the proliferation rate of WT OT1 cells could
be increased due to ex vivo IL2 treatment of the cells in a concentration dependent
manner. Of interest, the proliferative capacity of IRF4-decient OT1 cells increased
similarly IL2 concentration dependent but not with the same intensity. Although IRF4-
decient OT1 cells proliferated much better in the presents of high IL2 concentrations,
they could not reach the same proliferative capacity like WT OT1 cells (Figure 11.2B).
These results show that ex vivo treatment with high IL2 concentrations can partially
rescue the diminished proliferative capacity of IRF4-decient CD8+ T cells. Further-
more, they imply a special role for soluble factors like IL2 that promote T cell survival
and proliferation.
As mentioned earlier in Chapter 7, IRF4 deletion in matured CD8+ T cells leads to
the expression of eGFP after CRE-mediated recombination. Naive IRF4-decient CD8+
T cells from IRF4ox.E8Icre (IRF4KOCD8) and OT1.IRF4ox.E8Icre (OT1.IRF4KOCD8)
mice were always FACS sorted according to their surface marker expression (CD3+ CD4-
CD8+ CD44- CD62L+) and their eGFP expression. Of interest, results could observe
that under certain circumstances, some of the eGFP+ IRF4-decient OT1 cells loose
their eGFP expression under stressful conditions, such as bacterial encounter during
infection or low cytokine supply (Figure 11.2C/D). The examined successively disap-
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Figure 11.1: Ex vivo cytokine treatment inuences the proliferation of in vivo
primed IRF4-decient CD8+ T cells. Wild type (CD45.2+ CD90.1+)
and IRF4-decient (CD45.2+ CD90.1-) OT1 cells were adoptively trans-
ferred with equal numbers into wild type CD45.1 recipient mice. One day
later, recipient mice were infected with LM-OVA and transferred OT1 cell
subsets were re-isolated on day 4 after Listeria infection. Puried OT1 cells
were further ex vivo cultured with dierent cytokines, such as IL2, IL7,
IL12, and IL15. (A) Exemplary histograms of the proliferation dye dilu-
tion due to cell divisions on the cell surface of either WT (upper row) or
IRF4-decient (lower row) OT1 cells. Cells in the histrograms are divided
into 3 groups, namely strong proliferating cells ( indicated with orange),
intermediate proliferating cells (indicated with green), and not proliferat-
ing cells (indicated in violet). (B) The graph depicts the percentage of the
3 dierent groups depending on their proliferation rate of cells, identied by
reduced proliferation dye labeling, which were treated with the indicated
cytokine. WT OT1 cells are shown in blue and IRF4-decient CD8+ T cells
in red.
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pearance of the eGFP expression correlated with the proliferative behavior of the cells.
Results observed an upregulation of eGFP expression in proliferating cells. When fur-
ther cultivation without IL2 supplementation occurred, in vivo primed IRF4-decient
OT1 cells proliferated very poorly and almost all showed no eGFP expression anymore
after 3 days of ex vivo culture. In contrast, treatment with low or intermediated IL2
concentrations led to a separation into eGFP expressing and non-expression cells (Fig-
ure 11.2C). The ratio of eGFP+ and eGFP- cells was strongly inuenced by the IL2
concentration, as higher IL2 concentrations resulted in higher frequencies of eGFP ex-
pressing IRF4-decient OT1 cells (Figure 11.2D).
Present results observed that ex vivo cultured IRF4-decient OT1 T cells can be
partially rescued via treatment with high IL2 concentrations but nevertheless cytokine
treatment was not able to completely overcome the intrinsic problems of IRF4-decient
eector CD8+ T cells.
Interestingly, during the CD8+ T cell expansion phase IRF4-decient CD8+ T cells
showed decreased expression of the IL-2Rβ (CD122) compared to their WT counterparts.
This is shown in Figure 11.3. That might be a reason why IRF4-decient CD8+ T cells
can just partially be rescued by addition of IL2, because IL2 signaling is diminished due
to less receptor expression on the cell surface of ag-specic CD8+ T cells in the absence
of IRF4.
11.2 The impact of IL2 treatment during in vitro priming
for the IRF4-decient CD8+ T cells
Although, recent data claimed that IRF4-decient CD8+ T cells could not be rescued
by addition of high amounts of IL2 (in vitro) [188], presented results of this study
observed that ex vivo cultured IRF4-decient CD8+ T cells, could be partially rescued
via treatment with high amounts of recombinant IL2. Several publications demonstrated
that, in general, IL2 signaling promotes the generation of eector cells and longevity.
Therefore the question raised whether the IRF4-decient phenotype of CD8+ T cells,
which was detected early during immune response during the premature clonal expansion
phase, could be altered or even rescued due to a priming of those cells in the presents
of high IL2 amounts. Adoptive transfer experiments of in vitro primed OT1 cells were
performed to test this hypothesis. A scheme of the experimental setup is shown in
Figure 11.4.
Naive sorted (viable, CD3+ CD4- CD8+ CD44- CD62L+) WT and IRF4-decient
(eGFP+) OT1 cells, isolated from spleen and lymph nodes from untreated mice, were
in vitro primed with anti-CD3 and the co-stimulatory molecule anti-CD28. To moni-
tor cell proliferation, cells were prior labeled with ProliferationDyeV450 (Section 5.10).
From the start of the culture, the dye was equally distributed between the daugther cells,
as with each further cell division a successive halving the uorescent dye occurred. Cells
were cultured separately in supplemented RPMI medium with additional IL2 supply in
dierent concentrations (1U, 10U, and 50U).
After in vitro culture for 4 days, WT and IRF4-decient OT1 cells were rst analyzed
for their proliferation rate (Figure 11.5A). WT OT1 cells and IRF4-decient OT1 cells
proliferated nicely with 10U and 50U IL2 supplement, as indicated by the dilution of the
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Figure 11.2: Ex vivo IL2 treatment alters the proliferation capacity of CD8+
T cells concentration dependent. Wild type (CD45.2+ CD90.1+) and
IRF4-decient (CD45.2+ CD90.1-) OT1 cells were adoptively transferred
with equal numbers into wild type CD45.1 recipient mice. One day later,
recipient mice were infected with LM-OVA and transferred OT1 cell sub-
sets were re-isolated on day 4 after Listeria infection. Puried OT1 cells
were further ex vivo cultured with dierent IL2 concentrations (ranging
from 0 - 50U). (A) Graph shows the numbers of WT OT1 cells cultivated
with dierent IL2 concentrations on day 1, 2, and 3 after ex vivo culture.
(B) Graph shows the numbers of IRF4-decient OT1 cells cultivated with
dierent IL2 concentrations on day 1, 2, and 3 after ex vivo culture .
(C) Exemplary dot plot of IRF4-decient OT1 cells ex vivo cultivated for
3 days with dierent IL2 concentrations. No IL2 supply is shown in green,
while the administration of 2.5U IL2 is shown in gray and 50U in vio-
let. (D) Graph show the percentage of IRF4-decient OT1 cells expressing
eGFP dependent on the IL2 concentration, which was supplied.
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Figure 11.3: IRF4 deciency alters the expression of CD122 on ag-specic
CD8+ T cells. Wild type (WT) and IRF4KOCD8 mice were infected
with lymphocytic choriomeningitis virus (LCMV) Armstrong. Splenocytes
were surface stained with viability dye, anti-CD3, CD4, and CD8 antibody.
Splenic GP33-specic CD8+ T cells were analyzed via tetramer staining
on day 8 after LCMV Armstrong infection. (A) Exemplary overlaying his-
togram of the CD122 expression on splenic GP33-specic WT and IRF4-
decient CD8+ T cells. (B) Graph shows the percentages of CD122 ex-
pressing GP33-specic CD8+ T cells of the indicated mouse strain. Graph
in (B) shows the mean + SEM. WT CD8+ T cells are indicated in blue and
IRF4-decient CD8+ T cells are indicated in red. Data are representative
of two independent experiments with similar results (4-5 mice per group).
Data show statistical signicance with *p<0.05 (Student's t test).
Figure 11.4: Scheme of a co-transfer experiment of in vitro primed OT1 cells.
Naive sorted (viable, CD3+ CD4- CD8+ CD44- CD62L+) WT and IRF4-
decient (eGFP+) OT1 cells isolated from spleen and lymph nodes from un-
treated mice were in vitro primed with anti-CD3/anti-CD28 with dierent
amounts of IL2. On day 4 after culture, WT (CD45.2+ CD90.1-) and IRF4-
decient (CD45.2+ CD90.1+) OT1 cells primed under the same condition
were equally mixed and adoptively co-transferred into WT (CD45.1+) re-
cipient mice, which was subsequently infected with LM-OVA. On day 4
after infection, mice were sacriced and organs were analyzed for their pro-
portions of transferred OT1 cells.
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Figure 11.5: Increased proliferation rate of IRF4-decient CD8+ T cells by
addition of high amounts of IL2. Naive sorted (viable CD3- CD4-
CD8+ CD44- CD62L+) wild type and IRF4-decient (additionally GFP+)
OT1 cells were stimulated with aCD3/aCD28 in medium, which was sup-
plemented with dierent IL2 concentrations. Before cell culture, cells were
stained with ProliferationDyeV450 to monitor cell division. (A) Exem-
plary histograms of the proliferation dye dilution due to cell divisions on
the cell surface of either WT (shown in blue) or IRF4-decient (shown in
red) OT1 cells cultured for 4 days with dierent IL2 amounts as indicated.
(B) Graph depicts the mean uorescence intensity (MFI) values of the pro-
liferation dye of WT and IRF4-decient OT1 cells cultured for 4 days with
dierent IL2 amounts as indicated.
proliferation dye. As expected, the proliferation rate of both cell subsets was strongly
IL2 concentration dependent, as high amounts of IL2 increased the proliferative capacity
and low IL2 concentration led to diminished expansion (Figure 11.5B). This impaired
proliferation capacity was drastic in IRF4-decient CD8+ T cells, which proliferated
very poorly under this condition. An addition of high amounts of IL2 (50U) led to a
similar proliferation rate of IRF4-decient OT1 cells and their WT counterparts, almost
showing the same dilution of the proliferation dye after 4 days of in vitro culture.
Harvested cells were washed and both OT1 cell populations, which were primed
with the same amount of IL2 were equally mixed Figure 11.6A/B. Afterwards, this
congenically marked WT (CD45.2+ CD90.1-) and IRF4-decient (CD45.2+ CD90.1+)
OT1 cell mixtures were co-transferred into WT (CD45.1+) recipient mice, which was
subsequently infected with LM-OVA. After antoher 4 days, infected mice were harvested
and spleen, lymph nodes, blood and liver were analyzed for the proportions of transferred
OT1 cells.
Substantially greater proportions of WT OT1 cells relative to the proportion of IRF4-
decient OT1 cells were observed in spleen, lymph nodes, blood, and liver, as shown in
Figure 11.7A-D. This trend was observed in all organs tested and for all IL2 priming con-
ditions. The priming with dierent IL2 amounts did not led to an increased proportion
of WT OT1 cells in spleen and lymph nodes. However, analysis of the WT proportion
in blood and liver revealed signicantly increased proportion of WT OT1 cells, which
were primed with 50U IL2 compared to low IL2 (1U) addition. This was also observed
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Figure 11.6: Co-transfer of equally distributed IRF4-decient and WT OT1
cells after in vitro priming with IL2. WT and IRF4-decient OT1 cells
were mixed in a 1:1 ratio after in vitro priming with dierent IL2 amounts.
Before adoptive transfer of congenically marked OT1 cells was performed,
the ration of mixed cells was analyzed. (A) Exemplary histograms show
the ratio of each mixture of WT and IRF4-decient OT1 cells, which was
adoptively transferred into WT mice. (B) Graph shows the frequencies
of WT and IRF4-decient OT1 T cells, of the mixture which was primed
under the indicated condition.
for IRF4-decient OT1 cells, were cells which were primed with high amounts of IL2
(50U) showed a signicantly increase in proportion located in blood and liver of infected
recipient mice, compared to low IL2 (1U) primed cells.
Analysis of the dierentiation pattern of WT and IRF4-decient OT1 cells in the
spleen of infected recipient mice observed a similar expression of CD44, independent
on the initial priming condition, as shown in Figure 11.8. This suggests that both cell
proportions of each condition showed an similar activation status. Interestingly, also in
this experimental setup, IRF4-decient CD8+ T cells maintained CD62L expression in
all three conditions analyzed. In contrast, WT OT1 cells cleared the L-selectin from
their cell surface after activation as expected.
Nonetheless, these results show that addition of high amounts of IL2 during the
priming phase of IRF4-decient OT1 cells could not rescue ag-specic eector cells
during the early cause of Listeria infection. Overall, these ndings indicate a defect in
the ability to clonal expand to the same extend like the WT OT1 proportion. This
suggests that high amounts of IL2 supply during the priming phase and activation of
IRF4-decient CD8+ T cells is less important, compared to later time points during the
expansion phase of eector CD8+ T cells. This assumption was made based on the data
of this study, which showed that ex vivo addition of high amounts of IL2 could partially
rescue the ag-specic CD8+ T cells with IRF4 deciency and could signicantly increase
their proliferative capacity.
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Figure 11.7: Proportions of in vitro primed WT and IRF4-decient OT1 cells
in infected recipient mice. The proportions of in vitro primed WT
(CD45.2+ CD90.1-) and IRF4-decient (CD45.2+ CD90.1) OT1 cells after
adoptively co-transfer into WT (CD45.1+) mice, which were subsequently
infected with LM-OVA, were analyzed. Transferred OT1 cell proportions
in spleen (A), lymph nodes (B), blood (C), and liver (D) are shown in the
graphs. WT OT1 cells are shown in blue and IRF4-decient OT1 cells
in red. Cells were primed with aCD3/aCD28 and dierent amounts of IL2
(1U, 10U, and 50U). Data show the mean + SEM and statistical signifcance
with **p<0.001 and *p<0.05 (Student's t test).
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Figure 11.8: In vitro primed IRF4-decient OT1 cells maintain CD62L expres-
sion in infected recipient mice. The proportion of WT (CD45.2+
CD90.1-) and IRF4-decient (CD45.2+ CD90.1) OT1 cells, which were
adoptively co-transferred into WT (CD45.1+) mice, which were subse-
quently infected with LM-VA, were analyzed for their dierentiation pat-
tern. The expression of CD44 and CD62L was examined via surface staining
on WT and IRF4-decient OT1 cells from spleen of infected recipient mice.
(A) Exemplary histograms show the CD44 expression on WT ( in blue)
and IRF4-decient (in red) OT1 cells on day 4 after Listeria infection of





Special features of the
IRF4ox.E8Icre mice
12.1 IRF4 expression is exclusively absent in mature CD8+
T cells
Previous studies have already pointed out the essential role of IRF4 for a proper CD8+
T cell response against infection [86, 142, 162, 163, 166, 188, 262]. Several of these
experiments have been done using a transgenic mouse model based on the Cre-Lox
recombination technology [1, 83, 84, 218]. The advantage of this gene knockout system
by its self is that the gene of interest is selectively inactivated in a cell specic manner.
The majority of investigators of the above mentioned publications showed the essential
role of IRF4 in CD8+ T cell responses due to infection in IRF4ox mice [113] mated
with CD4cre mice. In this transgenic mouse model, the Cre protein expression causes
a recombination under the control of the Cd4 regulatory elements [130]. The Cd4
promoter therefore drives the Cre expression. Thus, when the Cd4 promoter becomes
active, the Cre protein expression causes the loxP sites to recombine and excise the LoxP-
anked IRF4 locus (known as oxed), hence progressively removing the IRF4 protein
expression in all αβT cells [162]. The fact remains, that mature CD4+ and CD8+
single positive T cells arise from double positive (DP) CD4+CD8+ T lymphocytes [63].
Therefore, transgenic IRF4ox.CD4cre mice lack IRF4 expression in both, the CD4+
and CD8+ T cell compartment, as the IRF4 deletion is initiated at the DP stage in
the thymus. It has already been published that the lack of IRF4 in CD4+ T cells has
led to dysfunctionality in several CD4+ T cell subsets, which also aects the regulatory
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T cells [267] and Th1/Th2 helper populations [85, 138], among other CD4+ T cell
subsets [21, 215].
Several studies have pointed out the requirement of CD4+ T cell help for the initiation
and persistence of the CD8+ T cell response [266]. Moreover, it has been shown that
CD4+ T cells are required for a proper primary and secondary CD8+ T cell response
[165], as well as for clonal expansion and survival of CTL [13]. Defects in CD4+ T cell
help can directly entail phenotypic and functional alterations of CD8+ T cells, as CD4+
T cells secrete cytokines and chemokines that activate and recruit other cells of the
immune system and therefore might be critically involved in controlling pathogen levels
and hence antigen load. On the basis of the above mentioned facts, experimental results
regarding the role of IRF4 for the CD8+ T cell response in IRF4ox.CD4cre mice might
be distorted due to the fact, that IRF4 expression is additionally absent in the CD4+
T cell compartment leading to results, which might be partially or completely modied
due to the loss of a proper CD4+ T cell help and not only due to the lack of IRF4
expression in CD8+ T cells.
Moreover it has been reported, that in untreated mice peripheral CD8+ T cells in
IRF4ox.CD4cre mice spontaneously convert into a memory-like phenotype and poly-
clonal activation of peripheral T cells occurs due to impaired Treg function [162]. Some
other investigators [142, 162] used bone marrow chimera models to determine the role of
IRF4 in CD8+ T cell responses. The source for the generation of these mix bone mar-
row chimera mice were performed with IRF4-decient mice created by Mittrücker and
colloquies [153]. In detail, in this mice the Exon 2 and 3 of the IRF4 gene is replaced by
a resistance gene, leading to the absence of the IRF4 protein in all developing cell types
in those mice. Importantly, there are several hints pointing out that IRF4 deciency
in all cell types and from the beginning of the onset of cell development causes several
disadvantages, which are discussed below.
It has been published that IRF4 is already critical for the T lymphoid-primed pro-
genitor cell fate to prevent conversion of these progenitors into myeloid cells at the
pre-thymic stage and for their homing to the thymus [246]. Furthermore, Nayar and
colleagues [162] demonstrated a transiently upregulation of IRF4 during the matura-
tion of CD4+CD8+ double positive into single positive CD4+ or CD8+ T cells in the
thymus. Hence, showing that IRF4 expression probably plays a critical role already in
intrathymic T cell development. However, they claim a normal thymic development of
IRF4-decient T cells. Furthermore, in intermediate CD4+ CD8low cells and CD4 single
positive thymocytes it has been recently shown that IRF4 represses Runx3 transcrip-
tion [27, 115], which is known to promote CD8 lineage commitment [258].
This present study examined the role of IRF4 in the CD8+ T cell development and
functionality during anti-pathogenic responses. In contrast to previous published data, a
conditional IRF4ox.E8Icre mice (termed as IRF4KOCD8 mice) or OT1.IRF4ox.E8Icre
mice (IRF4ox.E8Icre mice bred to transgenic OT1 mice termed as OT1.IRF4KOCD8),
were used in all experimental setups in this study. The big advantage, IRF4ox.E8Icre
mice and OT1.IRF4ox.E8Icre mice, both have a conditional deletion of IRF4 exclusively
in mature peripheral CD8+ T lymphocytes. The deletion of the IRF4 expression being
exclusively absent in mature CD8+ T cells was conrmed, going along with simultaneous
expression of eGFP in cells decient for IRF4 (Figure 7.1). Other immune cells, such
as non-lymphocytes (CD3- cells) and especially CD4+ T cells, being not aected from
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the IRF4 gene excision, as it was often the case in the recent published studies.
Before experiments started, the presence of any initial dierences between WT and
IRF4KOCD8 mice and the occurrence of any disease patterns in older mice were de-
termined. Analysis of untreated mice conrmed that there are no initial dierences in
numbers and frequencies of CD4+ and CD8+ T lymphocyte subsets, comparing num-
bers and frequencies of T cells in IRF4KOCD8 and WT mice (Figure 7.2). Additionally,
IRF4KOCD8 mice showed a normal phenotypic characterization of lymphocytes and
cell subsets were equally distributed upon all organs tested (Figure 7.3). Moreover,
IRF4KOCD8 mice showed no alteration in the B cell compartment (Figure 7.5). Fur-
thermore, mice showed no alterations in cell homeostasis and none disease pattern, such
as an enlarged spleen, also not with advanced age. As already mentioned, the mouse
model that has been used in this study allows normal homing of the T lymphoid pro-
genitor cells to the thymus, as well as a normal thymic development, and maturation of
all T lymphocytes. Neither the CD4+ nor CD8+ T cell development is aected by the
deletion of the IRF4 protein, as in IRF4ox.E8Icre mice the excision of the IRF4 gene
exclusively occurs in mature CD8+ T lymphocytes.
12.2 Untreated young and old IRF4ox.E8Icre mice
appeared phenotypically normal
Untreated IRF4KO mice, created by Mittrücker and colleagues [153], developed severe
lymhadenopathy, pointing out general defects in cell homeostasis. Up to 10-15weeks
of age, total IRF4 knock out mice showed an enlarged spleen. This occurred due to
a drastic expansion of the CD4+ and CD8+ T lymphocytes, as well as the B cell
compartment. These results suggest that, with ongoing age, those mice stay not healthy
and are therefore not similar to their wild type counterparts. This further implies that
CD8+ T cells generated in IRF4 total knockout mice might be initially altered in their
epigenetic programming, as they changed their dierentiation and homeostasis without
environmental inuences, such as infection or inammation. Therefore, the initial stage
of the IRF4-decient and sucient CD8+ T cells is not equal. IRF4-decient CD8+
T cells created by Mittrücker and colleagues [153] seem to be already directed into a
memory cell fate, which might have a further inuence on the ongoing cell development
and dierentiation during a primary infection. In addition, in the study published by
Nayar and colleagues [162] it has been claimed that the deletion of IRF4 in all αβT cells,
using mice with a conditional allele of IRF4, which was crossed to CD4cre transgenic
mice, resulted in an impaired peripheral tolerance besides the spontaneous conversion
into a memory-like phenotype of the majority of all CD8+ T cells. Further, impaired
Treg functionality resulted in polyclonal activation of peripheral T cells [267].
In contrast, untreated IRF4ox.E8Icre mice (here termed as IRF4KOCD8 mice), which
were used in this study maintained a naïve stage similar to their WT counterparts
(Chapter 7), also with advanced age. Furthermore, they did not spontaneously converted
into a memory-like phenotype (Figure 7.4) or showed any disease patterns. Indeed, also
with ongoing age, IRF4-decient CD8+ T cells from IRF4ox.E8Icre (IRF4KOCD8) mice
maintained the same phenotypic characterization and numbers of lymphocytes, as their
age matched wild type counterparts. These results strongly suggest that there are no
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alterations in the initial epigenetic programming of the CD8+ T cells in IRF4KOCD8
mice.
Chapter 13
IRF4 deciency leads to impaired
CD8+ T cell responses to infection
13.1 IRF4 expression is induced after TCR engagement
Dierent to the majority of the members of the IRF family of transcription factors,
IRF4 expression cannot be induced via IFN signaling. Instead, IRF4 expression is
rapidly upregulated after TCR activation, as already published by several studies [48,
146, 153]. As expected, recent results could show that TCR stimulation with anti-CD3
antibody and the co-stimulatory molecule anti-CD28 led to a robust expression of IRF4
in naïve murine CD8+ T cells (Section 8.1). In vitro, the expression level of IRF4 in the
murine infection model used in this study peaked between 24 and 36 hours after TCR
engagement in wild type CD8+ T lymphocytes and subsequent declined in the following
days. Thus, the induction of IRF4 expression transmits the TCR activation signal as
IRF4 act as downstream regulator of the p-MHC-TCR ligation.
13.2 IRF4 is required for the eector CD8+ T cell
generation after infection
In this study the role of IRF4 in CD8+ T cells in host defenses was determined against
the intracellular bacterial pathogen Listeria monocytogenes or against viral infection
caused by LCMV. At the peak of CD8+ T cell response, the total numbers and fre-
quencies of splenic IRF4-decient CD8+ T cells and ag-specic CD8+ T cells after
bacterial and viral infection in IRF4KOCD8 mice were drastically decreased compared
to WT mice (Figure 8.2). These results go in line with previous published data by vari-
ous groups [142, 163, 188, 262] similarly demonstrating a drastic reduction in numbers
and frequencies of ag-specic CD8+ T cells after bacterial and viral infection. Here,
it has been additionally shown that the discrepancy in the number and frequency of
OVA-specic CD8+ T cells and the altered proliferative activity, in the absence of IRF4
expression in peripheral CD8+ T cells, could already be detected on day 5 after LM-OVA
infection in IRF4KOCD8 mice. Of note, as in this study shown, this dierence in the
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CD8+ T cell response upon infection was not due to dierent initial numbers of naïve
CD8+ T cells recruited to the immune response in WT and IRF4KOCD8 mice (Fig-
ure 7.2). Therefore, the severely reduced overall quantity of ag-specic eector CD8+
T cells after infection in the absence of IRF4 expression in peripheral CD8+ T lym-
phocytes in IRF4KOCD8 mice correlated with a general reduction of the CD8+ T cell
compartment after primary response to infection (Figure 8.2). These results point out
that the lack of the transcription factor IRF4 resulted in an altered eector CD8+ T cell
generation. Thus, IRF4 is critical for the generation of ag -specic CD8+ T lymphocytes
during primary infection.
During the cause of an infection, naïve CD8+ T cells become activated and undergo
clonal expansion to generate high numbers of functional cytotoxic CD8+ T cells with
distinct eector functions to eliminate invading pathogens. To examine lymphocyte
proliferation, Ki-67 was used as a marker of proliferating cells, as KI-67 is expressed
during several phases of the cell cycle but not at the G0 phase [61].
Not surprisingly, the fraction of proliferating CD8+ T lymphocytes, as measured
by the percentage of cells expressing the marker Ki-67, was rather big in wild type
(IRF4ox) mice after Listeria infection (Figure 8.3). However, present data showed
that WT and IRF4KOCD8 (IRF4ox.E8Icre) mice had a distinct cell turnover of total
(1.5-fold dierence) and ag-specic (more than 2.5-fold dierence) CD8+ T cells during
the clonal expansion phase on day 5 after bacterial infection (Figure 8.3). Although,
Ki-67 expression occurred in total CD8+ T cells to a similar extend, as indicated by
similar MFI values. By having a closer look on SI-specic CD8+ T cells on day 5 after
bacterial infection, a drastic reduction could be examined comparing frequencies and
MFI values of the Ki-67 expression on IRF4-decient CD8+ T cells with their WT
counterparts. Thus indicating that in the absence of IRF4 expression, less ag-specic
CD8+ T cells express Ki-67, a marker selectively expressed in dividing cells [205], and
additionally to a reduced extend.
Ki-67+ CD8+ T cells were enriched in the activated CD44 expressing proportion
of IRF4-sucient CD8+ T cells in spleen and liver on day 7 after Listeria infection,
whereas less IRF4-decient CD8+ T cells expressed Ki-67 (Figure 8.3). Data revealed a
4.5-fold reduction in spleen and a 2-fold reduction in liver of Ki-67 expression on CD44+
CD8+ T cells. Overall, these data suggest a lower proliferative activity of total and
ag-specic CD8+ T cells in the absence of IRF4 expression at this stage of infection.
This proliferative defect was reected in the lower numbers and decreased frequencies of
ag-specic CD8+ T cells, found in IRF4KOCD8 mice on day 5 and day 7 after Listeria
infection (Section 8.2).
Analysis of BrdU incorporation by total IRF4-decient CD8+ T cells between day 5
and day 8 was found to be signicantly lower compared to their counterparts in WT
mice. More than double the total CD8+ T cells in WT mice were BrdU+, compared
with that by IRF4-decient CD8+ T cells in IRF4KOCD8 mice (Figure 8.4). This was
also examined in the absence of IRF4 expression for the recent activated CD8+ T cell
compartment indicated by CD69 upregulation, which showed a similar drastic reduction
in the BrdU incorporation. These results suggest reduced proliferation of IRF4-decient
CD8+ T cells compared to their WT counterparts at this early stage of infection. Thus,
IRF4 deciency in CD8+ T cells led to reduced proliferative capacity after an initial
expansion. In summary, although an activation and eector CD8+ T cell response can
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be induced in the absence of IRF4 expression, it became clear that sustained clonal
expansion of CTLs is crucial IRF4 dependent.
13.3 Remaining IRF4-decient CD8+ T cells acquire a
memory-like phenotype after infection
In WT mice, the majority of ag-specic CD8+ T cells evoked by an infection show an
eector phenotype (CD44high CD62Llow) after activation, as CD44 is rapidely upregu-
lated and L-selectin (CD62L) is cleared from the cell surface after antigen encounter.
In the infection mouse model, which was used in this study, both cell types showed
a similarly increase in the CD44 expression, indicating an antigen encounter with an
initial activation of IRF4-decient CD8+ T cells in the onset of infection. Nevertheless,
IRF4-decient CD8+ T cells showed drastic phenotypic alterations after Listeria infec-
tion compared to WT CD8+ T cells (Section 8.3). It is well known that after infection, a
heterogeneous pool of eector CD8+ T cells is formed, composed of SLECs and MPECs,
identied via their surface expression of KLRG1 and CD127 [101].
In this study as shown in Section 8.3, examination of these populations showed drastic
dierences between WT (IRF4ox) and IRF4KOCD8 (IRF4ox.E8Icre) mice on day 7
after infection. The majority of ag-specic CD8+ T cells in WT mice downregulated
CD62L and upregulated KLRG1, which is consistent with an eector phenotype. In
contrast, the few remaining IRF4-decient CD8+ T cells failed to acquire a CD62Llow
KLRG1high eector phenotype, as they maintained CD62L expression and could only
properly induce KLRG1 expression after activation (Figure 8.6). This clearly demon-
strated that this cell population showed a memory-like phenotype and could be mainly
characterized as MPEC (KLRG1low CD127high) subset. Furthermore, despite the in-
crease in the percentage of the MPEC population in IRF4KOCD8 mice, the absolute
numbers of MPECs and SLECs were drastically decreased compared to WT mice. Thus,
these results suggest that the few remaining IRF4-decient CD8+ T cells analyzed on
day 7 after Listeria infection phenotypically resembled eector memory cells (TEM). In
contrast, the CD8+ T cells in WT mice acquired a CD44high CD62Llow central memory
(TCM) phenotype (Figure 8.5).
Taken together, these data showed that IRF4 signaling is involved in the regulation of
the dierentiation pattern of CD8+ T cells. Furthermore, IRF4-decient CD8+ T cells
fail to further undergo a gradual dierentiation process into a robust eector CD8+
T cell population in an appropriate number and frequency, although an initial acti-
vation occurred. These results are in agreement with previous reports showing that
IRF4-decient CD8+ T cells fail to downregulate CD62L and upregulate KLRG1 after
antigen encounter after inuenza and LCMV infection [142, 163, 188, 261]. In sum,
IRF4 deciency leads to phenotypic alterations of the eector CD8+ T cell population
favoring memory cell formation.
Ordinarily, after activation via antigen encounter during infection, CD8+ T cells show
a rapid down regulation of the lymph node homing receptor molecule CD62L, as it is
required to facilitate the migration away from secondary lymphoid organs to the sites
of infection. However, IRF4-decient CD8+ T cells did not clear CD62L from their cell
surface after activation, as IRF4-sucient CD8+ T cells did (Section 8.4).
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To determine the eect of maintained CD62L expression, IRFKOCD8 and WT control
mice were infected with LM-OVA. On day 5 after infection, the frequencies of IRF4-
decient and IRF4-sucient CD8+ T cells among the CD11a expressing subset were
determined (Figure 8.7). In the present analysis, CD11a was used as a marker to dis-
tinguish ag-activated CD8+ T eector cells from naïve cells, as CD11a has been shown
that its expression is induced on T lymphocytes after antigen encounter but not due
to inammatory changes [190]. At day 5 after Listeria infection, no signicant dier-
ences were detected in the distribution of splenic ag-activated CD8+ T cells comparing
WT with IRF4KOCD8 mice (Figure 8.7). This result suggest that the migration and
accumulation of antigen-specic CD8+ T cells in the spleen is less dependent on the
downregulation of CD62L and therefore less aected by IRF4-deciency.
Of interest, ag-activated CD8+ T cells were found in both organs, lymph nodes and
liver, of infected IRF4KOCD8 mice. Although, the frequencies of CD11a+ CD8+ T cells
were signicantly reduced in the absence of IRF4 in mesenteric lymph nodes and the
target organ liver compared to day 5 infected WT mice (Figure 8.7). Results show over
3 to 4-fold reduction of ag-specic CD8+ T cells in the absence of IRF4 expression.
In sum, these results strengthen the presumption that the inability to downregulate
CD62L does not prevent the migration of the ag-specic CD8+ T cells to the sites
of infection, such as Listeria infected liver, although frequencies were dramatically re-
duced in this non-lymphoid peripheral tissue. These results suggest that the reduced
frequencies of IRF4-decient Listeria-specic CD8+ T cells are due to a drastic overall
reduction of ag-specic CD8+ T cells in the absence of IRF4 and not due to a defect in
the inltration or accumulation in the infected tissue.
13.4 IRF4 is indispensable for cytotoxic eector CD8+
T cell responses
To evaluate the functional activity of IRF4-decient CD8+ T cells according to their
phenotype, in this study the cytokine secretion was measured on day 7 after Listeria
infection. The production of IFNg, IL2, and TNFa were measured, as they play a major
role for the protective immune response to pathogens [108, 176].
Present results in Section 8.5 observed drastic dierences between WT and IRF4-
decient CD8+ T cells, as the few remaining IRF4-decient CD8+ T cells on day 7 after
infection were critically impaired in their cytokine production. Of note, the capacity
to produce eector molecules separately and simultaneously was strongly impaired in
IRF4-decient CD8+ T cells. Frequencies of IFNg single producers and IFNg/TNFa
and IFNg/IL2 double producers among the IRF4-decient CD8+ T cell population
were dramatically reduced, indicating a defect in single and simultaneous production
of eector molecules and therefore a conned functionality. Together, these results
indicated that the magnitude and the polyfunctionality of CD8+ T cell responses to viral
and bacterial antigens were much lower when IRF4 expression was absent in the CD8+
T cell subset. In conclusion, IRF4 is essential for the generation of eector CD8+ T cells
and their acquisition of cytokine production, as IRF4 deciency led to drastic defects in
the capability to produce eector cytokines during bacterial and viral infection. These
results are consistent with recent published studies demonstrating a strong impaiment
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in eector CD8+ T cell cytokine production in the absence of IRF4 after bacterial [188]
and viral infection, such as LCMV and inuenza [142, 262]. Therefore, IRF4-decient
CD8+ T cells showed a big disadvantage, as they lacked the ability to produce large
amounts of eector cytokines, which are important to alert other cells of the immune
system, to control infection in vivo, and to clear ecient the invading pathogens. The
decrease in the production of cytokines and cytotoxic molecules reported in this study
(Section 8.5), represents an important indicator that the lack of IRF4 expression in
CD8+ T cells selectively modulates the eector program of CD8+ T cells. This in turn,
is likely to be accompanied by additional changes in the gene expression program, which
negatively impacts the protective capacity of those cells.
Because there was a drastically impaired functional characteristics and a transition
into a memory-like phenotype of the few remaining IRF4-decient CD8+ T cells after
Listeria infection detected, this nding expected a reduction in the cytolytic activity
in the absence of IRF4. Ordinarily, after initial antigen encounter, naïve cells rst
need to become activated and clonal expand, while they dierentiate into eector CTLs.
Naïve CD8+ T cells are incapable of immediate of killing infected cells, therefore this
feature need to be acquired. Besides the expression of several eector cytokines, they
additionally acquire very high levels of cytotoxic activity. Several studies have shown
that cytotoxic eector CD8+ T cells kill their target cells by programming them to un-
dergo apoptosis [31]. Therefore, CD8+ T cells can express high levels of FASL (CD95L)
molecules [208]. In target cells, which express the death receptor FAS on their cell sur-
face, the FAS-FASL interaction leads to an activation of a death domain, which in turn
triggers a caspase-dependent apoptosis pathway [248].
In this regard, the determination of the cytotoxic functionality of eector CD8+
T cells was performed (Section 8.5). First, ow cytometric analysis of FASL expression
in CD8+ T cells of IRF4KOCD8 mice on day 5 after Listeria infection was examined. Not
surprisingly, present results observed dierences in the killing ability of CD8+ T cells, as
splenic CD8+ T cells from IRF4KOCD8 mice expressed lower levels of FASL compared
to wild type CD8+ T cells, on day 5 after Listeria infection (Figure 8.10A). Thus, the
induction of the FAS receptor induced apoptosis pathway in target cells was impaired
in IRF4-decient CD8+ T cells.
Despite this receptor binding induced apoptosis, eector CD8+ T cells store cytotoxic
molecules like granzymes and perforin in their lytic granules. These molecules can be
released to induce cell death of infected cells or directly act on cytosolic pathogens [136,
213]. Cytotoxic proteins, like granzymes and perforin, need to cooperate to trigger apop-
tosis in target cells, as released serine proteases cannot enter the membrane. First, per-
forin needs to lyse the target cells by creating pores in the membrane to allow granzymes
to enter the cell to induce fragmentation of cellular DNA. This process results in caspase-
dependent and -independent death pathways. This study therefore additionally analyzed
the expression of granzymB on both eector CD8+ T cell types and observed critically
decreased granzymeB expression in IRF4-decient CD8+ T cells compared to their WT
counterparts (Figure 8.10A).
In addition, recent studies have shown that cytotoxic CD8+ T cells express lysosome-
associated membrane protein CD107a (LAMP-1) [2]. The expression of this molecule
correlates with the cytotoxic cell-mediated lysis of target cells. In CD8+ T cells, CD107a
is used as a marker for cell degranulation and has been proposed to be involved in
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protecting the cellular membrane from attack by lytic enzymes in the granules [56].
Its surface expression is shown to correlate with the cytotoxic cell-mediated lysis of
target cells [2]. Furthermore, it has been shown to be needed to deliver granzymes and
perforin to the target cells [119, 183]. Reduced expression levels of CD107a in CD8+
T cells from IRF4KOCD8 (IRF4ox.E8Icre) mice were observed, which were 5 days prior
analysis intravenously infected with Listeria (Figure 8.10A).
These results indicate that IRF4-decient CD8+ T cells were impaired in their killing
ability of infected target cells via FAS-FASL engagement and granzymB mediated cell
death induction. Both death pathways inuencing the kinetic of the pathogen clearance.
Taken together, these results show that the absence of IRF4 expression in CD8+ T cells
during infection led to profound developmental and functional defects in eector CD8+
T cells. The ability to exert full eector capacity was drastically diminished in the
absence of IRF4 expression in CD8+ T cells (Chapter 8). Moreover, the dramatically
impaired eector cytokine production and declined cytotoxic capacity of IRF4-decient
CD8+ T cells, as well as the drastically reduced numbers of ag-specic CD8+ T cells,
correlated with an increase of the bacterial burden in IRF4KOCD8 mice after Listeria
infection compared to wild type mice (Figure 8.10B).
This is in agreement with previous reports also showing that IRF4 is critical for
bacterial clearance after Listeria monocytogenes infection [188] but also indispensable
for to protective CD8+ T cell response against viral infection, as demonstrated in an
inuenza infection model [262] and LCMV infection model [142]. Taken together, IRF4
is crucial for a protective CD8+ T cell response upon bacterial and viral infection.
13.5 IRF4 aects the trancriptional program of CD8+
T cells
T box transcription factor expressed in T lymphocytes (Tbet) and its counter player
eomesodermin (Eomes) represent a pair of transcription factors, which are crucial for
the determination of the CD8+ T lymphocyte phenotype, cell fate, and function [91].
In this study, results indicated that IRF4-decient CD8+ T cells have defects in their
eector gene expression, as they showed lower amounts of Tbet expression (Section 8.6).
However, dierences in frequencies of Tbet+ cells did not reach statistical signicance,
although a tendency was indicated with reduced Tbet expression in IRF4-decient CD8+
T cells on day 7 after infection. This result suggests that Tbet expression might be less
inuenced by IRF4 than other transcription factors inuencing the eector cell fate.
Nevertheless, the minor reduction of Tbet was already reected in a drastic impairment
of eector function and a severely impaired protective capacity, as well as drastically
reduced KLRG1 expression, measured at the peak of CD8+ T cell response after bac-
terial and viral infection (Section 8.5). These ndings are in agreement with recent
published data showing that Tbet deciency led to profound absence of a proper SLEC
(KLRG1high CD127low) population after infection [96], strongly urge the eector CD8+
T cells toward the MPEC pathway. Moreover, it has been shown that Tbet deciency or
reduced expression levels correlated with T cell dysfunctionality [106]. Thus, these pub-
lished results additionally go in line with the nding that IRF4-decient CD8+ T cells
maintained CD62L expression and failed to express KLRG1, as well as they displayed
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drastic diminished eector functionality (Section 8.5).
Interestingly, the lack of IRF4 expression in CD8+ T cells led to an increased Eomes
expression, which resulted in a downregulation of the cytotoxic programming (Fig-
ure 8.10) and an acquisition of a memory-like phenotype, instead of a terminal eector
cell type. Therefore, these data provide further evidence that IRF4 expression links
TCR activation to molecular and transcritional mechanisms. This is in agreement with
a recent report [162], which had demonstrated that IRF4 suppresses Eomes expression
after TCR signaling via IL2 inducible T cell kinase (ITK) and the mammalien target
of rapamycin (mTor), and thus regulates CD8+ T cell dierentiation after T cell acti-
vation. Furthermore, a recent report has suggested that the upregulation of Eomes in
CD8+ T cells is necessary to promote longevity and homeostatic proliferation of mem-
ory T cells [91]. Taken together, these and the presented data in this study suggest
that IRF4 expression inuences the cell fate of CD8+ T cells. This is consistent with
a previous published report, additionally demonstrating that IRF4 is esssential for the
expression of several transcription factors being important for the eector cell develop-
ment [100], such as Blimp-1, Id2, and RunX [188]. Furthermore, it has been shown
that IRF4 expression represses Bim and cyclin-dependent kinase (CDK) inhibitors to
control survival of eector CD8+ T cells [262]. In addition, IRF4 acts as interaction
partner for several other transcription factors, such as BATF [121], being important for
T cell dierentiation and functional development. Moreover, a recent study has demon-
strated that IRF4, together with its binding partner BATF, bind directly to the Tbet
and Eomes loci in eector CD8+ T cells, indicating a direct regulatory role of these key
transcription factors.
Consitent with recent publications [162, 188], the results shown in this study suggest
that the absence of IRF4 expression enforces a formation of CD8+ T cell MPEC pop-
ulation to the expense of a functional eector CD8+ T cell population. In summary,
IRF4-deciency led to dysfunctional programming of the eector CD8+ T cells subset,
which is reected by dramatic changes in a broad set of distinct pathways, an altered ex-
pression of eector genes, and lineage determining transcription factors, such as Eomes
and Tbet.
13.6 The role of IRF4 in CD8+ T cell memory formation
and eector recall response
After the peak of CD8+ T cell response, when the pathogens have been cleared, the
majority of eector CD8+ T cells undergo contraction to convert into a small but stable
pool of memory cells. Those memory cells are than able, upon antigen reencounter, to
form rapidly a robust and ecient eector population. IRF4-deciency had a drastic im-
pact on the generation of the SLEC compartment (Section 8.3), as it was almost absent
in IRF4 decient CD8+ T cells after primary bacterial and viral infection. Therefore,
the question came up whether IRF4-decient CD8+ T cells, which displayed a MPEC
(CD127+ KLRG1-) and central memory (CD127+ CD62L+) phenotype in the eector
phase (day 7 p.i.), would have a better memory formation. Additionally, the CD8+
T cell response upon secondary infection was determined to analyze the impact of IRF4
expression in the recall response.
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Consistent with the represented observations during primary bacterial infection, which
were made in this study, IRF4-deciency in CD8+ T cells resulted in a more than 4-fold
reduction of the antiviral CD8+ T cell response at the peak of primary LCMV infection
(Section 8.7). This was pointed out by a lower frequency of the GP33-specic CD8+
T cell population, being severely reduced in IRF4KOCD8 mice compared to WT control
mice on day 8 after primary LCMV infection. These data suggest that IRF4 deciency
impacts the eector CD8+ T cell formation independent of the type of infection.
Interestingly, IRF4-deciency in CD8+ T cells had no impact in the memory forma-
tion or T cell homeostasis. Both mice strains, WT and IRF4KOCD8 mice, showed a
similar memory formation on day 60 after primary LCMV infection with no signicant
dierence in the frequencies of LCMV GP33-specic CD8+ T cells on day 60 post in-
fection. However, similar to the here presented observations regarding the frequency of
eector CD8+ T cells during primary infection, the IRF4-decient CD8+ T cell popula-
tion during secondary infection was similar aected by the absence of IRF4 expression.
In detail, IRF4-deciency resulted in a more than 2-fold reduction of the GP33-specic
CD8+ T cells on day 8 after antigen reencounter.
This study (Section 8.1) and also others could show that IRF4 expression is induced
after TCR engagement in a transient manner. The expression of this transcription
factor peaks after induction but than declines in the following days after activation.
Although, IRF4 expression kinetic is dependent on the strength of the activating TCR
signal (Section 8.1), IRF4 expression decreases after some time. This could be an
explanation why IRF4 expression did not impact the T cell homeostasis of memory CD8+
T cells, as it is not expressed during this state of the immune response. But in contrast,
IRF4 deciency did impact the eector and eector recall response. These ndings
suggest that the expression of IRF4 not only contribute to the optimal dierentiation and
functionality of CD8+ T cells in primary infected hosts. Furthermore, it is also critical
for a proper phenotypic and functional maturation of CD8+ T cells upon secondary
antigen encounter.
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IRF4-decient CD8+ T cells have an
increased apoptotic potential
14.1 IRF4 deciency leads to increased susceptibility to
apoptosis
This present study analyzed whether IRF4-decient CD8+ T cells are more susceptible
to death and phagocytosis, as they go earlier into contraction phase than their wild type
counterparts. As it is well known that multiple death pathways driving contraction,
dierent cell-death inducing processes were analyzed.
First, several receptors and molecules being involved in dierent apoptotic pathways
were determined. Apoptotic cell death requires the expression of molecules that posi-
tively regulate several death pathways. This process requires, among others, the expres-
sion of death receptors, such as FAS. FAS expression initiates the FAS-mediated death
pathway due to its binding on its ligand, namly FASL. Additionally, when the signaling
cascade is triggered, it leads to the activation of key death-inducing enzymes, termed
caspases, which in turn lead to protein cleavage and cell death [4]. To determine whether
IRF4-decient CD8+ T cells are eliminated via the FAS-mediated death pathway, the
expression of FAS on day 5 after Listeria infection was examined. Results in this study
have observed that IRF4 deciency in CD8+ T cells led to an upregulation of the FAS
receptor expression, which might be the reason for the initiation of programmed cell
death in these cells.
Recent publications claim that high frequent expression of FAS on T cells occurs
during contraction phase, oering an additional ability to control the proliferation and
perform contraction of the eector CD8+ T cell subset via the FAS-FASL death path-
way [161]. These results are in agreement with the present previous data, where reduced
levels of ag-specic CD8+ T cells and less proliferative capacity already on day 4 after
bacterial infection (Section 10.2) in IRF4KOCD8 mice could be examined. In contrast,
their wild type counterparts kept on proliferation and showed a functional eector phe-
notype.
In sum, IRF4-decient CD8+ T cells expressed signicantly higher levels of the death
mediator FAS on their cell surface, which may result in a higher susceptibility to pro-
grammed cell death, mediated via caspase activation. Consistent with that nding,
Man et al. [142] and Yao et al. [262] published data showing that more IRF4-decient
CD8+ T cells than WT CD8+ T cells expressed the active form of caspase 3, strongly
indicating an activation of the caspase cascade, which have been shown to result in
programmed cell death. The here presented results provide additionally evidence for
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the importance of IRF4 expression to inhibit the expression of the FAS receptor and in
turn surpressing caspase activation. Therefore, this study claim that IRF4 deciency
led to an early onset of contraction phase, as its absence induced programmed cell death
already on day 5 after infection, much earlier than in WT CD8+ T cells, although mice
were infected with Listeria leading to strong TCR signaling.
Further analysis whether IRF4-decient CD8+ T cells expose eat-me signals, such as
phosphatidylserine (PS) to a higher extend than IRF4-sucient CD8+ T cells on their
surface, which facilitate their recognition and uptake by phagocytes, was performed. In
fact, present results detected increased exposure of PS on IRF4-decient CD8+ T cells,
indicated by increased AnnexinV levels. PS is an anionic phospholipid, which is nor-
mally conned to the inner leaet of the plasma membrane of the intact cell [145]. The
loss of the plasma membrane symmetry results in the increased exposure of PS on the
cell surface and thus, leads to the recognition by phagocytes via their membrane recep-
tors, which are involved in the elimination process of early apoptotic cells. This suggest
that IRF4 expression in CD8+ T cells is important to protect eector CD8+ T cells
from phagocytosis mediated by macrophages, monocytes, DCs, and granulocytes.
Second, analysis of the possibility whether IRF4 deciency in CD8+ T cells might
also leads to an activation of the complement system was performed. Its activation has
been shown to contribute to the elimination of eector CD8+ T cells early during clonal
expansion. Ordinarily, cells express surface proteins or recruit complement inhibitors,
which interfere with complement eector functions and delay or even block the comple-
ment cascade. The absence of a single protein might already result in incomplete local
protection. Changes in the expression of several complement regulatory proteins, indi-
cate that those cells are more susceptible to death. The downregulation of protective
molecules and the increase of eat-me signal exposure allow cell death to accur, due to
the initiation of the complement cascade [269].
The deposition of complement mediators, such as C1q, C4, and C3, was determined
to analyze whether IRF4-deciency results in an initiation of the complement cascade
during the clonal expansion phase (day 5 p.i.) of eector CD8+ T cells. Present results
could not detect increased C1q or C4 deposition on IRF4-decient CD8+ T cell surfaces
via ow cytometry analysis on day 5 after Listeria infection. Interestingly, the present
analysis observed an activation of the complement pathway due to an signicantly in-
crease of C3 convertase aviability on IRF4-decient CD8+ T cells.
Furthermore, an increase in the recruitment of phagocytes into infected spleens could
be detected in IRF4KOCD8 mice on day 5 post infection. Macrophages, granulocytes,
DCs, and monocytes were more then 2-fold enriched in infected spleens of IRF4KOCD8
mice compared to WT mice. The reason for this might be the increased display of early
apoptotic markers on the cell surface of IRF4-decient CD8+ T cells due to an early in-
duction of contraction. Furthermore, the induction of the complement pathway, which
was indicated by increased C3 deposition on IRF4-decient CD8+ T cells, promotes
opsonization and phagocytosis. Although, most tissues contain resident phagocytotic
cells, such as macrophages, it is not unusual that a recruitment of additional phago-
cytes ooccurs to the sites where the load of apoptotic cells is high. Those phagocytes
express a large number of membrane-bound receptors which facilitate the recognition
and clearance of cells undergoing apoptosis.
However, there are reports documenting discrepant results for the apoptosis induc-
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tion in IRF4-decient CD8+ T cells, claiming that there is no increased apoptosis in
the absence of IRF4 expression in CD8+ T cells [188]. In contrast, results shown in
this study suggest that IRF4 act as a potent inhibitor of several apoptotic pathways,
protecting eector CD8+ T cells from a premature termination of the expansion phase
and therefore from an early onset of contraction. Of interest, in contrast to the publi-
cation from Raczkowski et al. [188] but in agreement with the results obtained in this
study, recent reports could demonstrate that the absence of IRF4 expression in CD8+
T cells led to enhanced programmed cell death, as evidenced by increased AnnexinV
staining and enhanced percentages of active caspase 3+ CD8+ T cells [142, 262]. Taken
together, IRF4 expression is critical for the survival of eector CD8+ T cells.
In summary, IRF4 deciency in CD8+ T cells resulted in an altered apoptotic state
of eector CD8+ T cells already in the middle of the expansion phase. Results of this
study suggest that enhanced cell death and phagocytosis were the cause for the collapse
during proliferative CD8+ T cell response and the disappearance of the ag-specic CD8+
T cells.
14.2 IRF4-deciency does not enhance the expression of
inhibitory molecules
To investigate the inuence of regulatory molecules and receptors, the expression of
several molecules being associated with impaired T cell function, reduced proliferation,
and diminished eector function were analyzed. The CD8+ T cell compartment in the
spleen of WT and IRF4KOCD8 mice were analyzed 5 days after Listeria infection for their
expression of Tim3, 2B4, PD-1, CTL4 (known as CD152), CD160, and LAG3. No dif-
ference in the expression of any of those markers could be detected in ag-unexperienced
CD8+ T cells comparing IRF4KOCD8 with WT mice. This suggest that IRF4 deciency
does not impact the expression of inhibitory markers on CD8+ T cells in untreated
IRF4KOCD8 mice.
Comparison of the Tim3, 2B4, and LAG3 expression levels revealed an increase in
ag-experienced IRF4-defcient CD8+ T cells and WT CD8+ T cells compared to their
ag-unexperienced control cells. Although, no dierence could be detected between ag-
experienced IRF4-defcient and IRF4-sucient CD8+ T cells for the expression of 2B4
and LAG3 on day 5 after Listeria infection. An overall upregulation of 2B4 (known as
CD244), as detected in ag-experienced WT and IRF4-decient CD8+ T cells, has been
shown to be required for optimal activation and proliferation of T cells upon binding
to its ligand CD48 [104, 214]. Recent publication examine the role of the lymphocyte-
activation gene 3 (LAG3) to negatively regulate T cell expansion and memory cell
formation [256]. Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) is one of the
receptors that profoundly have been shown to inhibit immune activation after binding
to dierent B7 family members [107, 131]. However, WT and IRF4-decient CD8+
T cells showed similar LAG3 and CTLA4 expression levels after infection.
Interestingly, compared to their WT counterparts, a slightly increase was observed in
the expression of Tim3 in ag-experienced IRF4-decient CD8+ T cells. Most published
data regarding TIM3 expression have been shown that TIM3 expression negatively reg-
ulates eector responses and diminishes cytokine secretion or even induces cell death
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through its interaction with Galectin-9 [95, 268]. These ndings go in line with presented
previous ndings in this study, which suggest that IRF4-deciency resulted in impaired
cytotoxicity and cytokine production (Chapter 8), an induction of pro-apoptotic path-
ways, and the initiation of phagocytosis (Section 9.1) already during the clonal expansion
phase on day 5 after bacterial infection.
Recent studies have implicated that CD160 expression led to reduced proliferative
capacity and functional T cell impairment [242]. Programmed death 1 (PD-1, CD279)
molecule has been shown to inhibit T cell activation, the responses to infection, and reg-
ulating T cell exhaustion [10, 42, 109]. Furthermore, other studies claim that PD-1/PD-
L engagement antagonizes TCR signaling, leading to decreased cytokine secretion and
protein synthesis, as well as diminished proliferative capacity [55]. However, analysis
of the expression levels of CD160 and PD-1 could not detected any dierences between
ag-experienced IRF4-decient CD8+ T cells in comparison to their WT counterparts.
Additionally, there was no altered expression of CTLA4 detected on ag-experienced
CD8+ T cells, nor in the absence neither in the presence of IRF4 expression in CD8+
T cells on day 5 after infection.
In summary, IRF4-deciency did not altered the expression of immune-inhibitory
factors, which have been implicated in T cell dysfunction and have been put into the
context of apoptotic processes. Therefore, these results suggest that the drastically
impaired quality and quantity of the eector CD8+ T cell response in the absence
of IRF4 expression was not due to increased expression of inhibitory molecules and
exhaustion markers. In line with the ndings in this study, a previous publication [188]
claimed that reduced numbers of antigen-specic IRF4-decient CD8+ T cells are not
due to increased expression of exhaustion markers.
However, although previous reports showed increased susceptibility to programmed
cell death [142, 262], overexpression of Bcl-2 in the absence of IRF4 could not rescue
the impaired phenotype of IRF4-decient eector CD8+ T cells [142]. This further
supports the hypothesis that the cause of the diminished cell survival and disappearance
of IRF4-decient CD8+ T cells most likely occurs as a consequence of multiple eects,
which alters the proliferative behavior and activates dierent apoptosic pathways, one
complementing another to eciently eliminate those cells.
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IRF4 expression levels dictate the
onset of CD8+ T cell contraction
15.1 IRF4 expression kinetic is TCR strength dependent
This study (Figure 10.1) and also recent publications [142, 162, 262] could show that
IRF4 expression levels are dependent on the TCR signaling strength, whereas high and
low anity peptides are sucient to initial induce IRF4 expression. Here, results showed
that stimulation of OT1 cells with low anity ovalbumin (OVA)-derived peptides (T3,
Y4) induced IRF4 expression, very similar to the high anity peptide N4 (SIINFEKL).
But of interest, after low anity peptide stimulation, IRF4 expression levels declined
successive, while high anity peptide stimulation led to a robust and sustained IRF4
expression over the next following days. Thus, a varying strength of the TCR activation
led to a similar induction of IRF4 expression after 24 hour but in turn resulted in a
dierent kinetic prole of the IRF4 expression.
Consistent with recent published data, results of this study show that IRF4 expres-
sion levels can be directly linked to the strength of the TCR signaling, as interaction
with peptides having a dierent anity lead to dierent maintenance of high IRF4 ex-
pression levels. Strong TCR engagement resulted in a prolonged expression of IRF4
in CD8+ T cells and induced greater and prolonged expansion after activation. These
results strongly indicated that dierences in TCR anity of the CD8+ T cells in the
heterogeneous population of eector T cells lead to varying levels of IRF4, which in
turn might trigger a dierent transcriptional program of the eector CD8+ T cell pop-
ulation, compared to high TCR signaling activation, which induces high and sustained
IRF4 expression levels.
There is an extensive evidence that CD8+ T cells dierentiate and develop into a
robust eector cell subset dependent on the strength of the TCR signal [44, 112], which
critically determines the quality and quantitiy of T cell expansion and functionality.
The concept of TCR signaling shaping the outcome of eector cell population has been
described earlier [264] and has profoundly expanded with the nding that enhanced
IRF4 expression is required for the generation and maintenance of functional eector
CD8+ T cell population. Overall, these ndings let suggest that IRF4 plays a very
important role in translating the TCR signaling strength and therefore might act as key
regulator of eector CD8+ T cell development.
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15.2 Strong TCR signaling and normal environment could
not rescue IRF4-decient CD8+ T cells
Results shown in this study observed that the initial proliferation and maintenance of
IRF4-decient OT1 cells was similar to WT OT1 cells, as the ratio of WT and IRF4-
decient transferred T cells remained equally till day 3 after infection (Section 10.2).
These result supposed, that the initial activation and proliferation was similar after pri-
mary antigen encounter in the beginning of the infection. This data indicates that IRF4
expression is not required for the early activation of CD8+ T cells upon infection. Of
interest, IRF4-decient CD8+ T cells, although they initially increased in cell numbers
relative to that of wild type cells, were not able to further increase or maintain their
proliferative capacity and eector functionality from day 3 on after LM-OVA infection
(Figure 10.2). As shown in this study, further survival and proliferation of eector CD8+
T cells from day 3 on after infection was critically depend on IRF4 expression. This re-
sulted in a nearly disappearance of this cell subset on day 7 after infection. Therefore,
IRF4 is crutial for eector CD8+ T cells to maintain and further proliferate after acti-
vation. Additionally, these results demonstrate that IRF4-decient CD8+ T cells suer
from a cell intrinsic defect, which could not be revoked by a wild type environment. This
is in agreement with recent published data [188] showing that the proliferative defect
could not be rescued, as IRF4 is crucial for the dierentiation of CD8+ T cells into a
terminal eector cell population.
However, the reduction of ag-specic CD8+ T cells was not due to a dierent homing
behavior leading to altered tissue distribution, as present analysis observed similarly
very low levels in spleen and all other organs tested (Figure 7.3). The proportion of
ag-specic CD8+ T cells in spleen of IRF4-decient and sucient OT1 cells became
signicantly dierent during the cause of infection, suggesting that the levels of prolif-
eration or/and the survival capacity of ag-specic cells were not equivalent in both cell
subsets. This was further indicated by the reduced BrdU incorporation in IRF4-decient
CD8+ T cells compared to their WT counterparts between day 5 and day 8 after LCMV
infection (Figure 8.4). Moreover, also an day 7 after Listeria infection, IRF4-decient
CD8+ T cells showed less Ki-67 expression (Figure 8.3), indicating less proliferative
capacity at this state of infection.
In conclusion, these results demonstrate that IRF4 is crucial for maintained prolifer-
ation, sustained eector dierentiation, and normal T cell homeostasis of eector cells
during the expansion phase after primary response to infection. Neither strong TCR
engagement nor the environment of a wild type mouse could prevent the disappearance
of IRF4-decient eector CD8+ T cells, pointing out drastic intrinsic defects of IRF4-
decient ag-specic CD8+ T cells. Thus, optimal sustained expansion and continued
proliferation, both critically required IRF4.
15.3 IRF4 deciency mimics weak TCR signaling activation
Notably, the anity and strength of the TCR engagement critically inuences the phe-
notype and functionality of CD8+ T cells, with strong TCR stimulation favoring eector
cell dierentiation at the expense of memory CD8+ T cell dierentiation. Additionally,
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it has been published that although weak TCR engagement results in initial activation
and proliferation of low anity T cells, only strong TCR ligation led to a sustained
T cell expansion and a highly functional cytotoxic eector cell population [264]. Thus,
weak TCR engagement results in a premature termination of the clonal expansion and
an early onset of contraction as a result of clonal competition. IRF4 expression is upreg-
ulated after peptide-MHC-TCR ligation. Furthermore, the kinetic of its expression level
is dependent on the activating TCR signaling strength, as high anity peptides leading
to strong TCR engagement resulting in a sustained IRF4 expression. Thus, IRF4 trans-
lates the TCR signaling strength of the activating signal and transmits it into a proper
dierential program.
In this study, results have shown that IRF4 deciency, independent of the strength of
the TCR engagement, led to an impaired eector CD8+ T cell response, in respect to
frequencies of ag-specic cells (Section 8.2), their ability to produce eector cytokines
and cytotoxic molecules (Section 8.5), as well as to an altered dierentiation pattern
(Section 8.3). Although, weak and strong TCR signaling were sucient to induce initial
activation and proliferation, IRF4 deciency led to the absence of a sustained T cell
expansion and disappearance of the highly functional eector cell population. Therefore
this study hypothesized that IRF4 deciency mimics low TCR signaling and thus leads
to a false translation of the strong TCR signaling, which actually induced the activation
of the naïve CD8+ T cell. This in turn leads to an initiation of a developmental program
triggering a T cell fate, which is similar to low anity activated CD8+ T cells.
To elucidate a potential role for IRF4 in CD8+ T cell antigen-driven dierentiation,
proliferation, and its impact on the termination of the expansion phase, dependent on
the strength of the TCR engagement, a TCR transgenic system was used. Naïve wild
type OT1 and IRF4-decient OT1 TCR transgenic CD8+ T cells were adoptively co-
transferred into CD45.1 wild type recipient mice. One day later, recipient mice were
i.v. infected with a recombinant Listeria monocytogenes strain expressing OVA protein,
either containing the low anity epitope SIITFEKL (T4) or the high anity epitope
SIINFEKL (N4). The ratio and total numbers of transferred WT and IRF4-decient
OT1 cells from spleen of infected recipient mice were determined. Further analysis of
the exposure of PS on the cell surface, and the expression of Bcl-2 and FAS on each
OT1 cell population was performed.
Present results could show that on day 5 after LM-OVAN4 infection, IRF4-sucient
CD8+ T cells formed a robust eector cell population after strong N4-MHC-TCR liga-
tion (Figure 10.3). This goes in line with high anity CD8+ T cells being selectively
expanded during infections, indicating their importance in anti-pathogenic immune re-
sponses [264, 265]. Of interest, IRF4-decient CD8+ T cells could not proper trans-
late the strong N4-MHC-TCR interaction into an appropriate dierentiation program,
which leads normally to an enhanced proliferation and cytotoxic eector T cell forma-
tion. Instead, the lack of IRF4 expression upon T4-MCH-TCR activation mimicked an
activation via a weak TCR signal, which favors ordinarily memory cell formation and
the onset of contraction. Therefore, the signals which were transmitted in the absence
of IRF4 were much weaker than those in WT OT1 cells.
Interestingly, IRF4-decient OT1 and WT OT1 CD8+ T cells displayed the same
proliferative capacity after weak T4-MHC-TCR ligation, as their proportion sustained
equal as originally transferred (Figure 10.3). Moreover, it has been shown in this study
132
15.3 IRF4 deciency mimics weak TCR signaling activation
that under these conditions, WT and IRF4-decient OT1 cells showed a similarly in-
creased susceptibility to death and phagocytosis (Section 9.1). In this regard, CD8+
T cells cannot evade apoptotic pathways, if an engagement of death receptors or cy-
tokine derivation or inhibition of cytokine signaling occurs [43, 118, 144]. These results
are in agreement with previous published data [262] showing that consistent with their
IRF4 expression, WT CD8+ T cells stimulated with weak TCR activation signals show
enhanced cell death and diminished cell proliferation capacity after activation. Further-
more, present results in this study expand previous knowledge and conrm that low
anity activated CD8+ T cells and IRF4-decient CD8+ T cells limited their own ex-
pansion via ligation of cell surface molecules and the exposure of pro-apoptotic molecules
(Section 10.3). Both cell subsets exposed high levels of PS on their surface (Figure 10.3),
which promote the clearance of the target cell, as it facilitates recognition by engulfment
receptors on the surface of phagocytes [72]. Furthermore, both CD8+ T cell subsets
expressed high levels of the death receptor FAS (Figure 10.3), eciently implement the
FAS-mediated activation-induced cell death (AICD) [99]. This observation revealed that
both cell types suer similar from AICD at an early state of infection, which might be
one mechanism of the premature termination of the immune resonse of low anity T cell
clones.
Moreover, after weak TCR activation, both CD8+ T cell subsets showed a decrease
in their Bcl-2 expression compared to WT CD8+ T cells, which were activated via LM-
OVAN4. It has been shown that a reduction in the Bcl-2 expression leads to reduced
CD8+ T cell responses and less protection of the activated cell against death [6].
In this regard, IRF4-deciency mimicking low TCR engagement, or true weak pep-
tide-MHC-TCR ligation by itself, resulted in a premature termination of clonal expan-
sion and an early onset of contraction, due to the activation of several death inducing
pathways. IRF4-decient CD8+ T cells represented a terminally dierentiated popu-
lation, which was destined for clearance by apoptosis indicating that less functional
subpopulations of T cells being selectively depleted from the system.
In summary, the absence of IRF4, which mimicked weak TCR stimulation, although
a strong TCR engagement has occurred, led to an initially activation and expansion but
resulted in a hasted termination of the expansion and an inaccurate dierentiation of
CD8+ T cells with defective eector function. IRF4 is a key regulator of CD8+ T cell
fate choices and its expression levels are related to a particular transcriptional program,
dictating the activation and dierentiation status of the T cells and determines the
fate choice. Thus, these observations imply that IRF4 decient CD8+ T cells were not
capable of translating strong TCR signal activation into a proper intrinsic molecular
program and that the rate of T cell apoptosis in IRF4-decient CD8+ T cells occurred
concurrently during the phase of clonal expansion, even after strong TCR engagement.
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The inuence of cytokines on in vivo
primed IRF4-decient CD8+ T cells
16.1 The inuence of interleukins on IRF4-decient
CD8+ T cells
Present results of this study showed that IRF4 deciency led to drastically diminished ex-
pansion and to reduced viability of eector CD8+ T cells, starting around day 4 after pri-
mary bacteria encounter. As IRF4-decient CD8+ T cells could not be rescued in vivo,
neither via strong TCR signal activation nor due to a normal environment (Section 10.2),
the question raised whether ex vivo cytokine supply could support IRF4-decient CD8+
T cells to overcome their proliferation problems and the increased susceptibility to cell
death.
Several recent publications pointed out the important inuence of soluble factors
like cytokines, acting in an autocrine and paracrine manner on T cell proliferation,
dierentation, and homeostasis [7, 97, 203, 221]. Furthermore, recent studies indicate
an inuence of several cytokines like IL2 on distinct transcriptional programs [184].
Therefore, the impact of cytokine treatment, such as IL2, IL7, IL12, and IL15 on the
proliferative behavior in ex vivo cultures of in vivo primed WT and IRF4-decient CD8+
T cells after infection were analyzed.
Therefore, re-isolated OT1 cells (experimental setup as illustrated in Figure 10.2)
were labeled with ProliferationDyeV450 to quantify the number of cell divisions, prior
starting the culture. On day 3 of culture, independent of the cytokine which was supple-
mented, almost in all conditions WT OT1 cells proliferated much better than IRF4-
decient OT1 cells with the exception of IL15 treatment. Furthermore, similar to
WT OT1 cells, IRF4-decient OT1 cells showed the highest division rate when the
medium was supplemented with IL2 and the lowest proliferation capacity with IL12
supply. Present results provide the evidence that extrinsic provision of IL2 impacts the
proliferation of in vivo primed IRF4-decient OT1 cells. This result is contrary to a
recent published study claiming that IL2 administration has no impact on the survival
and proliferative capacity of IRF4-decient CD8+ T cells [188]. Therefore, although
the cytokine milieu inuences the proliferative potential and transcription factor pro-
le of CD8+ T cells, the intrinsic defects of IRF4-decient CD8+ T cells could not be
completely overcome.
In contrast, in agreement with previous studies, claiming that even during contraction
phase IL2 supply can increase the survival of eector CD8+ T cells [16], this study
could show that high IL2 supply protected the majority of the IRF4-decient in vivo
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primed T cells from cell death (Figure 11.2). Moreover, an interesting observation
was that ex vivo administration of high IL2 concentrations could partially restore the
proliferation and could rescue the majority (up to 70%) of IRF4-decient T cells from
cell death, although not to the same extend like in WT T cells (up to 90%). Furthermore,
the addition of IL2 into the culture of in vivo primed IRF4-decient CD8+ T cells
antagonized T cell contraction, as it promoted proliferation, albeit not to a full rescue.
This goes in line with recent published data demonstrating that the expression of the pro-
survival molecule Bcl-2 is induced via IL2 signaling [239]. This suggest that treatment
with recombinant IL2 increases the survival of ag-specifc IRF4-decient CD8+ T cells
during the premature contraction phase. These ndings suggest that the fate to undergo
apoptosis is not fully imprinted during T cell priming, as IL2 signals achieved from the
environment could partially rescue the IRF4-decient in vivo primed CD8+ T cells due
to improvement of their proliferation capacity. Results in this study could show rescue
of IRF4-decient ag-specic CD8+ T cells with high amounts of IL2 (although just
partially) whether other studies claim no rescue could be detected via high addition
of IL2 [188]. This discrepancy could arise from dierential priming conditions of CD8+
T cells between CD8+ T cells which were primed in vitro with aCD3/aCD28 and invitro
primed T cells in response to infection.
IL2 signaling via its receptor IL-2Rβ (CD122) has been shown to be crucial for the
generation of eector cells [253]. Analysis of the CD122 expression on GP33-specic
CD8+ T cells in WT and IRF4KOCD8 mice observed a signicantly reduced expression
in the absence of IRF4 (Figure 11.3). This suggests that IL2 signaling is diminished due
to a drastic reduction of the IL2 receptor expression on the cell surface of ag-specic
CD8+ T cells in the absence of IRF4. This nding might be a reason why IRF4-decient
CD8+ T cells can just partially be rescued by addition of high amounts of IL2, as its
inuence is limited by its receptor expression on the cell surface of the T cells.
16.2 IL2 treatment during in vitro priming could not rescue
the IRF4-decient phenotype after infection
Cytokines, such as IL2, have been shown to inuence the generation of CD8+ T cells
[253]. IL2 is a very potent cytokine, which promotes eects on lymphocyte cell survival
and proliferation. Present results in this study demonstrated that IRF4-decient CD8+
T cells could ex vivo partially rescued via addition of high amounts of IL2. Therefore,
the question raised whether the IRF4-defcient phenotype of CD8+ T cells, which was
detected early during immune response during the premature clonal expansion phase,
could be altered or even rescued due to a priming of these cells in the presents of high
IL2 amounts.
Adoptive transfer experiments of in vitro primed OT1 cells were performed, as illus-
trated in Figure 11.4. First, the proliferation rate (Figure 11.5) was examined 4 days
after in vitro culture. WT and IRF4-decient OT1 cells showed a high poliferative ca-
pacity under high IL2 supplementation (50U). The proliferation of both cell subsets was
highly IL2-concentration dependend, as high amounts of IL2 increased the proliferative
capacity and low IL2 concentration led to diminished expansion. This impaired pro-
liferation capacity was drastic in IRF4-defcient CD8+ T cells, which proliferated very
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poorly under this condition.
Both congenically marked OT1 cell populations, which were primed with the same
amount of IL2 were equally mixed (Figure 11.6) and adoptively transferred into WT
(CD45.1) mice. Recipient mice were infected and on day 5, the proportion of WT and
IRF4-decient OT1 cells were found drastical dierent (Figure 11.7). WT OT1 cells
formed a proper eector generation, which was detected in spleen, lymph nodes, blood,
and liver of infected recipient mice. Substantially smaller proportions of IRF4-decient
OT1 cells compared to WT proportions were found in all organs tested. This trend was
observed for all IL2 priming conditions and suggests that the addition of high amounts
of IL2 during the priming phase has no impact on the proliferative capacity, the survival,
and eector T cell fate of in vivo challenged ag-specic IRF4-decient CD8+ T cells.
Although, IRF4-decient OT1 cells, which were primed with high IL2 amounts, showed
initially similar proliferation rates compared to their WT counterparts, the defect in the
ability of IRF4-decient CD8+ T cells to expand was drastically diminished in the fol-
lowing in vivo conditions (Figure 11.7). The priming of IRF4-decient CD8+ T cells in
the presence of high amounts of IL2 initially increased the proliferative capacity during
in vitro culture but cells could not sustained their proliferation and survival capacity,
as the initial transfer ratio from 1:1 could not be maintained. Analysis of the dierenti-
ation pattern of both cell proportions in spleen of infected WT recipient mice observed
maintained CD62L expression on CD8+ T cells in the absence of IRF4, while WT CD8+
T cells cleared the molecule from their surface (Figure 11.8). Ordinary, the CD62L ex-
pression is down regulated after activation, as this is required for a proper migration of
T cells to the sites of inammation and infection. However, CD62Lhigh IRF4-decient
CD8+ T cells were found in all organs tested, although proportions were very small,
compared to their WT counterparts.
Overall, these results indicate that addition of high amounts of IL2 can not rescue
ag-specic CD8+ T cells in the absence of IRF4, when it is administered during the
priming phase. In contrast, ndings in this study showed that addition of IL2 during
the clonal expansion phase could improve the proliferative capacity and survival of ag-
specic IRF4-decient CD8+ T cells. This suggest that dierrences in the eect of IL2
treatment arise from dierences in the time points of IL2 administration. Based on the
results of this study, it seems that IL2 is not so important during the clonal expansion
phase of ag-specic IRF4-decient CD8+ T cells but showed an impact on the survival
and proliferation rate during early immune response upon infection. It might be, that an
administration of IL2 in infected IRF4KOCD8mice during the clonal expansion phase,
lead to an increased survival, proliferation and increased eector response of IRF4-




The transcription factor IRF4 is critically required for several cell types of the immune
system, such as B cells and several T lymphocyte subsets [21, 87, 138, 153, 215, 230].
During the cause of this study, a wealth of data have been additional subsequently
published in the last 2 years [86, 142, 162, 163, 166, 188, 262], indicating an extreme
important role of IRF4 for a proper CD8+ T cell expansion, eector cell development,
functionality, protective capacity, and energy metabolism. Nonetheless, it still has re-
mained unclear how IRF4 impacts the fate decision and continuance of eector CD8+
T cells. In this study, to examine in detail the impact of IRF4 on the expansion and
initiation of T cell contraction, a mouse model was used where the IRF4 gene is exclu-
sively excised in mature peripheral CD8+ T cells (IRF4ox.E8Icre mice) and murine
listeriosis was mainly used as an infection system.
In line with recent published data, also this study could show that IRF4 decient
CD8+ T cells fail to mount a protective T cell response upon bacterial and viral in-
fection, as IRF4 deciency strongly impaired the eector cytokine production, cyto-
toxic functionality, led to an altered dierentiation pattern, and a drastic reduction of
ag-specic CD8+ T cells. This drastically diminished protective CD8+ T cell response
could be observed upon bacterial and viral infection, nally not only due to dramat-
ically diminished numbers and frequencies of pathogen-specic eector CD8+ T cells.
Of note, remaining IRF4-decient CD8+ T cells exhibited a memory-like phenotype
compared with WT T cells. CD8+ T cells from IRF4KOCD8 mice showed a CD44+
CD62L+ KLRG1- CD127+ expression pattern, indicating a loss of short-lived eec-
tor cell formation during CD8+ T cell response against invading pathogens. Although,
IRF4 expression was not required for initial activation and expansion of ag-specic CD8+
T cells, it was essential for a sustained clonal expansion and for a proper and maintained
formation of a protective eector cell population. Therefore, IRF4 expression can be
directly put in relationship with the magnitude and quality of eector CD8+ T cell
responses, being essential for their development and critical for their cytotoxic function.
In summary, in the absence of IRF4, distinct functional properties and transcriptional
changes were assigned compared to WT CD8+ T cells, with respect to cytokine and
cytotoxic molecule secretion, proliferative potential and transcription factor expression,
as well as metabolic alterations.
The naïve T cell repertoire is diverse and this heterogeneous population contains
137
T cells that can respond to a foreign antigen with a broad range of low and high ani-
ties. There is a strong evidence that the TCR signaling strength determines the nature
of the CD8+ T cell response and the T cell fate. The quality and kinetic of the CD8+
T cell response is fundamentally depended on the overall strength, including anity and
duration, of the peptide-MHC-TCR ligation. Although, weak and strong TCR signaling
are sucient to induce initial activation and proliferation, only strong TCR engagement
is sucient for a prolonged expansion and formation of a terminal eector cell popu-
lation [264]. Strong or high TCR stimulation aects the metabolic programming, as
extensive proliferation during the clonal expansion phase requires high energy supply,
which can be optimal obtained via high glycolytic activity. Weak TCR signals diminish
the magnitude of clonal expansion and accelerate the onset of contraction, as they favor
the development of memory cells at the expense of eector cells. The depletion of low
anity T cells at the early stage of infection may occur to allow for maximal expan-
sion of high anity clones, which supposed to be the best responders and therefore
mainly participate in the control of infection. Moreover, high anity TCR stimulation
rescues eector cells from early apoptosis by strong antigenic stimulation and further
activate to proliferate and dierentiate into high functional eector T cells, which mount
a protective immune response.
The transcription factor IRF4 is upregulated after TCR engagement. Its expression
level and kinetic is strongly dependent on the strength of the TCR activation signal,
as strong signaling led to high and sustained IRF4 expression. In turn, graded IRF4
expression levels translate variations in the strength of the TCR signaling into an ap-
propriate transcriptional and dierential program. Thus, these results strongly indicate
that IRF4 act as a key player, determining the fate of activated CD8+ T cells by inu-
encing the kinetic of clonal expansion and dening the onset of contraction, as result
of clonal competition. Therefore the question raised, based on the fact that graded
levels of IRF4 directly translate the strength of the TCR ligand interaction, whether
the absence of IRF4 mimics weak peptide-MHC-TCR interaction, even when a strong
activation with a high anity peptide took place. Finally, resulting in a premature
termination of clonal expansion and on early onset of contraction.
Indeed, this study further expand the understanding of the role of IRF4 in TCR an-
ity dependent regulation of clonal expansion and CD8+ T cell contraction. The present
results give evidence that the absence of IRF4 expression in CD8+ T cells altered the
apoptotic state of eector CD8+ T cells early during primary infection. A hasted ter-
mination and premature contraction was initiated by the FAS-mediated death pathway.
Furthermore, present analysis demonstrated that IRF4-decient CD8+ T cells exposed
molecules on their cell surface, which facilitate their recognition and uptake by phago-
cytes. Of note, an increase in the recruitment of phagocytes could be detected in the
spleen of mice with IRF4-decient CD8+ T cells early during primary infection, which
might led to an increased recognition, uptake, and clearance of IRF4-decient CD8+
T cells, which are prone to undergo cell death already early after initiation of the protec-
tive immune response, as the absence of IRF4 initiates a premature contraction phase.
Moreover, present protein analysis revealed an increase of molecules correlating with
complement activation and the promotion of complement component binding. Addition-
ally, a decrease in the expression of the anti-apoptotic molecule Bcl-2 could be examined
in CD8+ T cells when IRF4 expression was absent or WT CD8+ T cells were activated
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via weak TCR signal. The frequency of dying CD8+ T cells in the absence of IRF4 were
similar in the second lymphoid organ spleen, as well as in infected liver tissue analyzed
from IRF4KOCD8 mice. Data strongly indicate that this early contraction of IRF4-
decient CD8+ T cells is a systemic process. The increased susceptibility to death and
phagocytosis, initiated due to the premature contraction phase of IRF4-decient CD8+
T cells, correlated with their progressive loss of function, their altered dierentiation
pattern, and examined changes in their energy metabolism.
Taken together, due to the lack of IRF4 expression in CD8+ T cells, independent
of the TCR signaling strength, IRF4-decient eector CD8+ T cells were unable to
mount productive eector cell response, although they were activated via a strong TCR
engagement, which leads ordinarily to a robust and protective eector CD8+ T cell
response. Instead, present results extent previous published data, by demonstrating that
IRF4-decient CD8+ T cells fated to die already early upon bacterial or viral infection,
independent of the activating TCR signaling strength. Their premature contraction
was mediated via several pathways resulting in apoptosis or phagocytosis. The results
in this study further support the hypothesis that the cause of diminished cell survival
and the almost complete disappearance of IRF4-decient CD8+ T cells occurred most
likely as a consequence of multiple eects, which altered the proliferative capacity and
activated dierent death inducing pathways, one complementing another to eciently
eliminate those cells.
Thus, strong TCR ligand activation does not result in the initiation of the appropri-
ate transcriptional dierentiation program in the absence of IRF4. This result provides
new evidence that IRF4 deciency mimics weak peptide-MHC-TCR interaction, result-
ing in a premature termination of clonal expansion and an early onset of contraction.
In sum, these results demonstrate that IRF4 is essential to promote a heterogeneous
eector CD8+ T cell population. As this transcription factor promotes the competition
between high and low anity T cell clones, favoring the expansion of high-anity T cell
clones by inuencing the transcriptional and metabolic program to maintain survival,
functionality, and proliferation. Of interest, WT CD8+ T cells displayed after weak
anity TCR activation, consistent with their tailed IRF4 expression after weak TCR
engagement, the same diminished proliferative capacity, as IRF4-decient CD8+ T cells.
Furthermore, weak TCR activation of WT CD8+ T cells with low anity peptides re-
sulted in an increased susceptibility to death and phagocytosis, very similar to the fate
of IRF4-decient CD8+ T cells.
In summary, these observations are well in line with previous published data and
further support the presumption that graded IRF4 expression levels translate the variety
in TCR signaling activation and initiates the transmission into a proper dierentiation
program. Results of this study reveal a previously unappreciated role of IRF4 for the
kinetic of the CD8+ T cell response upon infection in eector CD8+ T cells. IRF4 is
essential in CD8+ T cell responses, as its expression leads to an inhibition of the FAS-
mediated death pathway, decreased exposure of eat me signals on the cell surface, and
blocks complement activation and pro-inammatory signaling, all processes leading to
programmed cell death or elimination of these cells by phagocytes. Nevertheless, defects
in the clonal expansion and the premature contraction are the consequence of multiple
eects, including metabolic and transcriptional chances, altered proliferation behavior,
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